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Abstract 
This thesis presents the development and application of several computational tech- 
niques to aid in the design and analysis of small molecules and peptides that bind 
to protein targets. First, an inverse small-molecule design algorithm is presented 
that can explore the space of ligands compatible with binding to a target protein 
using fast combinatorial search methods. The inverse design method was applied to 
design inhibitors of HIV-1 protease that should be less likely to induce resistance 
mutations because they fit inside a consensus substrate envelope. Fifteen designed 
inhibitors were chemically synthesized, and four of the tightest binding compounds 
to the wild-type protease exhibited broad specificity against a panel of drug resis- 
t ance mutant proteases in experiment a1 tests. Inverse protein design methods and 
charge optimization were also applied to improve the binding affinity of a substrate 
peptide for an inactivated mutant of HIV-1 protease, in an effort to learn more about 
the thermodynamics and mechanisms of peptide binding. A single mutant peptide 
calculated to have improved binding electrostatics exhibited greater than 10-fold im- 
proved affinity experimentally. The second half of this thesis presents an accurate 
method for evaluating the electrostatic component of solvation and binding in molec- 
ular systems, based on curved boundary-element method solutions of the linearized 
Poisson-Boltzmann equation. Using the presented FFTSVD matrix compression al- 
gorit hm and other techniques, a full linearized Poisson-Boltzmann equation solver 
is described that is capable of solving multi-region problems in molecular continuum 
electrostatics to high precision. 
Thesis Supervisor: Bruce Tidor 
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Chapter 1 
General Introduction 
Automated design of small molecules and peptides that bind tightly and specifically 
to protein targets remains a formidable challenge in computational biochemistry. Two 
primary challenges must be overcome to develop such an algorithm. First, the space of 
molecular diversity, conformation, and orientation that must be searched to identify 
tight binders is extremely prohibitive. For example, consider the space of short de- 
cameric peptides containing natural amino acids, for which there are 201° sequences. 
All reasonable conformations of these peptides would need to be tested against all 
reasonable conformat ions of the protein target in all possible orient at ions within a 
potential binding site in order to identify those with desired properties. When design- 
ing small molecules, the space of molecular diversity is almost limitless, bounded only 
by organic chemistry. Consequently, almost all molecular design algorithms employ 
techniques to search this space highly approximately, in an attempt to focus in on 
regions of the space likely to be enriched in geometries compatible with tight binding. 
Even if searching such a space was possible, there would still be a challenge in 
correctly determining which members of the space, if any, suggest that the designed 
small molecule or peptide is indeed going to bind the target tightly. Current molecular 
design algorithms handle this through the use of a scoring function, which takes as 
input the geometry of the ligand-protein complex and outputs a numerical score 
indicating the likelihood that this structure predicts tight binding. Due to the massive 
search space that must be evaluated, scoring functions need to be very fast, and 
are consequently highly approximate. Often, these scoring functions are based on 
phenomenology instead of physical models, and even the energetic models themselves 
are computed inexactly. 
This thesis presents the development and application of several computational 
techniques that attempt to address some of these challenges in molecular design. The 
first method, known as inverse design, can reformulate the molecular design problem 
in a way that reduces the size of the search space while still retaining the ability 
to design tight-binding molecules. Inverse design methods originated in the field of 
airplane wing design in the 1950s, and were viewed as an alternative to traditional 
engineering design approaches. In traditional forward design, a prototype is initially 
built using guidelines and tested to determine whether or not it meets a set of design 
specifications. If not, the object being designed is modified in a way more likely to 
yield better results, and it is tested again against the specifications. This process is 
iterated until the design is successful. 
In the realm of protein design, the forward approach would most closely corre- 
spond to starting with a polypeptide sequence, solving the protein-folding problem, 
and testing to see if the folded protein has the desired structure or function. If not, 
mutations would be made to the sequence and the process repeated. Obviously, this 
approach is intractable considering the difficulty of the protein-folding problem [I, 21. 
For small molecule design, forward design methods correspond to taking a molecule 
and using docking calculations [3-61 to determine its best position inside the binding 
site and using scoring functions to determine the likelihood of tight binding. If the 
score is low, then a different small molecule would be selected, docked, and evalu- 
ated for fitness. Although this %irtual screening" met hod seems computationally 
inefficient, it is one of the most commonly used techniques for computational drug 
discovery [5,7,8]. 
In contrast, inverse design methods begin with the set of specifications, and try to 
directly solve for designs that meet these goals. Inverse methods were first proposed 
for the design of proteins by Drexler [9] and Pabo [lo] in the early 1980's. If the goal 
of a protein design effort is to design a protein with a particular structure, inverse 
methods begin with a fixed model for the protein backbone. Given this backbone, 
the only design problem remaining is to search over the space of amino acid side- 
chain identities and conformations to determine those that stabilize the fold. It 
turns out that the search over side chains, independent of backbone flexibility, is 
an approachable problem, unlike the protein-folding problem that allows all degrees 
of freedom to vary simultaneously. Given certain assumptions about the scoring 
function used to determine side-chain fitness, and given a discretization of side-chain 
geometries into rotamers, fast combinatorial search algorithms have been developed 
to solve the side-chain placement problem [ll-141. The hallmark of inverse design 
methods is that they take certain specifications as constraints or restraints, leaving 
behind a tractable search problem in a dramatically reduced space. 
Although inverse design methods have been extensively applied to design proteins 
with higher st ability [12,15], novel structures [16,17], and alternative binding inter- 
faces [18-211, they have not been extensively applied to the small-molecule design 
problem in drug discovery. Chapter 2 of this thesis presents one possible implementa- 
tion of an inverse strategy for small-molecule ligand design. Using the structure of a 
protein target, and knowledge of a binding site for ligands, we solve an inverse shape 
problem and an inverse electrostatics problem to determine the "optimal" theoretical 
ligand that would have the best binding properties given our computational models. 
These optimal shape and electrostatic features serve the same role as the fixed protein 
backbone in inverse protein design. The remaining search problem is to identify real 
molecules that reproduce the properties of the "optimal" theoretical ligand. 
The inverse shape problem, given the computational models presented in this the- 
sis, is relatively. straightforward. Two components of the energetic models used here 
are only functions of the ligand geometry. These include the van der Waals contri- 
butions to the binding energy, and the non-polar contribution to the solvation free 
energy, which is often referred to as the hydrophobic effect. In the models used here, 
the van der Waals binding energy gets more favorable as ligand atoms are packed 
into the binding site such that they make close contacts with the receptor. Conse- 
quently, the more of the binding site that the ligand occupies, the more opportunities 
it has to make favorable van der Waals packing interactions. Similarly, the non-polar 
solvation contribution is modeled as being directly proportional to the surface area 
buried upon binding [22], meaning that the more of the binding site the ligand fills, 
the more favorable the binding energy is predicted to be. Therefore, given these en- 
ergetic models, the optimal ligand shape would be a negative image of the binding 
site, as this shape maximally fills the site. 
The inverse electrostatic problem, however, is significantly more challenging. The 
goal of the inverse electrostatic problem is to determine the charge distribution that a 
ligand should have to minimize the electrostatic component of its binding free energy. 
If biological systems occurred in vacuum, the solution to the inverse electrostatics 
problem would be trivial, as the binding energy of the ligand could be increased 
without bound by assigning it larger and larger charge with an opposite sign to the 
receptor's. However, the presence of an aqueous environment disfavors large ligand 
charges, as ligands must pay a desolvation penalty before binding. This cost has been 
shown to eventually exceed the benefit obtained from increased direct electrostatic 
interaction with the target protein [23,24], leading to the presence of a charge op- 
timum. Previous work has solved the inverse electrostatics problem in the context 
of a mixed discrete-continuum electrostatics model, where solute molecules and sol- 
vent are represented by homogeneous regions of low and high dielectric, respectively. 
Point charges within the low dielectric region represent the partial atomic charges of 
atoms, and a Debye-Hiickel treatment is used to represent ionic strength in the sol- 
vent region. The classical electrostatic properties of this system are governed by the 
Poisson-Boltzmann equation [25-291, and the use of its linearized form permits the 
ligand charges that optimize the binding free energy to be obtained using a matrix 
equation derived from its solution in the bound and unbound state [23,24,30,31]. 
The optimal charge distribution within the optimal shape can be obtained on a cubic 
lattice, which is sufficient to approximate optimal electrostatic properties. 
Given the optimal shape and electrostatic properties of an ideal ligand, how can 
the essentially unlimited space of real small molecules be effectively searched to iden- 
tify those most similar to these properties? Two techniques were considered to solve 
this problem. In the first method, the optimal shape and charge distribution were 
considered as hard constraints, and computer vision algorithms, such as object-based 
model recognition [32] or geometric hashing [33,34], were used to identify molecules 
that looked like portions of the ideal ligand from a set of generated compounds. These 
compounds could then be combinatorially extended with various functional groups 
in an attempt to sequentially match more of the ideal target. However, obtaining 
consistent results with this method was difficult, most likely due to the fact that the 
optimal shape and charge distribution had little similarity to real molecules. 
Chapter 2 of this thesis presents an alternative method that met with more success. 
Rather than treat the shape and charge distribution as hard constraints, molecules 
being designed were directly tested for near-optimality by scoring the compounds in 
the objective functions used to determine the optimal shape and charge distributions. 
This scoring function was designed to have a similar functional form to those used 
in the side-chain placement problem in inverse protein design, allowing all of the fast 
combinatorial search algorithms developed in that field to be applied here. Molecular 
diversity was approximated by using a scaffold and functional group scheme, where 
the space of discrete functional group attachments was combinatorially searched for 
many discrete positions of the scaffold inside the binding site. Because it was rare that 
the shape of designed compounds exactly matched the optimal ligand shape, meth- 
ods were developed to re-score compounds using the real molecular shape such that 
guarantees provided by the combinatorial search techniques were nearly maintained. 
Overall, these features allowed the development of a full small-molecule design tech- 
nique, applicable to solving problems in de novo ligand design as well as the ability 
to evaluate combinatorial libraries in their fitness for a binding site. 
Chapter 3 of this thesis presents an application of the inverse design method 
to solving a real biological problem, which is the design of novel inhibitors that 
are less likely to induce drug resistance mutations. Drug resistance is a growing 
problem in the treatment of rapidly evolving pathogens [35-421, and drug development 
strategies need to be developed to minimize its occurrence. One such strategy, which 
is most applicable to cases where the drug target is highly mutable and an essential 
enzyme for the pathogen, is to create inhibitors that mimic the interactions that 
substrates make with the binding site. This idea, termed the "substrate envelope 
hypothesis" states that if an inhibitor stays within the consensus volume of substrates, 
resistance mutations that would disrupt inhibitor binding would also disrupt substrate 
processing, rendering the pathogen non-viable. 
In order to begin testing the substrate envelope hypothesis as an inhibitor design 
principle, HIV-1 protease was employed as a model system. The structures of sub- 
strate complexes with inactivated HIV-1 protease have been determined [43,44], and 
the consensus substrate envelope was used as a computational small-molecule inverse 
design target rather than an optimal shape that fills the entire binding site. In or- 
der to target the envelope, inverse design was performed using a molecular scaffold 
derived from known HIV-1 protease inhibitors, and a naive functional group library 
from chemical catalogs was used to diversify the scaffold at three positions. Fifteen 
computationally designed compounds were synthesized by collaborators and tested for 
binding against the wild-type protease. Of these compounds, four had inhibition con- 
stants (Ki) within 30-50 nM. To begin testing whether or not these compounds would 
induce resistance mutations, the inhibition const ant for these compounds against a 
panel of three drug-resist ance HIV- 1 protease mutants was experiment ally measured. 
Overall, the compounds lost no more than 6-13 fold inhibition against the mutant 
proteases, relative to wild type. This is in sharp contrast to first generation HIV-1 
protease inhibitors, which often lose more than 1000-fold inhibition relative to wild 
type in drug resistant mutants. This small molecule design project was also very 
useful in validating and identifying limitations in the computational inverse design 
technique. A comparison of predicted to experimental binding energies highlighted 
weaknesses associated with rigid treatment of the protease in initial design calcula- 
tions. Switching to design in a protease structure more compatible with the scaffold 
used for design results in improved rankings. Crystal structures of the four tightest 
binding design inhibitors were also determined by collaborators, and the structures 
agreed well with prediction when design was performed without the substrate enve- 
lope constraint. 
In Chapter 4, two inverse design methods were directly applied to improving 
the binding affinity of peptides for an inactivated mutant of HIV-1 protease. As 
demonstrated in Chapter 3, knowledge of how substrates bind to the protease is of 
value in learning about drug resistance. One important inhibitor property that has 
been shown to be useful in predicting drug resistance profiles is the balance between 
enthalpic and entropic contributions to the binding free energy [45,46], as deter- 
mined through calorimetry. Consequently, it was of interest to examine this balance 
when the peptide substrates themselves bind to an inactivated protease. However, 
in calorimetry experiments, the substrates bind so weakly (Kd 2 5 p M )  to the in- 
activated protease that accurate measurement proved difficult. Two computational 
techniques were applied to suggest peptide sequences predicted to improve binding, 
starting with the tightest binding substrate sequence as a template. The first tech- 
nique, charge optimization [23,24], replaces the partial atomic charges on the peptide 
side chains with those that optimize the electrostatic component of the free energy of 
binding. This procedure identified two peptide residues with suboptimal electrostat- 
ics, and in one case suggested a threonine-to-valine mutation that was predicted to 
improve binding. In addit ion, protein design techniques were applied to evaluate all 
single, double, and triple mutant peptide sequences for improved binding properties. 
This procedure recapitulated the mutation identified by charge optimization and sug- 
gested several other mutations. Three designed pept ides were tested for binding using 
calorimetry, and the single threonine to valine mutation resulted in a greater than 
10-fold improvement in binding. A triple mutant sequence predicted from protein 
design methods yielded a more modest 2-3 fold improvement. 
Chapters 5 and 6 of this thesis detail methods to address another challenge in 
molecular design, which is the accurate scoring of molecular geometries to deter- 
mine those that are predictive of favorable energetics or tight binding. Specifically, 
they propose an alternative way to solve the linearized Poisson-Boltzmann equation 
(LPBE) for the mixed discrete-continuum solvation model used to compute the elec- 
trostatic component of free energies throughout this thesis. The issue with current 
techniques is that, given the amount of computational resources currently available, 
their solution never seems to be fully converged. Therefore, when making predictions 
based on this popular solvation model, it is difficult to know whether errors are due 
to the model itself, or the inability to solve it accurately. 
In order to address this problem, we have applied boundary-element methods 
(BEM) to solve the LPBE, which are capable of achieving higher accuracy than 
traditional finite-difference methods (FDM). The boundary-element method a popu- 
lar technique for solving the partial differential equations that arise in electrostatics 
problems, especially in the electrical engineering community [47]. Finite-difference 
methods have fundamental inaccuracies when solving the molecular electrostatics 
problem because they represent molecular geometries and point charges using a rec- 
tilinear grid. In contrast, boundary-element methods using specialized curved panels 
can exactly represent molecular geometries as well as the point charges that represent 
partial atomic charges, allowing for enhanced accuracy. However, boundary-element 
methods also have their limitations. One example is that the BEM generates a dense 
matrix equation that must be solved. The size of the dense system of equations grows 
quadratically in the discretization of molecular surfaces, which increases rapidly as 
larger systems are considered or the desired accuracy is increased. Consequently, 
many matrix compression techniques have been developed to allow this dense system 
to be stored approximately, reducing the time needed to construct and multiply by 
this operator [48-501. However, one limit at ion of existing methods is that increasing 
the accuracy of the compression procedure results in large time and memory usage 
penalties. Chapter 5 presents the development of the FFTSVD matrix compression 
algorithm, which takes the best features of several existing boundary-element solvers 
and combines them into a single algorithm that is capable of achieving high accuracy 
with lesser computational expense. 
Given the FFTSVD algorithm, and other essential work performed by collabora- 
tors, it was possible to overcome all of the practical challenges associated with the 
BEM when solving problems in continuum molecular electrostatics with the LPBE. 
The culmination of this work is presented in Chapter 6, where a complete boundary- 
element method is presented capable of solving biomolecular electrostatics problems 
to high precision. The presented curved BEM was tested against standard FDM tech- 
niques for solving the LPBE on several classes of continuum electrostatic calculations 
commonly performed in the field. When calculating the electrostatic component of 
solvation energies of molecules, absolute rigid binding free energies within a protein- 
protein complex, or non-rigid binding free energies, the curved BEM solution appeared 
to have significantly better convergence properties with increasing compute time ex- 
pended, unlike FDM where the solution appeared to continually change. The only 
class of calculations for which FDM performed adequately was differential electro- 
static binding energies between mutant and wild-type protein complexes that could 
exploit error cancellation due a large portion of the complex remaining unchanged. 
Overall, the development of this highly accurate LPBE solver confirmed the suspi- 
cion that solutions from the FDM may not be well converged, and suggests that more 
accurate solution methods may be required to make accurate predictions with the 
LPBE continuum model. 
Chapter 2 
Inverse Design of Small-molecule 
Ligands for Drug Discovery 
Abstract 
A new strategy for the design of small-molecule ligands for binding macromolecular 
targets is described. The new formulation is comparable to inverse protein design, 
where instead of predicting a protein's fold from its sequence, all sequences compati- 
ble with a given backbone fold are considered. Analogously, this method differs from 
docking and other traditional approaches that take molecules or molecular fragments 
and try to determine their bound structure within the target site. The inverse design 
method described here begins with a desired ligand shape along with computed bind- 
ing potentials within, and constructs molecules that are energetically compatible with 
these features. The inverse design procedure described has a number of characteris- 
tics. It is combinatorial and discrete in that ligands are constructed by the joining of 
molecular fragments to scaffolds in individual rotameric and conformational states. It 
incorporates the guaranteed discrete search algorithms dead-end elimination and A*, 
which together provide the global optimum and an ordered list of all solutions higher 
in energy than the global optimum up to a chosen threshold. It is hierarchical in that 
the priorities of design candidates are initially ranked with a very rapid, physically 
based energy function, and the candidate list ordering is subsequently refined with 
increasingly accurate energy functions. Grid-based pre-calculations are used to speed 
energy computations, and the initial selection of the ligand shape allows solutions to 
the linearized Poisson-Boltzmann equation to be used to describe the electrostatic 
contributions to solvation and interaction from the earliest stages of the search. Be- 
cause of its combinatorial and complete nature, this approach has the potential to 
evaluate the expected feasibility of combinatorial libraries for targeting a given bind- 
ing site, as well as being useful in more traditional de novo design efforts and lead 
refinement. 
2.1 Introduction 
Automated exploration of the space of small molecules compatible with tight binding 
to a macromolecular target remains a formidable challenge in computational chem- 
istry [51,52]. The difficulties in developing such an algorithm are mainly two-fold. 
The first problem is the combinatorial complexity of molecular diversity, conforma- 
tion, and orient ation that must be effectively searched to identify molecules predicted 
to bind tightly as well as their predicted binding modes. Traditional de novo small 
molecule design algorithms fall into several categories depending on the way the search 
problem is handled. Many methods build ligands into a target site using sequential 
atom- or fragment-based growth, using strategies such as Monte Carlo, evolutionary 
algorithms, and tree search to select favorable attachments and orientations [53-611. 
Other algorithms determine optimal placements for individual functional groups fol- 
lowed by techniques to link them together into full molecules [62,63]. Several ad- 
ditional techniques allow atoms distributed throughout the site to merge and form 
real molecules under the influence of potential functions [64,65]. Molecular docking 
algorithms have also been used to explore a binding site using pre-existing libraries 
of compounds [5,7,8,66]. 
Alternatively, the field of protein design, with its recent successes [12,15-2 11 has 
taken a different approach to solving the problem of combinatorial complexity in 
molecular design. This success can be attributed, in part, to the phrasing of pro- 
tein design as an inverse problem [9,10]. In inverse protein design, the backbone 
is constrained in a desired conformation, leaving behind a tractable search over dis- 
crete side chain identities and conformations to find sequences predicted to stabi- 
lize the fold [67-691. Given a pairwise-additive scoring function, this smaller search 
space can be deterministically searched by algorithms such as dead-end elimination 
(DEE) [ll, 14,701 and A* [13] to identify global optimal and progressively sub-optimal 
energy structures. These deterministic search methods have been used in the small- 
molecule docking problem to account for ligand or receptor flexibility [71-731, but they 
have not been previously applied, to our knowledge, in de novo ligand generation. 
The second challenge in developing an automated small-molecule design proce- 
dure is a scoring function that can enrich the search space in molecules that are 
likely to bind tightly. Due to the vast search space involved in small-molecule design, 
traditional approaches often use computationally efficient, but approximate, energy 
models [3,4,74-811. One aspect that is often neglected or highly approximated is 
solvation, due to the high computational cost of computing its effects accurately. Sol- 
vation has been shown to be important to correctly rank and predict small-molecule 
binders [82,83], suggesting that it may be important to account for in ligand gen- 
eration strategies. The strong geometry dependence of solvation makes it especially 
difficult to model during ligand design, where the shape of the molecules being con- 
sidered changes as fragments are sequentially added. 
In this report, we propose one possible implementation of an inverse algorithm 
to design tight binding small molecules that includes solvation as part of the scor- 
ing. This implement at ion has several import ant characteristics. Firstly, the met hod 
reduces the combinatorial complexity of small-molecule design by applying early con- 
straints, in the same fashion as inverse protein design. A fixed shape is selected within 
the target binding site, which serves as a limit on the size and location of designed 
compounds, and also as the dielectric boundary for continuum solvat ion calculations. 
In addition, the search space of molecular diversity is described using a discrete set of 
molecular scaffolds and functional groups that can be attached. These scaffolds are 
placed discretely throughout the fixed shape, leaving behind a tractable combinatorial 
search over functional group space for each. 
Secondly, the search over small-molecule diversity is approximated with a scaf- 
fold and functional group approach, where the search over functional group space 
is complete and deterministic. The conformations of functional groups grown from 
each scaffold placement are sampled discretely, and the contribution to the binding 
score for any set of functional groups is pairwise additive. This allows existing de- 
terministic algorithms such as dead-end elimination (DEE) [l 1 ,14,70] and A* [13] 
to generate a guaranteed rank-ordered list of high scoring molecules, topped by the 
global optimum. Thirdly, fast grid-based energy functions [74,84-861 are employed to 
accelerate the pairwise binding score calculation. These include a pairwise solvation 
model, where screened interaction and desolvation potentials derived from Poisson- 
Boltzmann (PB) theory are recorded on a grid inside the fixed shape. Evaluation of a 
molecule against these grid potentials provides an approximate electrostatic binding 
free energy that assumes a fixed dielectric boundary. Lastly, to correct for grid-based 
energies and the approximate pairwise solvation model, the top scoring compounds 
across all scaffold placements are hierarchically re-ranked in more detailed energetic 
models that include explicit-atom calculations and full non-pairwise PB solvation 
models that take into account the correct molecular shape. 
Given the complete and deterministic nature of this inverse ligand design strategy, 
it is well suited as a tool for exploring the space of molecules compatible with binding a 
target site. To demonstrate this, we applied the method to identify ligands compatible 
with small engineered model binding sites in the hydrophobic core of T4 lysozyme. 
The presence of a complete search space allowed for an energetic analysis of designed 
compounds, revealing that those most similar to known binders tend to have better 
electrostatic complementarity. Using the T4 lysozyme system as an example, we also 
demonstrate the importance of the approximate pairwise solvation model in designing 
molecules with the correct polarity for a binding site. We also applied the inverse 
method in a more traditional de novo design protocol to identify small molecules well 
suited for the E. coli chorismate mutase active site. Top scoring ligands reproduced 
the hydrogen bonding patterns and functional group usage of known inhibitors, even 
though they employed different scaffold geometries. Finally, the completeness and 
determinism of the search protocol allows for a reasonably fair comparison between 
different combinatorial libraries targeting the same binding site. To this end, we used 
the method to evaluate the fitness of an example combinatorial library for binding 
the HIV-1 protease active site by comparing the compounds created from this library 
with those from a peptide-based reference design. 
Overall, the inverse ligand design method presented here is applicable to a variety 
of molecular design problems including exploring the space of molecules compatible 
with a target site, de novo ligand generation, and combinatorial library evaluation. It 
has several advantages over existing methods due to its complete nature and accurate 
electrostatic modeling. 
2.2 Theoretical and computational approach 
2.2.1 Constraints applied for search feasibility 
Our implementation of an inverse ligand design procedure, outlined in Figure 2-1, 
relies on several constraints and approximations in order to make the resulting search 
over molecular diversity feasible. The first constraint, which is also the first stage in 
the design procedure, is to select a target shape that limits the scope of the designed 
molecules, in that the atom centers of generated compounds must stay within its vol- 
ume. A second important constraint in the inverse ligand design methodology is the 
chemical space searched. Molecular diversity is described using a scaffold-functional 
group approach; the space of ligands searched consists of a set of specified molecular 
cores (scaffolds) decorated with a given library of functional groups. This dovetails 
nicely with combinatorial library and parallel synthesis approaches to laboratory lig- 
and construction, and can ensure that t'he search focuses on synthesizable molecules. 
Scaffolds are placed within the binding site in specified discrete conformations and 
orientations, and the functional groups grown from them are derived from generated 
discrete conformat ional ensembles. 
A further methodological constraint is the need for a pairwise additive function 
to describe the binding free energy. A hierarchical series of energy functions can be 
used to score and re-order the space of feasible binders, in which case only the base 
energy function needs to be pairwise additive. Discrete representation and pairwise 
energetics are essential for the search algorithms used to identify low-energy molecules 
in the combinatorial space. 
The overall goal of these constraints is to phrase small-molecule design in a manner 
similar to inverse protein design, with the specific aim of adopting the combinato- 
rial search algorithms than have been developed to solve protein design problems. 
With these constraints applied up front, it is possible to implement an inverse small- 
molecule design st rat egy as explained below. 
2.2.2 Target shape selection 
In addition to serving as a constraint on ligand size, the target shape also serves 
as an approximation to the final shape of the ligand throughout the combinatorial 
search over molecular space. In continuum models, the electrostatic component of 
binding is highly dependent on the shape of the ligand and the receptor, such that 
shape changes in one part of the ligand can affect the electrostatic contributions of 
other regions. These effects are captured directly in continuum solvation models but 
require significant sampling of solvent degrees of freedom to capture in explicit sol- 
vent models. As a result, small-molecule design approaches that place ligand groups 
progressively can lead to sub-optimal or even poor solutions, as addition of functional 
groups can change the electrostatic contributions of those already placed. By select- 
ing a target ligand shape and assuming that the molecule occupies all of this volume 
throughout the search procedure, this complication is avoided as well as allowing for 
fast approximations of solvation energies as described later. 
Energy ~ankin; 
Figure 2-1: Overview of the inverse ligand design algorithm. First, a ligand envelope 
is created in the active site (A), which will serve as a hard constraint on the size and 
shape of designed ligands as well as an approximation to the true molecular shape 
in solvation calculations. Next, grid-based energy functions are computed on cubic 
lattices within the shape (B) for van der Waals packing, electrostatic desolvation 
upon binding, and screened electrostatic interact ion. Then, a discrete conformat ional 
ensemble of molecular scaffolds is discretely sampled throughout the site in a variety 
of orientations (C). For each scaffold placement, self and pairwise contributions to 
the binding energy are computed for discrete functional group attachments using the 
grid-based energies (D). Finally, fast and guaranteed combinatorial search algorithms 
determine the global minimal binding energy configuration of functional groups for 
each scaffold placement (E), as well as a ranked list of configurations with increasing 
energy. The best scoring compounds can then be pooled across all scaffold placements 
and re-ranked in increasingly sophisticated binding energy models. 
The target shape also represents an idealized version of the shape for a completed 
ligand, and the objective function for design attempts to fill as much of this volume 
as possible. Given this role, it makes sense to select a target shape that would predict 
ligands of maximal affinity or encourage interaction with certain parts of the site of 
interest. In most physical models of molecular interaction, the hydrophobic (shape) 
contribution to binding has been shown to correlate with burial of surface area [87], 
implying that the optimal target shape for binding is one that fills the binding site 
completely. Therefore, a negative image of the binding site, approximated by a sphere 
packing, is used as the target shape in this inverse design procedure. In buried active 
sites, it suffices to pack spheres on a regular cubic lattice and accept any sphere that 
does not clash with the receptor. In open active sites, spheres can be placed and their 
geometry minimized or optimized such that they pack desired regions of the binding 
interface without extending too far into solvent. 
2.2.3 Calculation of binding potentials and energies 
Once the target shape is selected, the goal of the combinatorial search procedure is 
to design molecules into this shape that interact favorably with the receptor. Rather 
than directly scoring the interaction between a molecule in the shape and the receptor, 
we employ grid-based energy functions [74,84-861 and pre-compute binding energies 
or potentials on a regular cubic lattice inside the target shape. Grids can then be 
interpolated onto molecules or molecules projected onto the grids in order to compute 
binding energies. 
The scoring function employed in the combinatorial search procedure contains 
three primary components, a van der Waals packing term, a screened electrostatic 
interaction term, and desolvation penalties for both the designed ligand and the 
receptor. Grids for van der Waals energies are computed by placing a particular pa- 
rameterized atom type at each grid point and computing its van der Waals interaction 
energy with the rest of the receptor. This is repeated for every atom type. To derive 
the van der Waals binding energy for a given molecule, the energetic contribution 
of each atom is calculated by trilinearly interpolating energies from the surrounding 
eight points of the appropriate grid. 
Given that the target shape is fixed throughout the combinatorial search por- 
tion of t he algorithm, calculation of grid-based potentials useful in t he evaluation 
of electrostatic interaction and desolvation is straightforward using the linearized 
Poisson-Boltzmann equation (LPBE), and follows directly from charge optimization 
methods [23,24,30,31]. As shown previously for the LPBE [24,31], the electrostatic 
component of the binding free energy given a fixed shape for the bound and unbound 
states, fixed charges on the receptor, and a set of basis points within the ligand can 
be written as 
where ifis a vector whose elements give the charge values at ligand basis points, L 
is the ligand desolvation matrix, 6 is the screened interaction vector, and Rd, is the 
receptor desolvation penalty (a scalar). The ligand desolvation matrix is computed as 
the difference between two matrices, Sbound - Sunbound, where each is a solvation energy 
matrix such that f l q '  equals the solvation energy of the ligand in either the bound 
or unbound state. The symmetric S matrices are computed by charging each ligand 
basis point to a value of 1 .Oe with all other ligand points and receptor atoms set to O.Oe 
and solving the LPBE in the specified geometry. The resulting potentials at all of the 
basis points become one column of the S matrix. The interaction vector 6 is derived 
similarly, except only the bound state is considered and receptor atoms are charged 
to their parameterized values. The screened electrostatic potential projected by the 
receptor charges at each ligand grid point becomes the elements of C. The receptor 
desolvation penalty, Rdes, is computed by taking the difference between two states, 
where the receptor is charged and the ligand, uncharged, is either bound or unbound. 
Because the target ligand shape is fixed, this number is a constant throughout the 
combinat orial search. 
If the basis points within the ligand are set to a regular cubic lattice, the electro- 
static binding energy of any molecule can be approximated by trilinearly projecting 
each partial atomic charge to the grid points and applying Equation 2.1. This ap- 
proximat ion estimates t he electrostatic binding free energy of t he molecule within 
the target shape, rather than the correct molecular surface of the ligand derived from 
radius parameters. Keeping the target shape constant allows for precomputation of 
L, 6, and Rdes and is the basis for the fast grid-based electrostatics and solvation 
approximat ion. 
One important identity of Equation 2.1 is that two superimposed grid charge 
distributions, 6 and & can be distributed as shown in Equation 2.2 for the case of a 
symmetric L matrix. 
This distribution of terms can be extended to any number of superimposed charge 
distributions and provides the basis for a pairwise decomposition of electrostatic and 
solvation energies as subsequently described. 
In addition to van der Waals and electrostatic solvation terms, additional com- 
ponents of the score during the combinatorial search include a bump check against 
the target shape, ensuring that any molecule outside it has an infinite energy, as well 
as functional group-scaffold and functional group-functional group bump checks to 
ensure that designed molecules are not self-intersecting Bump checks were chosen 
over traditional molecular mechanics internal energies because it is unclear when de- 
signing a small molecule how much internal strain is paid upon synthesis rather than 
binding. 
2.2.4 Pairwise decomposition of the scoring function 
In order to use existing implementations of combinatorial search algorithms such as 
DEE and A*, the scoring function must be pairwise decomposable in functional group 
conformation and identity. This means that the total energy of a given scaffold with 
added functional groups must satisfy 
where n is the number of attached functional groups in discrete geometries. This 
expression consists of a const ant term (Econst ) , a sum over the self energy contributions 
of each functional group alone (Eself,), and a sum over contributions for each pair of 
functional groups (Epair,,j ). When functional groups are attached to the scaffold, a 
hydrogen on both the scaffold and functional group are removed and a bond is formed 
between the two antecedent atoms. Therefore, the blunt scaffold, with growable 
hydrogens removed, is invariant in a particular placement of the scaffold and search 
over functional groups, contributing only to the constant term in Equation 2.3. This 
const ant term includes the grid-based van der Waals and electrostatic binding energy 
of the blunt scaffold, as well as the constant receptor desolvation penalty and can be 
written as 
where &caffold,blunt are the grid projected partial atomic charges of the blunt scaffold 
with L, 6, and Rd, derived from the electrostatic approximat ion. 
The self energy for each attached functional group in a discrete conformation is 
the grid-based van der Waals contribution for all atoms except the hydrogen removed 
when attached to the scaffold, and the electrostatic energy is computed by placing 
the charge from the removed scaffold hydrogen on the functional group antecedent 
atom, and the charge on the removed functional group hydrogen on a dummy atom 
at the position of the scaffold antecedent atom to ensure charge conservation after 
attachment. The self electrostatic binding energy of the functional group can be 
computed through grid projection and application of Equation 2.1. In addition to 
electrostatic interaction and self desolvation, the indirect desolvation between the 
functional group and the scaffold must also be added to Eselfi, which can be computed 
from the cross terms in the symmetric desolvation matrix, as shown in Equation 2.2. 
Therefore, a final expression for Eselfi is 
where Gg,blunt are the projected grid charges for the charge-swapped functional group, 
(&caflold,blunt are the projected grid charges for the scaffold with growable hydrogens 
removed, and L, C,  and Rdes are derived from the electrostatic approximation. Any 
functional group geometry that fails a bump check with the scaffold or with the 
shape is removed from further consideration in the combinatorial search. Optionally, 
a discrete functional group conformation can also be removed from the space if it fails 
certain chemical criteria, such as making specified hydrogen bonding interactions. 
The contribution of a pair of functional groups to the binding free energy only 
contains the indirect solvation effects between them, as shown in Equation 2.6. If the 
two functional groups fail a bump check and clash, their pair energy contribution is 
infinite. 
if functional groups bump 
otherwise 
The pairwise energy decomposition presented above is crafted such that Equa- 
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tion 2.3 sums to same energy as if the entire molecule, complete with scaffold and 
functional groups, is evaluated with the grid-based van der Waals and electrostat- 
ics/solvation functions. 
2.2.5 Scaffold placement 
Once the target shape has been selected and precomputed grids generated within 
for van der Waals and electrostatics/solvation scoring, the next step in the inverse 
design procedure is to place the scaffold throughout the target shape in discrete 
conformations and orientations. These scaffold placements serve as the launching 
point for functional group attachment, and serve a similar role to a set of fixed back- 
bone geometries used in inverse protein design calculations. Finding optimal scaffold 
placements is similar to the problem of molecular docking, except that the ligand 
molecule is incomplete. As a result, finding the lowest energy docked structures for 
the scaffold may not be optimal, because these placements may limit functional group 
attachment. To solve this problem, we exhaustively sample scaffold orientations for 
a pre-generated conformational ensemble through uniform sampling of translational 
and rotational space. Any scaffold orientation that is within the target shape and 
passes a grid-based van der Waals energy cutoff is accepted. Another possibility 
for generating scaffold positions might involve docking the scaffold with minimal or 
representative functional groups attached and keeping only the scaffold placement. 
2.2.6 Combinatorial search over functional groups 
For each scaffold placed within the target shape, a complete search is performed over 
the space of possible functional group identities and conformations at each growable 
hydrogen position. Pairwise energies are computed as described above, and the dead- 
end elimination (DEE) [ll, 14,701 and A* [13] algorithms are used to identify the 
global minimum functional group structure as well as a ranked list upwards in energy. 
Operationally, the ranked list is extended until a certain number of unique molecules 
has been discovered and up to a given number of conformations are retained for each. 
The results of the combinatorial search across all scaffold placements are then pooled 
and sorted in energy score in order to determine the best structures as predicted by 
this approximate scoring function. 
2.2.7 Hierarchical rescoring of top structures 
The pairwise energy function presented above has several deficiencies that can be 
corrected by successively passing the highest scoring molecules to better and better 
energy functions in a hierarchical fashion. The most obvious of these deficiencies is 
the approximate pairwise solvation model because it assumes that all ligands have 
the same molecular shape. To initially correct for this approximation, the highest 
scoring molecules from the combinatorial search can be re-evaluated with fast but 
non-pairwise approximations to converged linearized Poisson-Boltzmann calculations 
that incorporate more knowledge of the actual molecular shape. To this end, we have 
implemented three approximate met hods that meet these criteria and are applicable 
to certain classes of design problems. 
The first of these "medium resolution" methods is suited for design problems where 
the target site is deeply buried from solvent, and the designed molecules fill the target 
shape reasonably well. In this case, the solvation and interaction potentials in the 
bound state computed from the grid-based fixed-shape assumption should agree very 
well with those computed with the LPBE because the shape of the bound state is 
mostly invariant to the ligand geometry. However, in the unbound state, the target 
shape may be a poorer representation of the ligand geometry and a correction is 
required. The advantage here is that the unbound state with the ligand alone is much 
smaller than the bound state and requires only a relatively fast LPBE calculation to 
obtain a converged answer. This procedure is summarized in Equation 2.7, which 
is analogous to Equation 2.1 except that the ligand desolvation matrix is broken up 
into its two solvat ion matrix components and the unbound st ate solvat ion energy is 
computed directly with LPBE calculations rather than the grid-based approximation. 
A second approximation to the full LPBE electrostatic binding calculation, which 
is more generally applicable, is to apply a fast method that approximates the change 
in solvation energy when the shape of the ligand shrinks from the target shape to 
the true molecular surface derived from parameterized radii. One such method, first 
proposed by Arora and Bashford [88] and later extended [89], involves integrating 
the energy density in the volume that changes from being inside the target shape to 
inside solvent assuming that the electric field is the same as computed from the target 
shape geometry. This is shown in Equation 2.8 
AAGsolv = f""' J ern01 - esolv / / I dv 
S O ~ V  87~ 
where Emol and esolv are the molecular and solvent dielectric constants, I? is the electric 
field computed when the target shape is present, and the volume integral is taken over 
regions that were in the target shape but became solvent when the actual ligand radii 
were used to generate the dielectric boundary. 
With this formalism, we can correct each desolvation component of the electro- 
static binding energy. The ligand desolvation upon binding is corrected by taking the 
difference between evaluation of the integral in both the bound and unbound states. 
Electric fields are calculated through finite-difference of the grid-based solvation po- 
t entials, derived from multiplying t he projected ligand charges by the appropriate 
solvation matrix S.  Integration is carried out by assuming the electric field is con- 
stant within a grid cube and summing the product of the square of the electric field 
magnitude with the volume of each cube in the differential region. Receptor desol- 
vation is similarly corrected through integration using the electric field derived from 
the interaction potential 6. 
One final method, which is slower but should provide a reasonable approximation 
in most cases, is simply to run a full electrostatic binding calculation by solving the 
LPBE at very low discretization, such that the solve time is fast but the answer still 
correlates with a fully converged calculation. 
The top ranking structures after re-evaluation with fast corrections to the fixed 
shape solvation approximation, which should be few in number, are then subjected to 
further hierarchical improvements to the energy function that take longer amounts of 
time to compute. These include a converged LPBE electrostatic binding calculation 
using the correct molecular surface for both the bound and unbound states and the 
addition of a surface area term to model the hydrophobic contribution to solvation. 
Additional calculations that could be performed at this st age include computing lig- 
and internal strain through modeling of the unbound state, assessing the error in the 
atomic charge swapping procedure used for functional group attachment by repeating 
partial atomic charge determination on the entire compound and recomputing binding 
energetics, or consideration of ligand conformational entropy losses upon binding. 
At each stage of hierarchical re-evaluation, enough structures are considered such 
that correlation between the more and less sophisticated energy model is observed. 
With enough correlation, one eventually reaches a point where additional top ranking 
structures from the lesser model are unlikely to score better than a certain threshold 
in the more accurate energy function. In this manner, we attempt to statistically 
guarantee that the top molecules in our best energy function have been identified 
even though we are unable to perform direct guaranteed searches on the best energy 
function due to non-pairwise effects. 
2.3 Results and Discussion 
2.3.1 Validation with engineered model binding sites in T4 
lysozyme 
To understand the operation of the inverse small molecule design method, we applied 
the procedure to two model binding sites previously engineered into the hydrophobic 
core of T4 lysozyme by Matthews and co-workers [go-921. The first site contains a 
single L99A mutation [go, 911, which opens a hydrophobic cavity that can be bound 
by hydrophobic small molecules [91,93]. The second site adds the additional M102Q 
mutation [92], which introduces a single hydrogen-bond acceptor into the cavity and 
causes it to bind polar molecules as well as hydrophobics. These sites are well suited 
for validation and testing because they are feasible to sample thoroughly due to their 
small size, have lists of experimentally known binders and non-binders, and although 
artificial, seem to present many of the same computational challenges found in natural 
binding sites [92,94]. 
The space of potential ligands for this study was constructed combinatorially from 
previous database screening efforts by Murcko and co-workers 195,961 that identified 
the scaffolds and functional groups most commonly used in the Comprehensive Medic- 
inal Chemistry (CMC) database [97]. Conformational ensembles were generated for 
these scaffolds, followed by uniform sampling in discrete positions and orientations 
throughout the target shape. The space of functional group attachments was combi- 
natorially searched for each scaffold placement, and the best structures were identified. 
The total number of structures searched was 3.2 x 101° for the L99A hydrophobic site 
and 1.1 x 10' for the L99A/M102Q polar site. For each of the two model binding 
sites, structures in the top 10 kcal/mol of the combinatorial search were re-evaluated 
by correcting the unbound state contribution to the solvation energy with LPBE cal- 
culations (because the sites are deeply buried), and by switching from grid-based to 
Table 2.1: Combinatorial search space sizes for inverse designs 
L99A/M102Q T4 lysozyme 
E. coli chorismate mutase 
Target Site 
L99A T4 lysozyme 
E. coli chorismate mutase 
HIV- 1 protease 
HIV- 1 protease 
a Reference [95 
Reference r6/ 
Reference 98 
Reference [99] 
CMC deriveda 
CMC deriveda 
Figure 2-7 
Bignelli-based (Figure 2-10A) 
Tetrapeptide 
Scaffold Library 
CMC deriveda 
CMC derivedb 1.1 x lo9 
CMC derivedb 1.5 x 1019 
CMC derivedb 2.5 x l0l9 
explicit-atom van der Waals binding energies. 
The correlation between the grid-based energy function used in the combinatorial 
search and the first set of "medium resolution" corrections is shown in Figure 2-2A 
for the L99A hydrophobic site. Although there is some degree of spread, mainly 
due to the target-shape based electrostatics approximation, there is significant cor- 
relation. We chose to draw a horizontal bounding line 3 kcal/mol above the best 
corrected score; it is likely that nearly all structures with a corrected score better 
than this threshold have been identified due to the correlation between uncorrected 
and corrected energies. In this manner, we can be reasonably confident that the best 
molecules in this non-pairwise correction have been identified. While it is not pos- 
sible to provide absolute guarantees that no low-energy structures with one energy 
function are missed by sorting with a different function, statistical confidence limits 
can be developed but are beyond the scope of the current work. 
These top structures were then further re-ranked using full LPBE binding calcu- 
lations and a surface-area dependent hydrophobic solvation term. The relationship 
between the first set of corrections and the full energy model is shown in Figure 2-2B, 
which indicates a strong correlation and high confidence that few, if any, low-energy 
structures are missing. 
One of the advantages of complete search is that the large space of generated 
ligand structures can be analyzed in terms of the trade-offs between portions of the 
Functional Library 
CMC derivedb 
Search Space 
3.2 x 10l0 
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Figure 2-2: Correlation between energy models in different stages of the inverse design 
procedure. The approximate energy model used in combinatorial search shows good 
correlation with the f is t  round of energy function correction (A), allowing a bounding 
line (black) to be drawn. It is unlikely that many, if any, additional structures re- 
ranked by the f is t  round of corrections will score better than this threshold. The 
same is true when the f is t  round of corrections is compared to the full energy model 
(B). The red lines indicate y = x. The correlation in (B) is offset from y = x due 
to the addition of a favorable hydrophobic solvation term in the full energy model. 
Lower energies indicate a more favorable binding score. 
scoring function. Figure 2-3A contains the top 10 kcal/mol of combinatorially gen- 
erated structures from the L99A hydrophobic site plotted as a function of their van 
der Wads and electrostatic contribution to the binding free energy after the first 
round of "medium resolution" energy function correction. The results in the Figure 
reveal trends in the design space. Firstly, there is an observed lower bound to the 
electrostatic binding free energy at approximately + 1.5 kcal/mol. Even the most 
electrostatically favorable ligands in the space are unable to fully recover the electro- 
st at ic desolvat ion of the ligand and receptor through intramolecular interact ions in 
the complex. 
A second feature is that in the regime of the best total binding energies, there 
is a direct trade-off between van der Waals packing and electrostatics/solvation, in 
that no ligands exist in the search space that simultaneously make the best packing 
and best electrostatic interactions. Possible explanations for this finding include 
an inherent incompatibility with simultaneously optimizing these terms, or possibly 
that the functional groups selected for the library are more optimal for packing than 
electrostatic interactions. To test the second idea, the search procedure was repeated 
using a functional group library that contained aliphatic or vinyllic versions of all polar 
groups, which could be more electrostatically optimal for the hydrophobic site but 
still capable of making the same packing interactions. However, the same trend was 
observed, indicating that polar groups may be selected for their packing interactions 
even though they pay additional desolvation penalties. 
A final feature is that when ranking compounds on the sum of the two energy 
terms (indicated by the black line with slope -1 and perpendicular arrows) the first 
compounds selected are more optimized for packing rather than electrostatic inter- 
actions. These compounds have excellent shape complementarity to the site (Figure 
2-3B) but pay desolvation penalties due to their use of polar functional groups. These 
molecules differ strongly from those known to bind this nonpolar site, and may indi- 
cate deficiencies in the energy function components or their weighting. 
A comparison of computed binding energy contributions with known experimen- 
tal binding results can reveal their relative reliability. Figure 2-3A shows generated 
molecules known to bind L99A T4 lysozyme in green, while generated molecules 
known not to bind are in red. The results show a rather strong relationship be- 
tween experimental binding and computed electrostatic binding affinity, and a weak 
or non-existent correlation with computed van der Waal's binding affinity. This could 
indicate a fundamental inaccuracy in the treatment of van der Waals and packing in- 
teractions, as the use of minimization or reduced van der Waal's radii [loo] do not 
improve the correlation (data not shown). Combined with previous findings that nat- 
ural ligands are electrostatically optimized [31,101,102], these results could suggest 
that tight binding ligands may be those that are nearly electrostatically optimized 
while maintaining a reasonable packing score. While a full analysis of these effects 
is beyond the scope of the current work, we note that the current energy model, 
which is in common use, tends to reward packing interactions of buried unsatisfied 
polar groups beyond that of buried hydrophobic groups. In Figure 2-3A, there are 
several green points (binders) that have similar electrostatic scores as red points 
(non-binders). These molecules are modestly polar ligands that happen to bind the 
nonpolar site, such as hexafluorobenzene and anisole [91], and are computed to have 
suboptimal electrostatic complementarity because they cannot make direct polar in- 
teractions upon binding. 
Results for exploring ligand space in the polar L99A/M102Q site were similar 
to that of the L99A nonpolar site (Figure 2-4). An electrostatic lower bound was 
observed, as well as the same trade-offs between electrostatics and packing in the 
structures with the best total score. Once again, compounds known to bind the 
polar site were heavily biased towards better electrostatic than packing scores. Due 
to the presence of a single hydrogen bond acceptor, the ligands with near optimal 
electrostatics and good packing were not limited to hydrophobics, but also included 
molecules with single hydrogen-bond donors (Figure 2-5). Many of these designed 
molecules are similar to those known to bind and recapitulate the single hydrogen 
bond observed in their crystal structures [92]. 
Overall, validation in these model binding sites proved useful in identifying the 
strengths and weaknesses in the search procedure and scoring model. Even though 
the pairwise energy model used in the combinatorial search is very approximate, it has 
enough correlation with non-pairwise corrections and the full-energy model such that 
identifying the highest ranked compounds can be statistically ensured. In addition, 
the combinatorial search is complete and deterministic, which allows for identification 
of the regions in the scoring function enriched in molecules likely to bind the target 
site. Even though the total energy may be biased to favor the use of polar groups 
to make packing interactions, structures closer to electrostatic optimality bear more 
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Figure 2-3: Energetic decomposition of ligand binding energies within 10 kcal/mol 
of the highest ranking structure from combinatorial search in the L99A T4 lysozyme 
site. Comparison of the explicit-atom van der Waals score and initial shape-corrected 
electrostatics score for each structure shows tradeoffs in the high scoring region (A). 
Green points are compounds known to bind the site, red points are designed com- 
pounds known not to bind, and blue points are other designed compounds. Green 
and red points were plotted in an alternating fashion to avoid hiding data. The black 
line with arrows is a line with slope -1 passing through the structure with the best 
total energy. As the line moves in the direction of the arrows, the top compounds 
in total energy sum are recovered. The structures of selected designed compounds 
are shown in (B-E). Their location in the energy decomposition (A) is denoted by 
letters. In (B), the designed compound (atom colors, vdW representation) is shown 
inside the target shape (transparent yellow). Toluene (D) is a known binder of the 
L99A T4 lysozyme site [9 11. 
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Figure 2-4: Energetic decomposition of ligand binding energies within 10 kcal/mol 
of the highest ranking structure from combinatorial search in the L99A/M102Q T4 
lysozyme site. Green points are compounds known to bind the site, red points are de- 
signed compounds known not to bind, and blue points are other designed compounds. 
Green and red points were plotted in an alternating fashion to avoid hiding data. 
Figure 2-5: Examples of designed molecules with near-optimal electrostatics in the 
L99A/M102Q T4 lysozyme site. Each molecule makes a single hydrogen bond to the 
carbonyl of the glutamine 102 side chain in a similar fashion to structures of known 
binders. The extra light blue atom in the first panel is chlorine and the green atom 
in the last panel is fluorine. 
similarity to known binders, providing a guideline for identifying such molecules in 
subsequent analysis. 
2.3.2 Importance of including desolvation effects in the com- 
binatorial search 
In order to measure the importance of including the approximate solvation model 
in the search procedure, design in the polar L99A/M102Q site was repeated except 
that all entries of the ligand desolvation matrix L were set to zero, leaving behind 
only the screened interaction energy to model electrostatics, as is common in many 
scoring functions. After combinat orial search, structures in the top 10 kcal/mol, 
designed with and without desolvation in the energy function, were re-evaluated for 
rigid binding using a full LPBE electrostatics model with correct molecular shapes. 
For reference, the correlation between the approximate grid-based electrostatics model 
including desolvation and the full electrostatics model is shown in Figure 2-6A. In 
contrast, the correlation between the grid-based electrostatic score lacking desolvation 
and the full LPBE model is greatly reduced, as can be seen in Figure 2-6B. Without a 
desolvation penalty, the combinatorial search strongly favors positively charged amino 
groups to interact with the side-chain carbonyl of E102. In fact, the generation of 
ligands with +2e and +3e charges was common, corresponding to the horizontal 
stripes in Figure 2-6B, where desolvation penalty is dominated by the net charge. 
These results show that even an approximate solvation model, such as the pairwise 
grid-based fixed-shape assumption, can be useful in the generation of compounds with 
appropriate polarity for the binding site. 
With Desdvaion 
8 10 12 14 
E!admt& Binding Energy (kcaVmol) 
-8 -4 -2 0 2 4 
Flxed-Shapa Sctwned Inbraction Ebctmtat!~ tlcBinding Energy (kcaVmol) 
Figure 2-6: The effect of ignoring desolvation penalties in the combinatorial search 
of the L99A/M102Q T4 lysozyme site. The correlation between the pairwise electro- 
static model including a desolvation approximation and the full electrostatics model 
(A) is superior to the correlation obtained when only using screened interactions to 
model electrostatics during the combinatorial search (B). 
2.3.3 Exploring the space of molecules complementary to the 
E. coli chorismate mutase binding site 
In order to further validate and test the inverse ligand design procedure, we ap- 
plied the algorithm to explore the space of molecules complementary to the binding 
site of E. coli chorismate mutase. This target site is interesting for several reasons. 
Firstly, the active site is highly positively charged and binds highly negatively charged 
substrates and ligands [98,103], which implies that modeling solvat ion accurately is 
import ant for this site. Secondly, this target is pharmaceutically relevant because cho- 
rismate mutases are essential enzymes for plants, bacteria, and fungi, but not found 
\ 
in higher organisms [104-1061. Lastly, there are relatively few classes of molecules 
known to bind this site, and they tend to only have moderate affinity [98,107-ill], 
indicating that exploration of new ways to generate site complementarity may be 
useful. 
To initially target E. coli chorismate mutase, the most common scaffolds in the 
CMC database [95] were discretely sampled throughout the sphere-packed site, result- 
ing in approximately 90,000 placements. Functional groups from the CMC database 
analysis [96] were grown in discrete conformations from any hydrogen on each of these 
scaffold placements, leading to a total search space of 1.5 x 10'' structures (Table 2.1) 
after eliminating conformations that clash with the shape or the scaffold. Once again, 
the top 10 kcal/mol of structures from the combinatorial search were passed to a first 
round of "medium resolution" energy function correction including explicit-atom van 
der Waals interactions and correcting for solvation in the unbound state. As before, 
the corrected binding energies were split into their van der Waals packing and electro- 
static/solvation components. Tkadeoffs were seen between packing and electrostatic 
contributions to the binding energy, and a set of 1000 structures that ranked the best 
in electrostatics while st ill maintaining good packing scores was examined further. 
Within this set, about 75% used one of two scaffolds from the library, namely cy- 
clohexane and tetrahydropyran. The prevalence of these scaffolds is interesting given 
that known inhibitors, mostly bicyclic transition state analogs presenting two car- 
boxylat e groups, contain such ring structures [98,107-1091. These generated molecules 
had either a -1e or -2e net charge, and interacted with the site primarily through 
carboxylate or nitro groups making either one or two electrostatic contacts with 
act ive-site arginines (Figure 2-8). This interaction pattern is similar to the known 
binding mode of an oxabicyclic diacid transition state analog [I031 (Figure 2-8A). 
With the top compounds utilizing only a small number of scaffolds, it might be 
possible to improve scores and attain higher diversity by expanding the scaffold li- 
brary to include additional structures. A previous study had identified several ring 
structures likely to be well suited for binding chorismate mutases [98], and the com- 
binatorial search procedure was repeated using these scaffolds as well as alternative 
versions in which some methylene groups were replaced by ether oxygens (Figure 
2-7). With this new scaffold library, the combinatorial search complexity remained 
about the same (Table 2.1) while first-round corrected scores of the highest ranked 
Figure 2-7: Extended scaffold library used for design in the E. coli chorismate mutase 
active site. Scaffolds shown here are derived from Husain et al. [98], scheme 1 and 2. 
The boxed scaffold is taken from a known transition state analog inhibitor [107,108]. 
compounds improved by almost 2 kcal/mol due to a combination of improved packing 
and electrostatics. Although these scaffolds are different from those derived from the 
CMC, the mode of interaction for generated compounds was extremely similar, pri- 
marily using carboxylates or nitro groups to make one or two bidentate electrostatic 
contacts with active site arginines (Figure 2-8). 
In order to quantify the prevalence of electrostatic contacts in designed com- 
pounds, the hydrogen bonding geometries for carboxylate and nitro groups used to 
interact with active-site arginines were compared to the geometry observed in the 
crystal structure of a transition state analog inhibitor bound to E. coli chorismate mu- 
tase [103]. The comparison was made by computing the root-mean-square deviation 
(RMSD) between the designed and experimentally observed groups. For the approxi- 
mately 32,000 structures within the top 10 kcal/mol of the combinatorial search, 99% 
made at least one carboxylate/nitro - active-site arginine interaction that was within 
1.5 A RMSD of an observed geometry. In addition, 21% of the designed compounds 
made two such interactions. As shown in Figure 2-9, the distribution of designed car- 
boxylate/nitro group RMSD as compared to the crystal structure is heavily biased 
towards lower values, demonstrating how the inverse design methodology identified 
this structural determinant of binding. 
One of the scaffolds in the expanded library (Figure 2-7, box) is derived from 
Figure 2-8: Results of exploring the space of small molecules compatible with bind- 
ing the E. coli chorismate mutase active site. The crystal structure of a known 
transition state analog (TSA) inhibitor (A, left center) interacts with the active site 
primarily through bidentate electrostatic contacts between its carboxylates and the 
side chains of Argll and Arg28. Molecules designed using scaffolds derived from the 
CMC database by Bemis and Murcko [95] (B-C, atom colors) and an extended scaf- 
fold library derived from Husain et al. [98] (Figure 2-7) (D-E, atom colors) replicate 
these interactions, as compared to the TSA in yellow. 
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Figure 2-9: Histogram of the RMSD between designed carboxylate or nitro groups 
and carboxylates found in a crystal structure of a known transition state analog. If 
the designed compound contained more than one such group, the lowest RMSD value 
was used. 
a known transition state analog inhibitor [107,108] (Figure 2-8A). Although the 
design algorithm did not reproduce the exact functional group arrangement on this 
inhibitor given the settings used for design, it did reproduce the inhibitor with one 
additional hydroxyl group. This structure was ranked 18,837 in electrostatics (after 
first-round corrections) in the design with the extended library, which is relatively 
good considering the size of the search space (Table 2.1). In addition, the relative 
ranking of compounds based on the known inhibitor scaffold improved as scaffold 
placement sampling increased, highlighting the importance of adequate sampling in 
the ability to recover known actives. 
Application of inverse combinatorial search to the E. colz chorismate mutase sys- 
tem highlights several of its advantages. These include rapidly identifying the major 
determinants of binding in this system and generating molecules with functional group 
patterns and binding modes similar to those of known inhibitors. It also demonstrates 
the ability of the combinatorial search procedure to identify different scaffolds that can 
make similar interactions within the target site, a useful tool in developing multiple 
strategies for inhibit or design. 
2.3.4 Evaluating scaffolds and combinatorial libraries in 
HIV-1 protease 
When combinatorial chemistry techniques are employed to identify molecules that 
bind a given target, it would be useful to bias libraries towards scaffolds and func- 
tional groups enriched in molecules compatible with the site. The completeness and 
determinism of the inverse ligand design algorithm make it an ideal candidate for 
performing such a task. To demonstrate and assess its effectiveness in this mode, we 
used the technique to evaluate the feasibility of a combinatorial synthetic scheme for 
the development of HIV-1 protease inhibitors. 
The example combinatorial scheme shown in Figure 2-10 is based on a solid-phase 
Biginelli reaction [99,112], where a P-ketoester, aldehyde, and urea are condensed to 
form a dihydropyrimidone ring scaffold [113] (Figure 2- 10A). In this particular case, 
the P-ketoester is attached to an a-amino acid linker, allowing for efficient solid- 
phase synthesis [99] and diversification with natural amino acids (except proline) at 
the R1 position. The R2 position can be varied by changing the aldehyde used in the 
condensation, and a set of four such molecules were considered (Figure 2-1OB). A 
ring nitrogen can also be reacted with the 24 chloroformates shown in Figure 2-10C 
to generate a carbamate linkage at R3. The stereochemistry of attachment at the R1 
and R2 positions are also unspecified, allowing for further diversity. 
To judge the fitness of this example combinatorial library for the HIV-1 protease 
active site, we began by applying the inverse inhibitor design procedure using the 
scaffold and functional groups shown in Figure 2-10. The structure for HIV-1 pro- 
tease was taken from a bound complex with the inhibitor TMC-114, and the fixed 
A (Scaffold) 
Figure 2- 10: Example combinatorial library used to target the HIV- 1 protease active 
site. The scaffold (A) is derived from a synthetic scheme based on solid-phase Biginelli 
chemistry, and contains three sites for diversification, denoted by R1, R2, and R3. 
Waved bonds indicate that both possible stereochemistries are permitted. The R1 
position was joined to all natural amino acid side chains (except proline) in either 
stereochemistry. The R2 position was diversified with the groups shown in (B), which 
are derived from their respective aldehydes. Chloroformate-derived moieties shown 
in (C) were joined to the R3 position on the scaffold. The atoms labeled D in (B) 
and (C) indicate hydrogen atoms that are also possible points of attachment to the 
scaffold. 
target shape was generated by minimizing the energy of a set of spheres placed inside 
the known location of the TMC-114 inhibitor until the central four pockets of the 
active site were well packed. In a similar fashion to the designs presented above, a 
pre-generated conformational ensemble for the scaffold was sampled throughout the 
fixed target shape for approximately 88,000 discrete placements, and the functional 
groups were grown from the scaffold in accordance with the synthetic scheme to iden- 
tify global minimal energy configurations. In the case of unspecified stereochemistry, 
functional groups were grown in one or the other configuration but not both simul- 
taneously. The total size of the search space was 3.3 x 1012 ligand structures (Table 
2.1). 
The designed molecules obtained after searching the Biginelli-based combinatorial 
scheme for HIV-1 protease compatibility need to be compared against a reference in 
order to measure fitness. HIV-1 protease, being an enzyme that cleaves proteins, 
should have an active site that is compatible with binding peptides. Consequently, 
we repeated the inverse design procedure using a tetrameric peptide backbone (with 
blocked terminii) as a scaffold, and all of the natural L-amino acid side chains (except 
proline) as functional groups, to serve as a control experiment. If the combinatorial 
compounds from the Biginelli scheme score significantly better than designed p e p  
tides, it suggests that this combinatorial scaffold/library combination is feasible. It is 
important to note that the level of sampling utilized in the combinatorial library and 
peptide reference designs was kept as similar as possible to ensure a fair comparison. 
Figure 2-11A shows an energy histogram of the top 1,000 scoring compounds 
from both the combinatorial Biginelli and reference peptide designs in the full en- 
ergy model. These compounds were identified through hierarchical energy functions 
by taking all designed structures within the top 15 kcal/mol of the combinatorial 
search, re-ranking them in an initial set of energetic corrections, and sending the top 
5 kcal/mol to the full binding energy model to identify the highest ranking 1,000 
structures. Top compounds derived from the Biginelli scheme scored approximately 
8 kcal/mol worse on average than tetrapeptides derived from the reference design. 
This energetic difference primarily came from reduced van der Waals interactions, 
as members of the combinatorial library were only able to partially fill the HIV-1 
binding site (Figure 2-12). To quantify this lack of shape complementarity, the vol- 
ume of the target shape filled by the best scoring molecules from each design was 
recorded. As shown in Figure 2-llB, the highest scoring molecules from the Biginelli 
scheme are consistently filling around 150 A3 less of the target volume than designed 
tetrapeptides. 
In sum, this study suggests that the particular Biginelli chemistry-based combi- 
natorial library, shown in Figure 2-10, is poorly suited for the HIV-1 protease active 
site due to its inability to fill the site adequately and score better than model pep- 
tides. This example also serves to highlight the ease in which combinatorial libraries 
can be evaluated with this inverse design method. Comparing combinatorially de- 
signed molecules against a reference library can quickly gauge feasibility through both 
energetic scoring and shape complementarity. 
2.4 Materials and Methods 
2.4.1 Protein structure preparation 
Structures of mutant T4 lysozyme used in this study were obtained from the Protein 
Data Bank (PDB), with accession codes 181L [91] and lLGU [92]. The structure 
181L contains L99A T4 lysozyme complexed with benzene, which was removed from 
the binding site. Structure lLGU contains the L99A/M102Q double mutant with a 
beta-mercapto ethanol molecule and a water molecule in the binding site, which were 
also removed. For the E. coli chorismate mut ase study, the structure 1 ECM [I031 was 
obtained from the PDB, containing the enzyme bound to a transition state analog. 
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Figure 2-1 1: Comparison of the top 1,000 scoring molecules in the full binding energy 
model for two libraries targeting the HIV-1 protease active site. A comparison in 
binding energy score (A), shows that molecules designed from a Biginelli chemistry- 
based library (Figure 2-10) score worse on average than compounds designed from a 
reference tetrapeptide library by approximately 8 kcal/mol. Comparing the volume of 
the target shape filled by these compounds (B) offers an explanation for this energetic 
discrepancy, as Biginelli-based compounds fill substantially less of the site. 
Figure 2-12: Visual comparison of a top ranking compound from the Biginelli-based 
combinatorial scheme (A), and a top ranking tetrapeptide design (B), in terms of their 
ability to fill the target shape (transparent yellow spheres). In general, compounds 
based on the Biginelli-derived scaffold are only able to partially fill the site. 
The analog from the second active site (chain M) was removed from the structure as it 
was the site targeted for design. The single active site water molecule was left in this 
structure because it mediates hydrogen bonds between the analog and the enzyme. 
HIV-1 protease structure 1T3R [I141 was obtained from the PDB, containing the 
protease bound to TMC-114, was used for the scaffold evaluation study after removal 
of the inhibitor. The flap water molecule, which mediates ligand binding in this 
structure, was left in place during design. All protein structures were further prepared 
by removing additional water molecules not completely buried by the protein. In 
addition, all glutamine, asparagine and histidine side chains were visually inspected 
for 180-degree flips about their final rotatable bond that would optimize the hydrogen 
bonding network. Ionizable residues were left in their standard states at pH 7. All 
proteins were parameterized using the general  CHARM^^^ force field [115]. Side 
chains with missing density were built back into the structure using default geometry, 
and missing terminal density was handled by adding acetyl and methylamine blocking 
groups to the missing N and C terminii, respectively. Hydrogen atom positions were 
built on all protein structures using the HBUILD functionality [I161 in the CHARMM 
computer program [117], using a distance dependent dielectric constant of 4. 
2.4.2 Scaffold and functional group library preparation 
Scaffolds and functional groups used for design in T4 lysozyme and E. coli chorismate 
mutase were derived from previous database screening studies of the Comprehensive 
Medicinal Chemistry (CMC) database [97] by Bemis and Murcko (reference [95] Chart 
2 and reference [96] Chart 1). Scaffolds that contain double-bond attachment sites 
(indicated by double dots in Reference [95] Chart 2) were combinatorially attached to 
every double bonded functional group and added to the scaffold library. In addition, 
only the site of attachment indicated for CMC-derived functional groups was allowed 
during design. Additional scaffolds for chorismate mutase were derived from Husain 
et al., Scheme 1 and 2. For the HIV-1 protease scaffold evaluation study, the Biginelli 
chemistry-based combinatorial scheme was derived from Zhang and Rana [99] and 
functional groups for these scaffolds were the natural amino acid side chains (except 
proline) at R1, and groups derived from 4 commercially available aldehydes and 24 
commercially available chloroformates at the R2 and R3 positions, respectively (Fig- 
ure 2-10). For the reference peptide design, tetraglycine with N-terminal acetyl and 
C-terminal methylamide blocking groups was used as the scaffold and the functional 
groups were the natural amino acids side chains (except proline) in the L configuration 
grown from the alpha carbons. 
All scaffolds and functional groups were built using GAUSSVIEW 3 [llg], and 
subjected to quantum mechanical geometry optimization using GAUSSIAN 98 [I 191 at 
the RHF/6-31G* level of theory. Partial atomic charges were fit to the electrostatic 
potential using the RESP method [120], and molecular mechanics parameters were 
assigned from the general all-atom  CHARM^^^ force field [I151 using a rule-based 
method. Conformations were generated for each scaffold and functional group by 
allowing torsional sampling according to simple rules based on the hybridization of 
the bonded atoms (sp3-sp3 every 120" starting at 180°, sp3-sp2 every 30" starting at 
0°, sp2-sp2 every 90' starting at 0'). In addition, torsional angles were allowed to vary 
by an additional f 10" about these cardinal angles, and self-clashing conformations 
were removed using a 75% van der Waals radii bump check. 
2.4.3 Defining the ligand envelope 
For the completely buried target sites of T4 lysozyme and E. coli chorismate mutase, 
packing was achieved by placing spheres with a 1.5 A van der Waals radius on a 
regular cubic lattice of 0.25 A throughout the site. Spheres were assigned a van der 
Waals well depth of -0.1 kcal/mol. If a sphere had an unfavorable van der Waals 
interaction with the protein, it was rejected. For the open HIV-1 protease active site, 
spheres with a 1.5 A van der Waals radius were placed on a regular cubic lattice of 
0.4 A inside the volume that the TMC-114 inhibitor would occupy. Sphere positions 
were then minimized to convergence using the van der Waals potential in CHARMM, 
keeping the protease fixed. A special van der Waals function was employed where 
the optimal distance between two spheres was 0.5 A, while the optimal distances for 
sphere-protein interactions used the standard mixing rules. This procedure used the 
known ligand as seed positions for the spheres, while allowing them to expand further 
to fill the site upon minimization. 
2.4.4 Calculation of grid-based potentials 
Grid-based energies for van der Waals scoring were computed on a regular cubic 
lattice placed within each target shape. For T4 lysozyme and E. coli chorismate 
mutase, a grid spacing of 0.125 A was used, while 0.2 A was used for the work in 
HIV-1 protease. The parameters used for van der Waals energies were derived from 
the general  CHARM^^^ [I151 parameter set, which contains specified parameters for 
particular pairs of atom types in addition to using traditional mixing rules. As a 
result, separate grids were computed for each van der Waals atom type rather than 
using one grid and factoring out the mixing rules. To generate the grid-based energies, 
an atom of specified type was placed at each grid point within the target shape and 
its van der Waals interaction energy was computed with the receptor. After the 
grids were generated, the van der Waals interaction energy of any given molecule was 
approximated by summing the contribution from each atom, derived from trilinear 
interpolation from the surrounding eight points on the appropriate atom-type grid. 
Grid-based electrostatic solvation and interaction potentials were also computed 
on regular cubic lattices within the target sites, with a spacing of 0.5 A for T4 
lysozyme and E. coli chorismate mutase, and 0.75 A for HIV-1 protease. Elements 
in the L matrix and 6 vector as well as Rdes were computed with a continuum 
electrostatic model by solving the linearized Poisson-Boltzmann equation (LPBE) 
using a locally modified version of DELPHI [25-27,12 11. In all cases, the LPBE was 
solved using a molecular dielectric constant of 4, a solvent dielectric constant of 80, 
a molecular surface probe radius of 1.4 A, an ionic-strength of 145 mM, and an ion- 
exclusion radius of 2.0 A. When computing the elements of L or 2, a 129 x 129 x 129 
finite-difference grid was employed, and a 257~257x257 grid was used to compute 
Rdes A focusing scheme was used where the system being solved first occupied 23% 
and then 92% of the grid, transferring boundary potentials from the lower to higher 
resolution run. When computing elements of the L matrix and 6 vector, an additional 
over-focusing stage at 184% fill, centered at the grid point being computed, was used 
to improve accuracy. In all cases, the final grid resolution was at least 0.25 A at the 
maximum percent fill. Radii and charges for the receptor proteins were derived from 
the PARSE parameter set [22], and a radius of 1.5 A was used for all target shape 
spheres. 
Elements in the L matrix were calculated by taking the difference between solv- 
ing the LPBE in the bound state, where the receptor and target shape defined the 
geometry, and the unbound state where only the target ligand shape was present. 
For the bound and unbound states, each grid point was charged to a value of one 
while all other grid points and receptor atoms had a charge of zero. After solving 
the LPBE, the resulting potentials at the charged grid point as well as all other grid 
points become one column of the solvation matrix S for that state. After computing 
the full S matrices for each state, the relation L = Sbound - Sunbound was used to com- 
pute L. Elements in the e vector were derived from bound state calculations, where 
the receptor atoms are charged to their parameter values and the grid points had 
zero charge. The screened Coulombic potential generated at the grid points defined 
the 6 vector. Rdes was computed by taking the difference between the bound- and 
unbound-state solvation energy when the receptor was charged and the fixed target 
shape uncharged. 
The approximate electrostatic binding energy for any given molecule inside the 
target shape was computed by first spreading each partial atomic charge on to the sur- 
rounding eight grid points with trilinear projection. If several partial atomic charges 
were projected to the same grid point, their contribution was summed. These grid 
charges were then used in Equation 2.1. In general, only a small number of grid points 
receive charge, and consequently Equation 2.1 was implemented using sparse vectors 
in order to decrease computation time. 
2.4.5 Scaffold placement 
Every generated conformation of each scaffold was discretely placed throughout the 
target shape using rigid uniform sampling. In all systems studied, scaffolds were 
sampled in translation on a regular 0.5 A cubic lattice. At each lattice point, many 
rigid rotations were considered by equal sampling in X, Y, and Z rotation using Euler 
angles. The angular step size for rotational sampling was set such that the arc length 
swept out by the atom furthest from the molecule center was 1.0 A for T4 lysozyrne 
and 2.0 A for E. coli chorismate mutase and HIV-1 protease. Each placed scaffold was 
then checked against the fixed target shape to ensure that all atom centers were within 
the shape and at least 0.5 A away from its boundary. The extra distance padding 
was necessary to ensure that partial atomic charges were not spread to grid points 
outside the fixed shape. If the scaffold placement failed this check, it was rejected. 
In addition, the grid-based van der Waals energy was computed for each scaffold 
placement, and if this energy was unfavorable the placement was also rejected. 
2.4.6 Functional group attachment and pairwise energy eval- 
uat ion 
Pairwise energies for the functional groups attached to each scaffold placement were 
computed in three stages. Firstly, all growable hydrogen atoms were removed from the 
scaffold, as the remaining atoms were constant throughout the search. The van der 
Waals and electrostatic grid-based energies were computed for this blunt scaffold and 
stored along with the precomputed receptor desolvation Rd, as the constant term 
in the pairwise energy decomposition shown in Equation 2.4. Secondly, functional 
groups in discrete conformations were attached to each growable site by removing a 
hydrogen and creating a single bond between the two blunt atoms along the same 
vector used by the scaffold hydrogen. The bond length was set to the equilibrium 
value from the  CHARM^^^ [I151 parameter set. Rotations were generated about the 
newly formed bond with the same hybridization-based rules used for conformational 
sampling. Re-attachment of the hydrogen was also permitted at each growable po- 
sition, with its original bond length preserved. Newly attached discrete functional 
groups were examined to ensure that all atom centers were no closer than 0.5 A to the 
target shape surface, and that the functional group did not intersect the blunt scaffold 
when 75% van der Waals radii were used. The 75% cutoff was selected because it 
allowed clashing yet synthesizable geometries, such as two methyl groups grown from 
neighboring hydrogens on a benzene ring, to be designed without penalty. If a dis- 
crete functional group failed one of these checks, it was removed from consideration 
in the rest of the search procedure. 
When the scaffold and functional group hydrogens were removed for attachment 
and the two molecules fused, their partial atomic charges needed to be adjusted to 
maintain integral charge and account for inductive effects. In this work, a simplistic 
method was used where the partial atomic charge on the removed scaffold hydrogen 
was placed on the atom bonded to the removed functional group hydrogen, and the 
charge on the removed functional group hydrogen was placed on an associated point 
charge located at the position of the atom attached to the removed scaffold hydrogen. 
The role of the point charge is to ensure that the transferred charge is part of the 
functional group rather than the scaffold in energy calculations. Although this method 
only accounts for charge transfer across the new bond, any pairwise decomposable 
charge spreading procedure would be allowable. This means that charge could have 
been spread anywhere in the functional group or the blunt scaffold, but not into a 
different functional group. In the case of reattaching a hydrogen, the partial charge 
was kept the same as it was in the original scaffold molecule. The grid-based van 
der Waals and electrostatic energy of the blunt functional group with point charge 
(or hydrogen), as well as the indirect desolvation between the functional group and 
the blunt scaffold was then computed using Equation 2.5 to generate the self-energy 
terms. 
The final stage of pairwise energy calculation was to compute the pair contribu- 
tions to binding, which are either the indirect desolvation terms between each pair 
of discrete functional groups, or an infinite energy if the two functional groups clash 
when 75% van der Waals radii were used (Equation 2.6). If one of the two functional 
groups being considered was a re-attached hydrogen, the bump check was skipped 
because the hydrogen was forbidden from being eliminated. To increase the compu- 
tational efficiency of the quadratic matrix product in Equation 2.6, which was the 
slowest step in the energy calculation, the projected grid charges for all acceptable 
discrete functional groups were precomputed, and the inner Lp' product was stored 
and reused. 
2.4.7 Combinatorial search 
For each scaffold placement, the global minimum (binding) energy configuration 
(GMEC) of functional groups, as well as a ranked list of structures with progressively 
59 
increasing binding energy, was determined with a locally developed implementation of 
the dead-end elimination (DEE) [l 1 ,14,70] and A* [13] algorithms. After determining 
the GMEC, a ranked list of configurations with increasing energy was computed in 
2.5 kcal/mol increments until the list contained 10 conformations for 100 "unique" 
ligands, or a limit of 25 kcal/mol above the global minimum was reached. Ligands 
were considered "unique" if the receptor-ligand complex differed by more than ro- 
tations about dihedral angles in the functional group attachments. In other words, 
"unique" ligands differ in their functional group attachment pattern, and not solely in 
conformation. These best 1,000 (10 x 100) structures were pooled across all scaffold 
placements, sorted on total energy, and the top one million structures were stored. 
2.4.8 Hierarchical rescoring of highly ranked molecules 
The molecules with the most favorable computed binding affinity from the combina- 
torial search procedure were first re-evaluated with fast but non-pairwise corrections 
to the energy function, termed "medium resolution". These include approximations 
to correct for the fixed-shape assumption in the electrostatic calculation and an im- 
provement from grid-based to explicit-atom van der Waals packing energies. The best 
compounds found in the T4 lysozyme and E. colz chorismate mutase buried sites were 
electrostatically corrected by computing the unbound state solvation energy via the 
LPBE and true shape rather than grid-based energies (Equation 2.7). The solvation 
free energy in the unbound state was computed with a locally modified version of 
DELPHI 125-27,1211 using the same parameters as for grid generation except that a 
65 x 65 x 65 grid was used. PARSE radii [22] were assigned to the ligand. 
The compounds with the most favorable binding affinity from combinatorial search 
in the solvent exposed HIV-1 protease site were corrected using the presented vari- 
ational method [88,89]. The electric field in the bound or unbound states, present 
in the integrand of Equation 2.8, was computed through finite difference of the grid- 
based potentials, 4 = 2S& where $are the projected grid charges for the designed 
molecule and S is the solvation matrix for the appropriate state. In order to perform 
numerical volume integration, the computed electric field was assumed to be con- 
stant in the surrounding cube for each grid point, making its contribution equal to 
an evaluation of the integrand at the point times the grid spacing cubed. A grid cube 
contributed to the integral only if its associated point was inside the target shape, 
but became inside solvent when the dielectric boundary shrank from the target shape 
to a molecular surface derived from PARSE radii [22]. In order to determine solvent 
accessibility for a grid point, triangulated surfaces were generated in DELPHI using its 
boundary-element features [122], and point-in-polyhedron tests were performed using 
the GNU triangulated surface library (GTS) [123]. 
The best molecules after re-scoring with these fast but approximate corrections 
were subjected to further re-evaluation with a more sophisticated met hod of com- 
puting binding energies, utilizing a full Poisson-Boltzmann/surface area (PBSA) 
model [22]. In this approach, the differential solvation energies between the bound and 
unbound stlates were added to the vacuum ( 6  = 4) interaction energy between ligand 
and receptor. Solvation energies were computed by solving the linearized Poisson- 
Boltzmann equation with a locally modified version of DELPHI [25-27,1211 using a 
129x 129x 129 grid and the same parameters as for computing grid potentials. PARSE 
radii [22] were used for both the receptor and designed molecules, while PARSE charges 
were used only for the receptor. Charges on the designed molecules were the same 
as those used in the combinatorial search, which consisted of quantum mechanically 
derived charges for scaffolds and functional groups merged as described above. The 
hydrophobic contribution to solvation was computed as directly proportional to the 
solvent accessible surface area buried upon binding, using a probe radius of 1.4 A and 
a scaling factor of 5 cal/A2 [Z]. Vacuum electrostatic interactions used a constant 
dielectric constant of 4, and explicit-atom van der Waals interactions were carried 
over directly from the "medium resolution" energy function correct ion. 
Chapter 3 
Computat ional Design of Substrate 
Envelope Inhibitors to Avoid 
Resistance Mutations: HIV-1 
Protease as a Model System 
Abstract 
Drug resistance is a growing concern in the treatment of rapidly evolving pathogens. 
One of the most common mechanisms of drug resistance, especially in viral infections, 
is the accumulation of escape mutations in the drug target that reduce drug binding 
while maintaining normal protein function. Consequently, it is necessary to develop 
new therapeutics that are less likely to induce escape mutations, especially in cases 
where the exact mechanisms of resistance are unknown. One such strategy, which is 
especially applicable to drug targets that are essential enzymes for the pathogen, is to 
design inhibitors that mimic the structural features and binding modes of substrates. 
This idea, termed the substrate envelope hypothesis, suggests that target enzymes 
would not be able to mutate against inhibitors that remain inside a consensus sub- 
strate shape without also disrupting substrate binding. In order to begin testing the 
substrate envelope hypothesis as a drug design principle, we have employed HIV-1 
protease as a model system. Computational inverse small-molecule design techniques 
were applied to design inhibitors that would stay within a consensus substrate en- 
velope and were predicted to have high affinity. Fifteen envelope inhibitors were 
chemically synthesized and tested for binding against wild-type HIV-1 protease, with 
four compounds having inhibition constants (Ki) ranging from 30-50 nM. These four 
compounds exhibited broad specificity against a panel of three drug resistance HIV-1 
protease sequences, losing no more than 6-13 fold affinity relative to wild-type. A 
comparison of predicted to experimental binding energies as well as predicted to crys- 
tallographic structures for inhibitors highlights the limitations and strengths of our 
computational models. Overall, these results suggest that designing inhibitors that 
mimic substrates may be a viable strategy in the development of therapeutics with 
better resistance properties. 
'All experimental work presented in this chapter was performed by collaborators at  the University 
of Massachusetts Medical School in the laboratories of T. M. Rana and C. A. Schiffer. Specifically, 
chemical synthesis was performed by A. Ali and K. Reddy, HIV-1 protease inhibition assays were 
performed by H. Cao, and crystallography was performed by M. Nalam. 
3.1 Introduction 
One of the most important limiting factors in the current treatment of rapidly evolv- 
ing pathogens is drug resistance [35-421. Although drug resistance can be caused by 
a variety of mechanisms [40,124-1271, one of the most common, especially in viruses, 
is when the drug target mutates such that drug binding is reduced while the nor- 
mal function of the target is maintained [40,126,128,129]. Due to the increasing 
prevalence of this form of resistance, drugs need to be developed that do not in- 
duce these viable escape mutations. Most current efforts to design therapeutics with 
improved resistance profiles have focused on analyzing the failure modes of existing 
drugs and designing new compounds that have high efficacy against known resistant 
mutants [114,130-1321. Although this strategy has met with success [132,133], it has 
also resulted in the identification of new, unanticipated modes of resistance [134,135]. 
It is clear that a strategy is needed to design drugs that will not encourage escape 
mutations to form even when the possible modes of resistance are unknown. 
One such strategy, which is especially applicable to targets that are essential 
enzymes, is to design drugs that mimic the structural features of substrates [44,136- 
1391. If a drug molecule makes the same interactions and contacts with the target 
as substrate, meaning that its determinants of affinity are the same, it could be 
difficult for mutations to evolve that block inhibitor binding but maintain substrate 
recognition. Consequently, escape mutations should never form because they would 
render the pathogen non-viable. This idea can be summarized as the "substrate 
envelope hypothesis," meaning that inhibitors that stay within a consensus substrate 
shape should be less likely to induce resistance mutations than those that exceed 
the envelope and provide handles for escape mutations to lower inhibitor affinity 
selectively (Figure 3- 1). 
The goal of this work is to begin testing the substrate envelope hypothesis as an 
inhibitor design principle using HIV-1 protease as a model target and computational 
Figure 3-1: Example of the substrate envelope hypothesis. In the wild-type drug 
target (A), the traditional inhibitor (top) occupies more of the binding site and makes 
more contacts than a substrate (bottom). In (B), the drug target has mutated to 
expand the active site in a region that only contacts the inhibitor (star). The inhibitor 
(top) loses contacts and consequently binding affinity, while the substrate (bottom) 
loses no affinity as it never contacted the mutable residue. If the inhibitor had been 
designed to look more like the substrate, this resistance mutation would have little 
effect on its binding affinity. 
ligand design techniques to generate inhibitors that mimic the substrate shape. HIV- 
1 protease was selected as a model system due to the vast amount of structural, 
inhibitor, and resistance data available. Mechanisms of drug resistance in HIV- 1 
protease have been well studied [36,40,140], and binding modes of several HIV- 1 
protease peptide substrates have been determined [43,44]. The substrate complexes 
suggest a consensus substrate envelope 1441 that can serve as a drug design target. In 
order to design inhibitor molecules that stay within the envelope and are predicted 
to have high affinity to the protease, we employed a combinatorial small-molecule 
design technique based on an inverse approach (Chapter 2). The inverse ligand design 
strategy is particularly well suited to generating molecules within a specified envelope 
because a fixed target shape is a requirement in the algorithm, serving as both a limit 
on the size and shape of the ligand as well as a molecular boundary for electrostatic 
modeling. Inverse small-molecule design takes a library of scaffold molecules, places 
them discretely within the envelope, and performs guaranteed combinatorial searches 
over a discrete space of functional group attachments to identify molecules that fit 
in the shape and are predicted to have high affinity. For this work, the scaffold 
employed was a variant of the core of the clinical inhibitor amprenavir [I301 (Figure 
3-2), which is known to fit well inside the substrate envelope [136], is relatively easy 
to chemically synthesize, and has three sites for functional group attachment. The 
functional group library, however, was selected naively, and consisted of reagents from 
chemical catalogs. 
In order to measure how well the substrate envelope inhibitors perform, a set 
of fifteen compounds suggested by computation were chemically synthesized. These 
compounds were assayed for binding against the wild-type protease and all exhibited 
inhibitory activity, with four compounds having Ki values in the range of 30-50 nM. 
In addition, the affinity of these top four compounds was measured for three drug 
resistant proteases derived from co-evolving mutations in clinical isolates [141,142]. 
Compared to two clinical inhibitors, these compounds exhibited broad specificity, los- 
ing similar fold affinity to the clinical inhibitor amprenavir, known for its effectiveness 
in vivo against multi-drug resist ant HIV- 1 strains [143]. Ultimately, these compounds 
need to be tested in accelerated evolution studies [144,145], where HIV-1 protease is 
grown in vitro under strong selection pressure from protease inhibitors to determine 
if it is possible to evolve escape mutants against them. 
Overall, the successful design of compounds that stay within the HIV- 1 protease 
substrate envelope and have broad specificity against resistant mutants supports the 
substrate envelope hypothesis, setting the stage for more complete validation studies. 
Currently, efforts are underway to design a second round of inhibitors that stay within 
the envelope and have higher affinity, as well as to specifically design inhibitors that 
exit the substrate envelope. These compounds should have poor resistance profiles, 
providing negative controls for the substrate envelope hypothesis in a design format. 
3.2 Computational strategy 
In order to computationally design compounds predicted to stay within the substrate 
envelope and have high affinity to the wild-type HIV-1 protease, we employed a 
previously described inverse small-molecule design algorithm (Chapter 2). In this 
section, we provide a brief overview of the method and how it was directly applied to 
the design of compounds capable of binding within the envelope, highlighting choices 
that were specific to this system as well as any deviations from the established inverse 
design protocol. 
3.2.1 Substrate envelope selection 
The inverse small-molecule design strategy requires several inputs. The first of these 
is a fixed envelope that serves as a hard outer constraint on the size and shape of 
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designed ligands. Two fixed shapes, based on the superimposed structures of five 
peptide substrate-inactivated HIV-1 protease complexes, were generated by placing 
spheres on a regular grid surrounding the superimposed substrates and keeping those 
that were within 1.0 A of a substrate atom center in either 1 of the 5, or 3 of the 5 
substrates. The shape generated when requiring that spheres are near atoms in 3 of 
the 5 substrates provided a tighter envelope. 
3.2.2 HIV-1 protease structure selection 
Another requirement of the inverse design algorithm is that the fixed envelope must 
be placed inside a protein structure such that binding energetics for molecules built 
inside can be evaluated. When designing compounds that are attempting to mimic 
substrate geometries, it makes sense that the protein receptor should be well suited 
for binding substrates. Consequently, both envelopes were placed back into one of the 
inactivated HIV- 1 prot ease structures, specifically the reverse transcript ase-RNaseH 
(RT-RH) substrate complex (PDB code IKJG), using the same alignment that gen- 
erated the substrate superposition used for envelope generation. This structure was 
selected because the RT-RH substrate is the largest peptide in volume, and its as- 
sociated protease accommodated the substrate envelope well. However, there were 
a few substrate envelope spheres that clashed with the protease structure when the 
envelope was placed in the site, and these spheres were removed. In addition, extra 
spheres were added to the envelope within 3.5 A around the catalytic dyad. This was 
necessary because the substrates do not closely interact with the catalytic residues, 
but most inhibitors make direct hydrogen bonding interactions. Adding these spheres 
should not increase the chance of escape mutations because the catalytic aspartates 
are invariant. In some sense, the role of the extra spheres is to more closely mimic 
the transition state envelope at the site of catalysis. 
One final modification that needed to be made to the protease structure was 
the "re-activation" of the catalytic residues. The protease-complex structures were 
solved in the context of a deactivating D25N mutation in order to prevent substrate 
processing. Consequently, the catalytic residues were mutated back to aspart ate, 
using the same side-chain dihedral angles as the crystallographic asparagines. The 
protonation state of the aspartyl dyad in HIV-1 protease has been the subject of 
much debate [146-1481. Therefore, two protonation states were considered separately 
in the inverse design procedure. One model has the dyad doubly deprotonated, and 
the other is singly protonated such that a hydrogen bond is formed that bridges the 
two aspartates. 
3.2.3 Scaffold and functional group search space 
The inverse small-molecule design method expresses the combinatorial space of in- 
hibit or molecules as molecular scaffolds with functional group attachment s. For this 
work, it was important to select a molecular scaffold that was easy to chemically syn- 
thesize and that fits well inside the substrate envelope. The scaffold selected to form 
the core of all designed compounds is shown in Figure 3-2. It has three sites for at- 
tachment, denoted by the R groups. Given the synthetic scheme for molecules based 
on this scaffold, functional groups at the R1 position are derived from carboxylic 
acids, groups at the R2 position are derived from primary amines, and attachments 
at R3 come from sulfonyl chlorides. This scaffold is very similar to the core of the 
clinically approved inhibitor amprenavir (APV) [130], except that an amide linkage 
is used to attach the R1 group rather than a carbamate linkage. 
Functional groups were selected naively from chemical databases. A set of 2,327 
carboxylic acids and 379 primary amines for the R1 and R2 positions respectively were 
obtained from the ZINC database [I491 (as of December 2004). 274 sulfonyl chlorides 
were obtained for the R3 position directly from the Sigma-Aldrich and Maybridge 
catalogs. 
R1 : From Carboxylic Acids (R1 -COOH) 
R2: From Primary Amines (R2-NH2) 
R3: From Sulfonyl Chlorides (R3-S02CI) 
Figure 3-2: Hydroxyethyl sulfonamide core used as the scaffold for substrate envelope 
inhibitor design. The scaffold can be diversified at three positions, R1, R2, and R3, 
using functional groups derived from carboxylic acids, primary amines, and sulfonyl 
chlorides, respectively. The scaffold is similar to the core of the clinical inhibitor 
amprenavir [130] and the pre-clinical inhibitor TMC-114 [I 141. 
3.2.4 Grid-based energies and scaffold placement 
The next stage in the inverse design inhibitor procedure was to compute pairwise 
grid-based potentials and energies within the fixed envelopes that will be used for 
fast evaluation of binding energetics [74, 84-86]. Overall, four sets of grids were 
computed, for both the tight and loose substrate envelopes and both protonation 
states of the protease. Once grid generation was complete, the next stage involved 
finding docked conformations for the scaffold that had a good disposition for growing 
functional groups that could interact favorably with the grid potentials. Two methods 
were used to achieve this goal. The first method used uniform sampling to build the 
scaffold into the envelope by rigidly docking a scaffold fragment and extending it to a 
complete molecule while sampling torsional degrees of freedom. Scaffold placements 
that remained in the envelope, scored well against the grid-based potentials, and could 
successfully grow prototypical functional groups from all three attachment points were 
accepted. 
The second scaffold sampling method used knowledge of the known binding mode 
of this scaffold observed in crystal structures. The structure of the amprenavir com- 
plex (PDB accession code 1HPV) [130] was aligned to the substrate structure and the 
coordinates of amprenavir were retained. Scaffold placements were then derived by 
threading onto the known binding mode to generate an ensemble of scaffold positions 
that had an RMSD less than 1.0 A. Again, placements were accepted if they scored 
well and could grow three functional groups. 
3.2.5 Combinatorial search and hierarchical re-scoring 
A total of eight independent inverse design runs were carried out, to cover all com- 
binations of both the tight and loose substrate envelopes, the singly and doubly de- 
protonated protease structures, and both the uniform and knowledge-based scaffold 
sampling techniques. For each scaffold placement in each independent design, discrete 
conformations of the functional group library were grown from each attachment site, 
computing the self energy of each functional group as well as pair energies between 
groups. Because the energy function used in this stage of the inverse design is pairwise 
additive, global minimal and rank-ordered energy arrangements of functional groups 
could be identified using the deterministic and guaranteed search algorithms dead- 
end elimination (DEE) [ll, 14,701 and A* [13]. The top ranking compounds across 
all scaffold placements in each design run were pooled and hierarchically re-evaluated 
using more sophisticated energy models to correct for approximations such as the use 
of grid-based energy functions and a fixed envelope in electrostatic calculations. In 
this manner, we could ensure that the top ranking compounds had been identified in 
a full binding energy model, which included explicit-atom van der Waals interactions, 
a full continuum solvat ion treatment of electrostatic effects, and a non-polar solvat ion 
term directly proportional to the surface are buried upon binding. 
3.3 Results and Discussion 
3.3.1 Development of a substrate envelope inhibitor library 
After inverse design calculations were performed to generate ligands within the sub- 
strate envelope and predicted to have high affinity, the space of top-ranking com- 
pounds was hand pruned to select a set of twenty compounds for chemical synthesis 
(Figure 3-3). Several criteria were used to generate the final library when examining 
the top compounds from all eight design efforts. First, nine compounds were selected 
(Figure 3-3, Compounds 1-9) where a functional group attachment made direct hy- 
drogen bonding interactions with backbone atoms of the protease in at least one of 
the design runs. The next set of five compounds (Figure 3-3, Compounds 10-14) were 
selected because they scored highly in all eight inverse design conditions, with the idea 
that these compounds were robust to changes in the design protocol. Two additional 
compounds (Figure 3-3, Compounds 15-16), were selected because they scored very 
highly in one particular design, which used the loose envelope, the doubly deproto- 
nated protease structure, and uniform scaffold sampling. The final four compounds 
(Figure 3-3, Compounds 17-20) were selected because they cross-validated well with 
other computational small-molecule affinity estimation techniques. The first two of 
these compounds scored well in a molecular docking algorithm [150,151], and the last 
two scored well in the commercial docking program Glide [6,152] from Schrodinger, 
Inc. For the docking studies, the doubly deprotonated model of the protease was used 
as a target. 
3.3.2 Experimental binding affinities to wild-type HIV-1 pro- 
tease 
Of the twenty designed compounds, the inhibitory activity (Ki) of fifteen was exper- 
imentally measured against the wild-type HIV-1 protease using an enzymatic inhi- 
Figure 3-3: Twenty compounds proposed by computational inverse ligand design to 
bind HIV-1 protease within the substrate envelope and with high affinity. 
Figure 3-4: Predicted interactions for isoxazole rings designed at the R3 position. 
The ring oxygen and nitrogen were predicted to make favorable hydrogen bonding in- 
teractions with the backbone amide hydrogens of protease residues Asp29 and Asp30. 
However, the isoxazole group was detriment a1 to binding, as compounds containing 
the ring had inhibition constants (K,) greater than 10 pM. 
bition assay [153]. The results of these assays are shown in Table 3.1. All fifteen 
compounds tested had measurable inhibitory activity against the wild-type protease, 
with Ki values ranging from approximately 30-26,000 nM. For reference, the Ki val- 
ues for two clinically approved inhibitors, lopinavir (LPV) and amprenavir (APV), 
were also measured. 
When comparing the structures of the compounds and their relative binding affini- 
ties, several trends emerged. Firstly, the use of a methylated isoxazole ring at the 
R3 position (Compounds 6, 10, and 14) was detrimental to binding, resulting in in- 
hibition const ant s greater than 10 pM. This was surprising considering that these 
compounds were predicted to make strong hydrogen bonding interactions with the 
backbone amide hydrogens of protease residues Asp29 and Asp30 (Figure 3-4). The 
five untested compounds were not measured because they all contained this isoxazole 
ring and would likely have poor affinity. 
Several other groups that were predicted to make hydrogen bonding interactions 
were well tolerated in this set of compounds, including an alanine substitution at 
R1 (Compound I) ,  a catechol ring at R1 (Compound 3), and a meta anisole at R3 
in several compounds. In addition, several non-polar groups were well tolerated, 
including fluorinated groups at R1 and R3 in several compounds, and a thiophene 
ring at R2. 
Overall, even the best binders in the set of designed compounds were still 2- 
4 orders of magnitude weaker than the clinical inhibitors lopinavir and amprenavir. 
One possible explanation is the commonly designed thiophene ring at the R2 position, 
which interacts with the PlIP1' pocket of the protease. The far majority of known 
tight-binding inhibitors of HIV-1 protease use highly aliphatic or aromatic groups 
to interact with this hydrophobic pocket [154]. Therefore, it is possible that the 
thiophene ring may still be too polar for the hydrophobic P1 subsite. However, 
the thiophene moiety was one of the least polar functional groups available in the 
naive primary amine library used to diversify the R2 position in the inverse design 
calculations. Unsubstituted aliphatic and aromatic groups were not present in the set 
of compounds searched at R2. Therefore, the low affinity observed in this first-round 
library may be due to limited diversity in the initial selection of functional groups, 
rat her than deficiencies in the design algorithm it self. 
3.3.3 Experimental binding affinities to drug resistant HIV-1 
proteases 
In order to gain initial insight into whether compounds designed to stay within the 
substrate envelope would be less likely to elicit escape mutations, the inhibition con- 
stants for several designed compounds were experimentally measured in drug resistant 
proteases. Three drug resist ant HIV- 1 protease mutants were selected from previously 
identified sets of co-evolving mutations in drug resistant clinical isolates by Shaffer 
Table 3.1: Experimentally measured inhibition constants against wild-type HIV-1 
protease for two clinically approved inhibitors and fifteen inhibitors computationally 
designed to stay inside the substrate envelope. 
Compound / Ki (nM) I Compound 
LPV 
APV 
and coworkers [I411 and Swanstrom and coworkers [142]. The three drug resistant 
proteases contained either "Group 2" mutations (LlOI, G48V, I54V, L63P, V82A) 
which are tightly linked to lopinavir (LPV) resistance, "Group 3" mutations (D30N, 
L63P, N88D), which co-evolve in response to treatment with nelfinavir (NFV), or 
"Group 4" mutations (LlOI, L63P, A71V, G73S, I84V, L90M) which confer mod- 
erate resistance to a variety of inhibitors. The four designed compounds with the 
highest affinity to the wild-type protease were tested against the three drug resist ant 
proteases, in addition to the two clinical inhibitors lopinavir (LPV) and amprenavir 
(APV). The results of the binding assays are shown in Table 3.2. 
The clinical inhibitor lopinavir (LPV) exhibited the worst resistance profile, losing 
1,220-fold inhibition relative to wild type in the Group 2 resistant protease, which was 
unsurprising given that the Group 2 mutations were known to co-evolve in response 
to lopinavir treatment [142]. On the other hand, amprenavir (APV) exhibited a 
relatively flat resistance profile for these protease mutants, losing at most 11-fold 
inhibition in Group 4. Group 4 mutations, especially I84V, are known to correlate 
with amprenavir treatment [142]. Although the designed inhibitors bound weaker 
than the clinical compounds, they had resistance profiles similar to or better than 
amprenavir, losing 6-1 3 fold inhibition in the three mutants tested. One interesting 
Table 3.2: Experimentally measured inhibition const ants against wild-type and three 
drug resistant HIV-1 proteases for two clinically approved inhibitors and four in- 
hibitors cornputationally designed to stay inside the substrate envelope. 
Compound I Wild-type 1 Group 2 1 Group 3 1 Group 4 1 Worst Fold 
APV 1 0.13 f 0.11 10.15 5 0 . 3 7  10.21 f 0.44 1 1.4 f 1.0 I 11 
LPV 
feature in the resistance patterns of the designed inhibitors was that small changes in 
structure were sufficient to shift the resistance profile. For example, when an alanine 
group at R1 in Compound 1 was changed to a fluorinated hydrocarbon in Compound 
11, the resistance profile shifted from being Group 2 sensitive to strongly Group 4 
sensitive. 
Although the designed compounds show broad specificity against this particular 
set of drug resistant proteases, these results do not guarantee that the designed com- 
pounds will not be susceptible to alternative resistance pathways. For example, the 
clinically approved inhibitor amprenavir (APV), exhibits broad specificity in these 
assays but induces an alternative resistance pathway in clinical isolates involving the 
I50V mutation [134]. Therefore, to fully test the substrate envelope hypothesis, it will 
be necessary to ensure that alternative or previously unknown resistance pathways 
do not develop in response to treatment with the envelope inhibitors. One possible 
way to accomplish this would be to use the designed compounds as selection pressure 
in accelerated evolution studies of HIV-1 in cell culture [144,145]. 
Ki (nM) 
0.005 5 0.02 
Ki (nM) 
6.1 f 2.0 
Ki (nM) 
0.04 f 0.23 
Ki (nM) 
0.9 5 0.7 
LOSS 
1220 
3.3.4 Comparison of predicted to experimental binding 
affinities 
In order for computational inhibitor design algorithms to enrich libraries with com- 
pounds that bind tightly experiment ally, it is import ant that the scoring functions 
used for design correlate well with experimental affinities. The energy function used 
to perform the final ranking of compounds in the inverse design procedure was based 
on a rigid-binding Poisson-Boltzmann surface area (PBSA) approach [22]. It included 
contributions to the binding free energy from van der Waals forces, electrostatic sol- 
vation as computed with the linearized Poisson-Boltzmann equation, and a non-polar 
solvation term directly proportional to the surface area buried upon binding. A com- 
parison between computed and experiment a1 binding energies is shown in Figure 3-5A 
for the 15 designed compounds measured as well as the clinical inhibitor amprenavir 
(APV) . 
Overall, little or no correlation was observed between the computed and experi- 
mental binding energies for the designed compounds. One possible explanation for 
this finding is that previous reports have shown that it is difficult for computation to 
discriminate between compounds that are separated by less than 3-4 orders of magni- 
tude in binding affinity with energy functions similar to those used in this work [155]. 
However, it is surprising that amprenavir (APV) is not ranked significantly better 
than the designed compounds, considering that its experiment a1 inhibit ion const ant 
was five orders of magnitude tighter than the weakest binding designed inhibitors. 
In an attempt to improve the correlation, several modifications to the scoring func- 
t ion were tested. These included using several dielectric const ants for the molecular 
interior, several minimization protocols for the designed structures before scoring, 
and recomputing partial atomic charges for the entire designed molecules, rather 
than the fragment-based approach used in the inverse design technique. In addition, 
several methods for weighting the various energy terms in determining a final score 
were tested. However, none of these efforts resulted in significantly better agree- 
ment with experiment (data not shown). The inability to improve correlation led 
to a close examination of the predicted structure for amprenavir from inverse design 
in the minimal shape. Due to the position of the I84 side chain in the substrate- 
bound protease structure, the isobutyl group of amprenavir was unable to adopt the 
conformation observed in its own crystal structure due to the presence of a van der 
Waals clash. Therefore, another possible explanation for the poor energy ranking was 
that the substrate-bound protease structure lacked the induced fit required to bind 
amprenavir . 
In order to significantly improve the correlation, it was ultimately necessary to 
change the the model used for inhibitor envelope as well as the structure used for the 
protease. In the inverse design protocols described thus far, the target shape for de- 
sign was set to the substrate envelope. Experimentally, there is no requirement that 
the lowest-energy structure for the inhibitor-protease complex stay within this enve- 
lope, and the addition of this artificial constraint on ligand geometry may have been 
partially responsible for decreased correlation. The fact that the designed inhibitors 
scored well within the substrate envelope only signifies that there exists a low energy 
envelope structure, which is not necessarily the overall structural minimum. However, 
the use of a "maximal" ligand envelope in inverse design, which completely fills the 
central four pockets of the protease active site, was still insufficient to observe correla- 
tion with experimental affinities when used in conjunction with a protease structure 
derived from a substrate complex. It was also necessary to switch from using the 
protease from the RT-RH substrate complex to using a protease structure that was 
bound to an inhibitor containing a scaffold similar to the one used in the designed 
compounds. 
The inverse design procedure was repeated using the protease structure from a 
complex with the tight-binding small-molecule inhibitor TMC- 1 14 [I 141. TMC- 114, 
a variant of amprenavir, contains a similar scaffold to the one used for design and its 
known binding mode was used to generate scaffold placements for the inverse design 
procedure. Instead of using the substrate envelope as the target shape for design, 
a "maximal" shape was employed that completely packs the central four pockets 
of the protease with spheres. The functional group library used for design contained 
the fragments necessary to regenerate the fifteen previously designed compounds that 
had experimental affinities as well as those for regenerating amprenavir and TMC-114. 
The highest ranking combinatorially generated structures for each of these compounds 
were evaluated using the full PBSA scoring function, and the correlation between 
these energies and those from experiment is shown in Figure 3-5B. 
After changing the envelope definition and protease structure, there was some 
improvement in the correlation, as the scores for amprenavir (APV) and TMC-114 
were now predicted to be better than those for the designed compounds. However, 
there was not much improvement in the relative ranking of the designed compounds, 
most likely due to their small binding energy differences. Overall, the improved 
correlation highlights the effect of the receptor model in correctly ranking inhibitor 
affinities. Although results were only presented for the TMC-114-bound protease 
structure, re-designing the compounds in a protease structure derived from a complex 
with amprenavir (PDB accession code 1HPV) [130], which contains the same scaffold 
as TMC-114, led to similarly improved correlation (data not shown). These results 
reinforce the importance of induced fit in correctly scoring inhibitor affinity [156]. 
3.3.5 Comparison of predicted to experimental structures 
In addition to observing correlation between predicted and experimentally determined 
binding energies, it is important that the structural models used for scoring in com- 
putational design are predictive of the true experimental structures. To this end, four 
crystal structures were determined of complexes between wild-type HIV-1 protease 
Figure 3-5: Comparisons between predicted and experimental binding affinities. In 
(A), the fifteen designed compounds with measured affinities, as well as the clinical 
inhibitor amprenavir (APV), were generated and scored using a substrate envelope in- 
side a protease structure derived from a substrate complex. In (B), these compounds, 
in addition to the tight-binding inhibitor TMC-114, were designed and scored inside a 
"maximal" envelope that completely fills the active site of a HIV-1 protease structure 
derived from a complex with TMC-114. Generating and scoring compounds without 
the substrate envelope constraint and inside a structure bound to a similar scaffold 
improves the ability to differentiate between tighter and weaker binders. Experimen- 
tal Ki values were converted to binding energies by assuming that Ki = Kd and that 
AG = -RTlnKd. 
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and the tightest binding designed inhibitors, Compounds 1, 3, 11, and 15. When 
comparing predicted to experimental structures, two structural models were available 
for each designed compound. The first was the initial structure designed against the 
substrate envelope in a substrate-bound protease used to propose compounds for syn- 
thesis, and the second was the structure used for improved energy function correlation 
designed without the substrate envelope constraint in the TMC-114-bound protease. 
Because a crystal structure is a representative low energy structure, it made sense 
to initially compare geometries against the structural prediction designed without 
envelope constraints. 
In general, the structural agreement between the predicted (without envelope) 
and experimental structures was reasonably high (Figure 3-6). After aligning the 
protease structures, the root-mean-square deviation (RMSD) in coordinate positions 
for non-hydrogen atoms of the inhibitors were 0.8, 1.0, 0.9, and 1.2 A for compounds 
1, 3, 11, and 15 respectively. The major structural differences included a flip of the 
thiophene ring orientation in all four compounds, and misalignments of the positions 
for the R1 and R3 groups, especially in Compound 15. The prediction of the scaffold 
geometry and placement agreed well with the crystal structures for all compounds. 
When the substrate envelope was superimposed on the crystal structures of the 
inhibitors, it was clear that the thiophene ring contained in all of the crystallized 
designed compounds protruded (Figure 3-7A). This finding is significant because it 
implies that a lower energy structure can be obtained if the inhibitors are allowed 
to leave the envelope. Consequently, the predicted structures for the inhibitors de- 
signed using the envelope constraint in a substrate-bound protease structure had far 
less similarity to the crystal (Figure 3-7B). In order to stay within the confines of 
the substrate envelope, the sulfonamide nitrogen inverts and the thiophene ring at 
R1 rotates almost 180" with respect to its linkage to the scaffold. This predicted 
geometry, where the substituents interacting with the PI and PI' protease pockets 
Figure 3-6: Comparison between predicted and experimentally determined structures 
for four of the tightest binding designed compounds, Compounds 1 (A), 3 (B), 11 (C), 
and 15 (D). The structure drawn in thicker bonds is the prediction, and the structure 
with thinner bonds is the crystallographic geometry. Green atoms are fluorine. 
are pointing away from each other, is very reminiscent of the binding mode that the 
substrates utilize [44]. These findings suggest that the designed compounds may be 
able to retreat inside the envelope and adopt this alternate conformation with a small 
energy penalty, which may explain the broad specificity that the envelope compounds 
exhibit towards drug resistant proteases. 
Conclusions and Future Work 
In conclusion, this work establishes a framework for and begins to test the substrate 
envelope hypothesis as a design principle for the development of inhibitors less likely to 
induce resistance mutations in a drug target. Using HIV-1 protease as a model system, 
an inverse small-molecule design strategy was employed to design protease inhibitors 
predicted to have favorable binding energetics while remaining inside the substrate 
envelope. These compounds were combinatorially generated using a molecular scaffold 
Figure 3-7: Experimental and predicted structures compared with the substrate enve- 
lope. In (A), the crystal structure of Compound 1 is superimposed on the substrate 
envelope (purple dots represent envelope sphere centers). The white arrow shows 
a portion of the molecule that protrudes from the envelope. In (B), the predicted 
structure for Compound 1, when designed with the substrate envelope constraint, 
uses an alternate conformation that stays within. This generates the hypothesis that 
the broad specificity of these compounds may be due to their ability to easily retreat 
inside the substrate envelope. 
known to bind and stay within the HIV-1 protease substrate envelope, as well as 
a naive functional group library derived from chemical catalogs. Fifteen designed 
compounds were chemically synthesized and experimentally tested for inhibition of 
the wild-type HIV-1 protease. Four of these compounds had inhibition constants 
(K,) between 30-50 nM, and these compounds were experimentally tested for binding 
against a panel of three drug resistant protease mutants. The designed compounds 
exhibited broad specificity against the drug resist ant mutants, losing only 6-1 %fold 
inhibition relative to wild-type in the worst case. This is in sharp contrast to the 
clinical inhibitor lopinavir (LPV), which loses over 1,200-fold in relative inhibition for 
a particular drug resistant protease. 
Comparison of computed with experimental binding energies initially showed lit- 
tle correlation, even after attempting several modifications to the energy evaluation 
protocol. However, re-designing compounds in a "maximal" shape that filled the 
HIV-1 protease active site and utilizing a protease structure bound to an inhibitor 
containing a similar scaffold to designed compounds were sufficient to correctly rank 
the inhibitors amprenavir and TMC-114 ahead of the designed compounds. These 
results point to active site rearrangement and induced fit being important in the 
correct ranking of inhibitor binding affinity. In addition, a comparison of the pre- 
dicted and experimental structures for the four tightest-binding designed compounds 
shows good agreement when the structural prediction is derived from design with- 
out the substrate envelope constraint. This was not surprising given that the crystal 
structure geometries for the designed compounds protrude from the envelope. The 
predicted structures for the compounds designed within the envelope in a substrate- 
bound protease structure were significantly different from the crystal geometries and 
more substrate-like, offering the hypothesis that these designed ligands may be able 
to retreat inside the envelope in response to resistance mutations. 
Although the fact that these inhibitors show broad specificity to drug resist ant 
mutations is encouraging, it does not guarantee that these inhibitors will not be sus- 
ceptible to alternative resistance pathways. One way to answer this question would be 
to use the designed envelope inhibitors as selection pressure in an accelerated evolu- 
tion study of HIV-1 in cell culture [144,145], to see if it is possible to evolve resistance 
against the compounds. However, a practical factor limiting these experiments is that 
the binding affinity for the designed compounds is still significantly worse than the 
weakest binding clinical inhibitors. In general, the ICS0 for HIV- 1 protease inhibitors 
in cell-based assays is weaker than their Ki values in solution [145], making it chal- 
lenging to work with weaker inhibitors in viral culture. Therefore, we are currently 
designing a second round of envelope inhibitors using a more proteaselike set of func- 
tional groups and a substrate envelope built into the TMC-114 protease structure for 
improved scoring. Hopefully, this library will be enriched in tighter-binding inhibitors 
that still remain inside the envelope. 
Another important feature of the work presented here is that the substrate enve- 
lope hypothesis has only been tested as a design principle in the positive direction, 
meaning that compounds designed to stay inside the envelope have been shown to 
have broad specificity against mutant proteases. It is also important to test the 
hypothesis in the negative direction, meaning that compound libraries specifically 
designed to protrude from the envelope yet are predicted to have high affinity should 
exhibit poor resistance profiles. Consequently, computational design efforts are cur- 
rently being carried out to design such inhibitors. 
3.5 Materials and Methods 
3.5.1 HIV-1 protease structure preparation 
Cryst a1 structures of five inactivated HIV- 1 protease-substrate peptide complexes 
were obtained from the Protein Data Bank (PDB) (Accession codes 1F7A, 1KJ7, 
IKJF, lKJG, and 1KJH) [43,44] in addition to a structure of HIV-1 protease bound 
to the inhibitor TMC-114 (Accession code 1T3R) [114]. Although a sixth substrate 
complex was available, it was not used in this study because of its poorer resolu- 
tion. For structures with multiple occupancy, the first conformation was used in all 
calculations. In all structures, the terminal side-chain dihedral angle for asparagine, 
glutamine, and histidine residues was considered for a 180 degree rotation if it would 
visually improve the hydrogen bonding network. All water molecules were removed 
from the protease-substrate complexes except for five that were highly conserved 
across all structures [44]. In the TMC-114-bound structure, only the flap water was 
retained. Hydrogen atoms were added to all structures using the HBUILD module [I161 
in the CHARMM computer program [I171 using the general  CHARM^^^ parameter 
set [I151 and a distance-dependent dielectric constant of 4. In addition, any missing 
side-chain atoms were built back into the structures using CHARMM and the default 
geometry in  CHARM^^^. All ionizable residues were left in their standard states at 
pH 7. 
For subsequent inverse design calculations, the protease from the RT-RH sub- 
strate complex (PDB accession code 1KJG) and the TMC-114 bound protease struc- 
ture were used as design targets. In the case of the RT-RH-bound protease, the 
inactivating D25N mutations were reversed by building aspartate residues directly 
on top of the crystallographic asparagines. To create a singly protonated protease 
structure, the re-activated aspartate in the A chain was protonated on the 0 6 2  atom 
such that it formed a hydrogen bonding interaction with Asp25B across the dimer 
interface. For both of these protease structures, PARSE radii and charges [22] were as- 
signed for solvation and electrostatic calculations, while  CHARM^^^ parameters [I151 
were assigned for computing van der Waals interactions with potential ligands. 
3.5.2 Preparation of scaffold and functional group libraries 
A 3-D structure for the scaffold used for computational inhibitor design (Figure 3-2) 
was created using GAUSSVIEW 3 [ll8]. 3-D structures for 2,327 carboxylic acids and 
379 primary amines were obtained from the ZINC database [I491 in December 2004 
for subsequent attachment to the R1 and R2 sites respectively. Compounds obtained 
from the ZINC database were limited to the vendors Sigma-Aldrich, Maybridge, and 
Ryan Scientific. 2-D structures for 274 sulfonyl chlorides were obtained for the R3 
position directly from the Sigma-Aldrich and Maybridge catalogs in December 2004, 
as they were not present in the ZINC database at the time of retrieval. 3-D structures 
for the R groups needed to reconstruct amprenavir and TMC-114 were built by hand 
using GAUSSVIEW 3. 
Structures were converted from 2-D to 3-D (if necessary), and 3-D structures were 
sampled in ring conformations, tautomeric states, and protonation states using the 
program LIGPREP from Schrodinger, Inc. At this stage, carboxylate groups were 
removed from members of the R1 library, amines were removed from members of 
the R2 library, and the sulfonyl chloride moiety was removed from members of the 
R3 library to facilitate attachment to the scaffold. In all cases, the removed groups 
were replaced by a hydrogen atom designated for attachment. As previously de- 
scribed (Chapter 2), geometries for all scaffolds and functional groups were optimized 
and partial atomic charges determined using quantum mechanical calculations, with 
conformational ensembles pre-generated for all functional groups. 
3.5.3 Computational inverse inhibitor design to target the 
substrate envelope 
Computational inverse inhibitor design was carried out as previously described (Chap- 
ter 2), with the following changes to the protocol. Rather than use a target ligand 
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shape that filled the entire binding site, inverse design was performed using an enve- 
lope based on the HIV-1 protease substrate structures. To generate the envelope, the 
five HIV- 1 protease-substrate pept ide complexes were simultaneously aligned on all 
Ccu atoms using the program PROFIT [157]. Spheres of radius 1.5 A were placed on a 
cubic lattice of dimension 0.5 A that surrounded the superimposed substrate peptides. 
Spheres were accepted if they were either within 1.0 A of any substrate non-hydrogen 
atom, to create a loose envelope definition, or if they were simultaneously within 
1.0 A of non-hydrogen atoms in 3 substrates, to create a tighter envelope. In both 
cases, spheres were also accepted if they were within 3.5 A of the side chain of Asn25 
(inactivated catalytic residue) in either monomer to ensure that designed inhibitors 
would be permitted to interact with these non-mutable residues. These envelopes 
were placed back into a protease structure derived from a complex with the largest 
substrate peptide, RT-RH. The orientation of the envelope inside the protease was 
the same as the one used for substrate superposition. 
When placing the scaffold inside the substrate envelope, two techniques were em- 
ployed that differed from the previously described methods for rigid sampling of pre- 
generated scaffold conformations (Chapter 2). Because the scaffold used here had 
numerous rot at able bonds, it was not possible to generate a complete conformational 
ensemble ahead of time. Instead, the scaffold was broken into rigid pieces across ro- 
tatable bonds, and the largest (in this case the benzene ring) was sampled discretely 
throughout the envelope in translational steps of 0.25 A and rotational steps in X, 
Y, and Z such that the arc length swept out by the atom furthest from the geometric 
center was 1.0 A. Next, the placed fragments were extended into complete scaffold 
molecules by attaching the remaining rigid pieces sequentially while sampling about 
torsional degrees of freedom in 30-degree increments. Scaffolds were accepted if they 
remained inside the envelope by at least 0.5 A, had a favorable grid-based van der 
Waals score, and were able to grow at least one functional group from the library at 
each attachment site. 
In an alternate procedure, scaffold placements were obtained by threading the 
scaffold on an experimentally determined binding mode. This mode was generated by 
aligning a protease structure bound to amprenavir (PDB accession code 1HPV) [I301 
to the substrate-bound protease, and only retaining atoms that corresponded to the 
scaffold. To perform threading, the scaffold was again broken into rigid pieces, and 
the largest was aligned to the known binding mode by minimizing the RMSD. Then, 
the remaining scaffold pieces were sequentially reattached, sampling torsional angles 
in 30-degree increments. After each attachment, each conformation was aligned to 
the known binding mode, minimizing the RMSD between the corresponding atoms. If 
the best RMSD fit, assuming all of the unplaced atoms were perfectly superimposed, 
was less than 1.0 A, the fragment was accepted for another round of attachment. This 
procedure was repeated until a set of completed scaffolds was generated. Overall, this 
procedure generated all conformations for the scaffold such that the best-fit RMSD 
to the known binding mode was less than 1.0 A. Each best-fit conformation was then 
finely sampled in translation and rotation, using three steps of 0.125 A in X, Y, and 
Z translation and three steps of 0.25 A arc length in X, Y, and Z rotation. Again, 
scaffold placements were accepted if all atoms were within the envelope by at least 
0.5 A, the molecules scored less than zero against the van der Waals grids, and at least 
one functional group library member could be grown from each attachment point. 
During the process of computing self energies for functional group attachments, 
an additional filter was employed beyond those used in the standard inverse design 
met hod. Conformations for functional group attachments that contained polar atoms 
were eliminated from the search space if their polar atoms were buried and not in- 
volved in hydrogen bonding interactions with the protease. Polar atoms were consid- 
ered buried if they were within 4.5 A of any protease atom, and an acceptor atom 
and donor hydrogen were considered hydrogen bonded if their distance was less than 
3.5 A. If two polar atoms were bonded, such as in a hydroxyl group, only one needed 
to make a hydrogen bond if the group was buried. The addition of this filter was 
useful for two reasons. First, it significantly reduced the size of configurational space 
sent to the combinatorial search procedure, by pre-eliminating functional groups that 
would bury unsatisfied polar groups. Second, it attempts to minimize a previously 
identified shortcoming of this energy function (Chapter 2), where polar groups may 
be unfairly rewarded in van der Waals interactions for burial in a non-polar region. 
3.5.4 Inverse inhibitor design for affinity prediction 
To improve the correlation between predicted energies and experimental binding 
affinities, the inverse design methodology was repeated using a protease structure 
derived from a complex with the inhibitor TMC-114 (PDB accession code lT3R) and 
a ligand envelope that filled the central four pockets of the HIV-1 protease active site 
(P2-P2'). This "maximal" ligand envelope was generated by initially packing the 
volume occupied by the known binding mode of TMC-114 with spheres, and then 
allowing the spheres to energy minimize with a van der Waals potential function as 
previously described for HIV-1 protease (Chapter 2). For the affinity evaluation, the 
functional groups allowed in the combinatorial search were limited to those needed 
to cover the designed compounds (Figure 3-3) and the inhibitors amprenavir and 
TMC-114. 
All affinity predictions presented were calculated using a Poisson-Boltzmann / 
Surface Area (PBSA) binding energy model, which is the standard energy model 
used in the inverse design procedure for the final ranking of compounds. This en- 
ergy function was computed as described previously (Chapter 2), and consists of 
explicit-atom van der Waals interaction, desolvation penalties and electrostatic in- 
teractions computed through solution of the linearized Poisson-Boltzmann equation, 
and a hydrophobic solvation term directly proportional to the surface area buried 
upon binding. In the case that the same molecule was designed multiple times in 
the combinatorial search procedure, the best PBSA score was chosen to represent its 
energy. 
To compute experimental binding free energies from inhibition constants (Ki), we 
assumed that the inhibition constant was equal to the dissociation constant (Kd = 
Ki) , and used the relationship AG = -RT ln Kd. 
3.5.5 Comparison of predicted to experimental structures 
In order to compare predicted and experimentally determined structures, predicted 
complexes were superimposed on crystal structures by minimizing the RMSD be- 
tween the coordinates of Ca atoms in the protease using the program PROFIT [157]. 
After superposition, the RMSD between non-hydrogen atoms in the inhibitors was 
measured and the structures analyzed. 
Chapter 4 
Computational design and 
experimental study of tighter 
binding peptides to an inactivated 
mutant of HIV-1 protease 
Abstract 
Drug resistance in HIV-1 protease, a barrier to effective treatment, is generally caused 
by mutations in the enzyme that disrupt inhibitor binding but still allow for substrate 
processing. Structural studies with mutant, inactive enzyme, have provided detailed 
information regarding how the substrates bind to the protease yet avoid resistance 
mutations; insights obtained inform the development of next generation therapeutics. 
Although structures have been obtained of complexes between substrate peptide and 
inactivated (D25N) protease, thermodynamic studies of peptide binding have been 
challenging due to low affinity. Peptides that bind tighter to the inactivated protease 
than the natural substrates would be valuable for thermodynamic studies as well as 
to explore whether the binding mode observed for substrate peptides is a function of 
weak binding. Here, two computational methods, charge optimization and protein 
design, were applied to identify peptides sequences predicted to have higher bind- 
ing affinity to the inactivated protease. Of the candidate designed peptides, three 
were tested for binding with isothermal titration calorimetry, with one measured to 
have more than a ten-fold improvement over the tightest binding wild-type substrate. 
Crystal structures were also obtained for the three designed peptide complexes show- 
ing good agreement with computational prediction. Thermodynamic studies of the 
designed peptides show that binding is entropically driven, and structural studies 
show strong similarities between natural and tighter-binding designed peptide com- 
plexes, which may have implications in understanding the molecular mechanisms of 
drug resistance in HIV-1 protease and other rapidly evolving drug targets including 
those involved with other infectious agents or cancer treatment . 
l All experimental work presented in this chapter was performed by collaborators at the University 
of Massachusetts Medical School in the laboratory of C. A. Schiffer. Specifically, the calorimetry 
experiments were performed by E. A. Nalivaika, and the crystallography was performed by M. 
Prabu- Jeyabalan. 
4.1 Introduction 
Current treatment for HIV-1 infection has been increasingly limited by the growing 
trend of drug resistance [36,40,140]. One of the most common forms of resistance is 
mutations in the protease, an enzyme essential for the viral life cycle and a common 
target for drug treatment [40,158-1601. One consistent feature of multi-drug resistant 
HIV-1 protease is that binding to inhibitors is significantly reduced while substrate 
binding and processing remains at viable levels [161,162]. Therefore, in order to 
understand mechanisms of drug resistance and gain insight into how to design new 
drugs, it becomes import ant to understand how the substrate peptides themselves 
interact with the protease and can be catalytically cleaved by variants containing 
resistance mutations. Several recent studies have been conducted to address this issue, 
mostly through structural analysis of complexes between the protease and substrate 
analogs [163-1651, or between inactive protease and actual peptides derived from 
cleavage sites [43,44]. These studies have revealed structural motifs that may be used 
for substrate recognition [44], as well as compensatory structural changes in response 
to resistance mutations [164-1671. Besides structural analysis of substrate complexes, 
another useful tool in understanding drug resistance in HIV-1 protease has been to 
examine the thermodynamics of inhibitor binding to both wild-type and drug resistant 
protease using calorimetry [136,168]. These studies support a connection between 
the enthalpy and entropy of binding with the ability for inhibitors to evade resistance 
mutations [45,46]. A combination of these two experimental approaches, to determine 
the thermodynamics of binding for peptides in the context of the inactivated protease, 
may be very useful in learning more about how peptides interact with the protease. 
Although the structures of six decameric substrate peptides have been solved 
in complex with an inactivated (D25N) protease [44], obtaining calorimetric mea- 
surements of peptide binding has been challenging, most likely due to poor affinity. 
The protease forms a homodimer that places a pair of aspartic acid residues (Asp25 
from each monomer) at the active site. Although the charge state of this aspartyl 
dyad during substrate binding is uncertain [146-1481, it is likely that the D25N in- 
activating mutation causes a net charge change of at least one charge unit, possi- 
bly accounting for the low affinity. Only one substrate peptide, derived from the 
reverse transcriptase-RNase H (RT-RH) cleavage site (wild-type P5-P5' sequence: 
GAETF* WDGA), shows marginally detectable binding and low micromolar affinity 
for the inactivated D25N protease (Figure 4-3A). In order to obtain clean thermody- 
namic data, and to determine if there exist fundamental difference in the way weaker 
and tighter binding peptides interact with the protease, it became necessary to design 
tighter binding substrat e-like peptides to the inactivated prot ease, using the RT-RH 
peptideinactivated protease complex as an initial model. 
Computational techniques are well suited for generating suggestions to improve 
afEinity of protein-protein and peptide-protein interfaces; thermodynamic and struc- 
tural studies of the binding of enhanced affinity peptides can provide insight into sub- 
strate binding, as well as into computational methodology. To this end, we applied 
two computational techniques to design tighter binding peptides to the inactivated 
protease. The first technique, charge optimization [23,24,30,31,101,102,169-1731, 
has been shown to be a useful tool in identifying chemical groups that have poor elec- 
trost atic complementarity for t heir binding partner. Charge optimization, based on 
a linear response continuum electrostatic model, varies the partial atomic charges on 
a protein or peptide side chain so as to balance the cost of desolvation with favorable 
interactions made upon binding. The resulting charge distributions are optimal in 
that the electrostatic component of the computed binding free energy is maximally 
favorable. Mutations to improve binding can be suggested by identifying amino acid 
substitutions that have charge distributions similar to that of the global optimum, or 
by repeating the optimization under several charge constraints and selecting muta- 
tions that match those that are favorable. 
One of the current limitations of charge optimization theory is that the con- 
cept makes sense only when the geometry of the bound and unbound states for the 
ligand being optimized are pre-determined, which is required to express the elec- 
trostatic binding free energy as a pairwise additive function of the partial atomic 
charges [24,174]. Consequently, amino-acid substitutions suggested by charge opti- 
mization must also have a similar shape to the wild-type residue, in addition to a more 
optimal charge distribution. Because all amho-acid substitutions involve some degree 
of shape change, one reasonable way to evaluate a suggestion from charge optimiza- 
tion is to build the mutation using molecular mechanics and evaluate its computed 
change in binding free energy using the same continuum electrostatics model [173]. 
Although the charge optimization and building procedure does allow for flexibility in 
the designed side chain, it is still ultimately limited because the initial set of suggested 
mutations are derived from fixed geometry calculations. 
In order to allow for side-chain flexibility in both the designed peptide and the 
protease active site, relax the requirement that suggested mutations are shape con- 
servative, and to see how much of a difference these features make, we have applied 
a second computational technique to improve peptide affinity - namely, protein de- 
sign. Computational protein design methods [67-691 have been successfully applied 
to stabilize protein folds [12,15], create new protein folds [16,17], and design protein 
interfaces [18-211. Protein design techniques search a combinatorial space of discrete 
amino-acid identities and geometries in order to identify either global minimum or 
low energy sequences and structures with desired properties. In the case of designing 
tighter binding peptides to the inactivated protease, we allowed the RT-RH peptide 
side chains to change their amino-acid identity and conformation, protease active site 
residues to change their conformation only, and searched this combinatorial space 
using discrete search algorithms [I 1,13,14,70] to identify global minimum energy 
complexes and an ordered list of weaker binding complexes sequentially from the 
global minimum. These complexes were then examined for predicted improvements 
in binding affinity. 
Three peptides predicted to bind tighter to the inactivated protease resulted from 
computational techniques and were tested experiment ally using isothermal titrat ion 
calorimetry (ITC). One peptide, containing a valine mutation at the P2 position of the 
wild-type RT-RH substrate, bound ten-fold tighter. Thermodynamic measurements 
of binding showed that peptide-inactive protease association is entropically driven, 
and that mutations predicted to improve peptide binding tended to increase the 
entropic contribution even further. Crystal structures were also obtained for each of 
the three designed peptide complexes, showing good agreement with calculation and 
substrate peptide complexes. Overall, agreement between both charge optimization 
and protein design along with experimental validation reinforces the usefulness of 
these computational methods in improving binding interfaces. 
4.2 Results and Discussion 
4.2.1 Electrostatic optimization of peptide binding 
Charge optimization was applied to each RT-RH substrate peptide side chain inde- 
pendently, keeping the charges of all other peptide or protease side chains and all 
backbone atoms at their parameterized values. Four different sets of constraints were 
applied to the resulting charge distributions; in separate calculations the optimized 
side chain total charge was required to be negative (-le), neutral (Oe), or positive 
(+le),  and, as a control, all partial atomic charges in the optimized side chain were set 
to zero, which in all-hydrogen model is equivalent to a shape conserving hydrophobic 
replacement. The results of these charge optimization studies are summarized in Ta- 
ble 4.1. Charge optimization produced new partial atomic charge values that satisfy 
the sum-of-charges constraint for the side chain without modifying the shape, which 
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is a useful guide for design studies. 
Out of the nine peptide residues visible in the structure, the four between the P3 
and P1' positions show computed, idealized improvements greater than 1.0 kcal/mol 
upon charge optimization. In addition, these four residues can achieve a significant 
portion of this improvement by selecting an all-zero charge distribution, creating a 
hydrophobic isostere. This signifies that there is little energetic advantage to hav- 
ing strong dipolar groups or net charge, as the electrostatic interaction gained upon 
binding is generally unable to offset the cost of desolvating the side chain. This find- 
ing is consistent with the dominantly hydrophobic nature of the side-chain binding 
pockets of the protease. Overall, most residues best optimum corresponded to the 
same net charge as their standard state at pH 7, with the exception of Glu-P3 which 
is relatively indifferent to the net charge constraint. This is due to the fact that Glu- 
P3 is relatively solvent exposed in the bound state, with the -1e optimized and Oe 
optimized charge distributions having a difference of only 0.9 kcal/mol in desolvation 
penalty, compared to a corresponding value of 9.5 kcal/mol for Thr-P2. 
Given the energetics of charge optimization and the resulting partial atomic charge 
distributions, mutations were considered that have a similar shape but an altered 
charge distribution that closely matches optimality. The charge optimization results 
for the P3 and P2 positions are indeed suggestive of mutations that have a similar 
shape but with a more optimal charge distribution. The glutamate side chain at P3 
shows possible improvements of 3 kcal/mol or greater upon optimization to a neutral 
or negative net charge. In addition, the energy of the hydrophobic isostere is a 2.4 
kcal/mol improvement over the parameterized charges, indicative of a desolvation 
penalty that can not be fully recovered through direct electrostatic interaction with 
the protease upon binding. This result can be explained by the environment of the 
Glu-P3 side chain in the bound complex (Figure 4-l A), where the partially solvent 
exposed side chain is not making any electrostatic contacts with the protease. In the 
case of the neutrally optimized side chain, the partial atomic charges depolarize by 
moving towards zero, and in the negatively charged case, charge tends to accumulate 
near the C7 atom and its bonded hydrogen atoms. The clustering of negative charge 
on these atoms is reflective of their proximity to the positively charged Arg8B side 
chain on the protease (Figure 4-1B). These results are suggestive of three mutations. 
The first is conversion to glutamine, which eliminates the net charge, has a less polar 
charge distribution, is very shape conservative, and is suggested by the large improve- 
ments from depolarization. The second is leucine, which is hydrophobic and has less 
shape conservation due to the change in hybridization at the branched carbon, but 
has a charge distribution similar to a hydrophobic isostere. The third is conversion to 
aspartate, which although very different in shape, may mimic the increase of negative 
charge near the C7 atom of the glutamate side chain upon optimization to a -1e 
total charge. 
At the P2 position, the wild-type threonine has a similar optimization profile to the 
glutamate at P3. The P2 side chain is surrounded by a hydrophobic pocket (Figure 
4-lB), and the threonine hydroxyl does not make hydrogen bonding interactions in 
the crystal structure. As a result, both the hydrophobic isostere and Oe optimization 
results show significant possible improvements because the desolvation penalty of the 
hydroxyl can not be recovered in direct electrostatic interaction with the protease. 
The obvious candidate mutation at P2 is valine, which has a similar shape to threonine 
yet is very hydrophobic. 
For the other two residues that show possible improvement greater than 1 
kcal/mol, Phe-P1 and Tyr-PI', there are no clear candidate mutations. In both 
cases, conversion to a hydrophobic isostere is favorable, and optimization to a neutral 
side chain results in a charge distribution that depolarizes the phenyl ring even fur- 
ther than the parameterized charges, which consist of -0.125e and +O. 125e dipoles 
along each C-H bond. For Phe-PI, no obvious mutation to a naturally occurring 
Table 4.1: Changes in Electrostatic Binding Energy upon Charge Optimization of 
Peptide Side Chains 
Residue Position 
Ala 
Glu 
Thr 
Phe 
Tyr 
Val 
ASP 
G ~ Y  
Ala 
Gln, Leu, Asp 
Val 
AAGh+ AAGiit AAG:,, AAGi$, 
0.00 +4.39 -0.23 +0.89 
Changes in the electrostatic component of the binding free energy after optimization 
of the side-chain partial atomic charges. Results are shown in kcal/mol for con- 
straining all partial atomic charges to zero (hydrophobic isostere, AAGa+), as well 
as constraining the total residue charge to -le, Oe, and +le. Negative free energy 
changes correspond to improved binding. For several positions, mutations suggested 
by the optimization data are provided. 
Mutation 
- 
amino acid exists that has these properties. In the case of Tyr-PI', one might con- 
sider conversion to Phe; however, most of the 0.6 kcal/mol improvement going from 
a hydrophobic isostere to an optimal neutral residue involves increasing the dipole of 
the hydroxyl group. This is due to a hydrogen bonding interaction between the hy- 
droxyl group of Tyr-PI' and the side chain of Arg8A in the protease. Unfortunately, 
there is no naturally occurring amino-acid side chain that can maintain this favorable 
hydrogen bonding interaction, have a similar shape to tyrosine, and be otherwise less 
polarized than an aromatic ring. Therefore, the optimization results for the P1 and 
P 1' positions do not suggest obvious mutations. 
Figure 4-1: Molecular environments of the Glu-P3 (A) and Thr-P2 (B) peptide 
residues found to be suboptimal for electrostatic binding in the RT-RH crystal com- 
plex. The position of the P3 glutamate (A, atom colors, center) is pointed away 
from Arg8B and makes contact with Phe53A. Calculations suggest an alternative 
conformation (yellow) that makes better electrostatic interact ions with Arg8B at the 
expense of packing. The wild-type P2 threonine residue (B, center) is situated in a 
pocket composed of four hydrophobic residues and makes no polar interactions. 
4.2.2 Computed binding energetics of mutants suggested 
from charge optimization 
Although the charge optimization methodology is extremely useful in identifying re- 
gions of poor electrostatic complementarity, it is limited in that it assumes the con- 
formation of the side chains are rigid during the calculation, and any prediction based 
on the results is only accurate within this fixed shape assumption. Because all mu- 
tations involve some degree of shape change, the suggested mutations were explicitly 
modeled in order to further screen for improved binding candidates. 
To this extent, the wild-type side chain as well as candidate mutations proposed 
in the previous section were built into the structure and their computed energetics 
were compared to that of the crystal, as summarized in Table 4.2. At the P3 posi- 
tion, rebuilding t he wild- type glut amat e using t he same procedure applied to mutants 
led to an unexpectedly large energetic improvement over the crystal conformat ion, 
mainly due to its selection of an alternative conformation that made more favorable 
interactions with the side chain of Arg8B (Figure 4-1A). In this alternative confor- 
mation, improved electrostatic interactions were offset by worsened van der Waals 
packing. The significance of this finding is that if this alternative conformation were 
truly populated, a mutation at this position would need to exceed this 1.5 kcal/mol 
improvement over the crystal structure in order to be a good candidate for observable 
tighter binding. 
The mutation to glutamine at P3, irrespective of whether the side chain was built 
in its minimum energy conformation or directly on top of the crystal glutamate, led 
to  a calculated improvement of about 1.5 kcal/mol over the crystal structure, mainly 
due to improved electrostatics as identified by charge optimization. However, if the 
wild-type glut amate can adopt the alternative conformation, mutation to glutamine 
is not predicted to be a significant binding improvement. Therefore, the mutation 
of glutamate to glutamine at P3 is a good choice for an experimental test, because 
if the binding energy were to remain the same, it would suggest that the wild-type 
glutamate residue may spend some of its time interacting more favorably with Arg8B 
in solution. 
Additional mutations suggested by charge optimization at the P3 position include 
leucine and aspartate, which attempt to mimic the optimal charge distributions for 
a neutral and negatively charged side chain, respectively. Designing a leucine at P3 
leads to a computed electrostatic benefit of 1.6 kcal/mol over the crystal structure, as 
expected from charge optimization, with nearly identical van der Waals interactions. 
This results in an energetic profile similar to that of the glutamine mutation, where a 
predicted improvement is dependent on the likelihood of the alternative wild-type glu- 
tamate conformation. Building and relaxing aspartate at this position led to greatly 
improved electrostatic interactions, due to proximity to ArgBB, but weakened van der 
Waals packing due to the reduced size of aspartate compared to glutamate. These 
effects canceled, leading to the same predicted binding energy as the crystal struc- 
ture, and indicate that the aspartate mutation is not a good candidate for binding 
improvement. 
At the P2 position, rebuilding of the wild-type threonine residue leads to similar 
energetics as the crystal, with a small tradeoff between electrostatics and packing. 
The suggested valine mutation at this position is computed to be favorable by 1.5- 
2.5 kcal/mol depending on whether the valine is rebuilt on top of the threonine or 
in an energy minimized geometry. This improvement is mainly accounted for by 
eliminating the desolvation penalty for the threonine hydroxyl group. Because valine 
has roughly the same shape as threonine, and is predicted to bind better in several 
built geometries, this mutation is an excellent candidate for improved binding. 
Overall, building mutations into the structure is a useful tool to assess the fea- 
sibility of mutations suggested by charge optimization. In some cases, the building 
procedure highlights weaknesses of the rigid binding model used in charge optimiza- 
tion, as exemplified by the P3 Gln, P3 Leu, and P3 Asp suggested mutations, and in 
other cases it confirms its usefulness, such as the P2 Val mutation. Mutations that 
are good candidates for experimental validation are the shape conservative P3 Gln, 
computed to have improved binding if the crystal structure is the correct reference 
structure, serving as a good diagnostic for the interactions of the wild-type glut amate, 
and the P2 Val mutation, highly shape conservative and computed to be favorable in 
multiple geometries. 
4.2.3 Improving binding through protein design 
The charge optimization and building procedure presented above, although very use- 
ful for rapidly identifying side chains with poor electrostatic complementarity, is still 
ultimately limited by its fixed-shape approximation. Mutations initially suggested 
for building need to maintain shape similarity, and side chains on the protease and 
at peptide positions not being optimized and built must be kept in fixed confor- 
mation. To relax these requirements, we have applied a full computational protein 
design treatment that systematically considers all twenty common amino acids, ex- 
Table 4.2: Binding Energies of Mutants Suggested From Charge Optimization 
Residue Posit ion Mutation 
Glu P3 Glumin 
Estimated change in binding free energy for rebuilt wild-type and mutant structures 
suggested from charge optimization. All energetics are relative to the cry st a1 struc- 
ture, and are in kcal/mol. Negative free energies correspond to improved binding. 
Energy differences are shown for two rebuilding techniques, one where a minimized 
structure is obtained for the mutating residue (min), and an alternative method where 
the crystal structure dihedral angles are used to rebuild the mutant side chain (crys- 
tal). For the Glu to Gln mutation, there are two possible orient at ions using the crystal 
dihedrals. Energetics are shown for the electrostatic and van der Waals (vdW) com- 
ponents of the energy, as well as the total energy difference, including a surface area 
contribution. 
A A G ~ , " ~ ~  A A G ~ ' ~ ~ ~ "  V ~ W  A A G ~ ~ ~ ~ ~ ~ ~  total 
-3.2 +1.7 -1.5 
- 
Thr P2 Thr min 
Valmin 
VaLr vst a1 
+0.9 -0.9 0.0 
-2.2 -0.1 -2.4 
-0.7 -0.7 -1.5 
cept proline, in multiple conformations for the central eight side chains (P4-P4') of 
the peptide, while simultaneously considering active-site side chains in all rotamer 
combinations. Thus, this procedure permits side chain but not backbone relaxation 
to accommodate peptide mutations. Due to the large number of possible peptide se- 
quences to consider, global minimal energy conformations were obtained for all single, 
double, and triple mutants from the wild-type RT-RH peptide sequence in a discrete 
conformational space, and their rigid binding energetics were computed to identify 
complexes with improved predicted binding properties. 
When the wild-type RT-RH sequence was rebuilt using this protein design proce- 
dure, the same conformational heterogeneity observed at the P3 glutamate position 
in the charge optimization protocol was again identified. These two conformations for 
the P3 glutamate are separated by 0.5-2.0 kcal/mol depending on parameter set, and 
show the same energetic tradeoff between electrostatics and van der Waals packing 
upon the change of geometry to make closer interactions with Arg8B (Figure 4-1A). 
In addition, different parameter sets disagree about which state is more favorable, 
with van der Waals energies derived from PARAMIS favoring the crystal conforma- 
tion, and those from united-atom AMBER favoring the alternative conformation. To 
factor out this uncertainty, the energetics for any sequence that does not involve a 
mutation at P3 was referenced against the wild-type structure with the same con- 
formation for P3 Glu, and any structure involving a mutation at P3 was required 
to score better than both P3 conformations of the wild-type sequence. In all cases, 
sequences predicted to have improved binding were also required to score better than 
the reference in both electrostatics with solvation and van der Waals energies across 
multiple parameter sets. That is, given uncertainty in structure and some disagree- 
ment between models, we required all models to validate a prediction, which is a 
conservative criterion; because the balance between packing and electrostatic inter- 
actions is sometimes difficult to quantify, we further required improvements in both 
terms simultaneously, which is again conservative. 
The binding energetics for all single mutations to the RT-RH sequence are pre- 
sented in Figure 4-2, showing the worst change in binding free energy across two 
different van der Waals parameter sets (Figure 4-2A) and two different electrostat- 
ics/solvation parameter sets (Figure 4-2B) relative to the appropriate wild-type ref- 
erence structure. In terms of packing interactions, there exist many opportunities 
for improvement, especially at the P4 and P2 positions. Substitution for the solvent 
exposed wild-type alanine at the P4 position to larger amino acids was almost always 
an advantage for van der Waals' interactions due to their ability to pack against the 
side of the binding interface. The wild-type valine residue at P2 sits in a pocket that 
computations suggest can accommodate a slightly larger amino acid, and moderately 
sized amino acids provide a packing advantage. Other pockets such as P I ,  PI'  and P2' 
appear also to accommodate larger amino acids for improved packing interactions. 
The P3' and P4' positions show no opportunity for improvement; no side chain 
except the wild-type could be grown from the fixed backbone with a reasonable energy 
score. In the case of the P3' aspartate, mutation to any other side chain caused the 
energy of the bound complex to be at least 5 kcal/mol worse than that of the wild 
type, thereby excluding it from further consideration. At the P4' position, any amino 
acid besides the wild-type glycine caused a large van der Waals clash with another 
region of the fixed backbone. 
Single mutations predicted to offer a binding advantage in electrostatics and sol- 
vation were much less numerous, with only one position, P2, offering any significant 
opportunities. Mutations to valine or isoleucine at P2 were predicted to be better 
electrostatically than the wild-type threonine, in excellent agreement with charge op- 
t imizat ion calculations. Again, t he valine and isoleucine mutations were computed to 
avoid the desolvation penalty associated with burying the threonine hydroxyl group in 
a hydrophobic pocket. Although no additional positions yielded significant solvation 
improvements, there were several mutations that were computed to have similar elec- 
trostatics as wild type, for example, a serine mutation at P3, a glutamine mutation 
at P2, or a leucine mutation at P2'. 
Van der Waals packing and electrostatics (with solvation) are important forces 
governing binding, but it is unclear that they contribute equally to successful molec- 
ular design. One may assign higher confidence to mutations that score well in both of 
these properties across multiple parameter sets, represented by substitutions that are 
white to blue in both Figures 4-2A and 4-2B. In Figure 4-2C, several of the sequences 
that scored best in electrostatics/solvation while still maintaining a favorable van der 
Waals binding free energy change are presented, along with their improvements over 
wild type in two parameters sets. Mutations at P2 to isoleucine and valine were pre- 
dicted to be quite favorable, along with leucine at P2', while other mutations such as 
glutamine at P2 and asparagine at P4 were computed to be excellent for packing but 
slightly unfavorable for electrost atics/solvat ion. 
Double and triple mutant sequences were also computationally screened for im- 
proved binding, and five of the top sequences in electrostatics/solvation that main- 
tained good packing are also shown in Figure 4-2C. Overall, the double and triple 
mutants were additive in that their predicted improvements could be explained by 
adding together the benefit of their individual single mutations. This allowed less 
favorable mutations to be carried along into high ranking sequences by pairing them 
with the most favorable individual mutations, as was often observed in the triple 
mutant sequences. For example, one of the highest electrostatically ranked triple 
mutations, containing the favorable isoleucine mutation at P2 and leucine mutation 
at P2', permits the P3 aspartate mutation which, although deficient in van der Waals 
interaction, is electrostatically reasonable. 
The mutations identified from protein design calculations served to support and 
extend those derived from charge optimization calculations. The protein design re- 
sults recapitulated the ability to improve electrostatics at the P2 position by substi- 
tuting the wild-type threonine with a valine mutation. In addition, they go beyond 
the fixed shape assumption and propose that isoleucine can achieve additional packing 
interact ions at this position in addition to improving electrostatic complementarity. 
Although the protein design methods did not identify improvements at the P3 posi- 
tion, this was largely due to the difficulty in making predictions when the wild-type 
reference structure was in question, and the strict requirements placed on predicted 
improvements at this position. Protein design also identified several sites where im- 
proved packing interactions could be made, such as the P2' position, but did not 
discover any additional electrostatic improvements beyond those identified by charge 
optimization. 
4.2.4 Experimental determination of binding energetics for 
designed peptides 
In order to experimentally test the effectiveness of the computational design pro- 
cedures, three designed peptides, one from protein design and two suggested from 
charge optimization, were tested along with wild-type RT-RH peptide for binding to 
the inactivated (D25N) protease using isothermal titration calorimetry (Figure 4-3A). 
These designed peptides include one of the high scoring triple mutants from protein 
design (Peptide I), as well as the shape conserving T-P2-V mutation (Peptide 2) and 
diagnostic E-P3-Q mutation (Peptide 3) suggested from charge optimization. The 
triple-mutant peptide selected for synthesis and testing (Peptide 1) was computed to 
be less favorable for packing than other triple mutants (Figure 4-2C), most likely due 
to the aspartate mutation at P3. However, it was chosen because of the promising 
electrostatic profile of the Asp-P3 mutant (Table 4.2), and the computed optimality 
of the corresponding wild-type aspartate at P3'. 
The wild-type RT-RH sequence has an observed dissociation constant of about 
C 
Energy Term vdW vdW Elec/Solv Elec/Solv 
Parameter Set PARAMIS AMBER UA PAR AM^^ PARSE 
P4-P4' Sequence 
AELFYVDG -4.0 -3.0 -1.4 -1.1 
AEIFYVDG -1.6 -0.8 -1 -3 -1 .O 
AETFYLDG -1.5 -2.2 -0.1 -0.2 
AEQFYVDG -6.2 -4.4 +0.7 +0.2 
NETFWDG 
- -4.1 -2.3 +O. 1 +0.6 
AELFYLDG -5.5 -5.2 -1.5 -1.2 
AEIFYLDG -3.1 -3.0 -1.4 -1.1 
SELFYVDG 
- -5.2 -4.4 -1.7 -1 .O 
SELFYLDG 
- -6.8 -6.5 -1.8 -1.1 
ADDFYLDG -1.2 -2.8 -1 .O -1.1 
TELFYLDG 
- -8.1 -7.5 -0.9 -0.9 
Figure 4 2 :  Changes in binding free energy contributions predicted for mutants de- 
rived from protein design calculations. The worst-case changes across two van der 
Waals (vdW) (A) and two electrostatics/solvation (Elec/Solv) (B) parameter sets 
were computed for all single mutations (except proline) at each peptide position rela- 
tive to the appropriate wild-type RT-RH sequence. Changes upon mutation in excess 
of +3 kcal/mol, or mutations ranked worse than +5 kcal/mol from the wild-type se- 
quence in stability of the complex, were dropped from consideration in the protein 
design calculation and are represented as the darkest red. Sequences and energetics 
for several of the best electrostatically ranking single, double, and triple mutations are 
also presented (C), broken down by energy term and parameter set relative to wild 
type. Mutations to the sequence are underlined, relative energies are in kcal/mol, 
and negative numbers indicate predicted improvements to binding. 
5 pM, and an overall poor experimental binding profile, marked by a lack of a clear 
binding transition (Figure 4-3B). In contrast, Peptide 2, corresponding to the T- 
P2-V mutation suggested by both charge optimization and protein design, shows a 
very sharp transition (Figure 4-3C), and an apparent Kd of about 0.5 pM, a more 
than a ten-fold improvement over wild-type RT-RH. The improvement in binding 
seen here supports the analysis from both charge optimization and protein design 
calculations, as the wild-type threonine side chain was consistently calculated to pay 
a significant and uncompensated desolvation penalty upon binding due to its buried 
hydroxyl group with unsatisfied hydrogen bonds. Replacement with a valine side 
chain eliminates this penalty while maintaining the same capability for packing in- 
teractions. 
Peptide 1, a triple mutant derived from protein design, exhibited a more modest 
improvement of 2-3 fold over wild-type RT-RH. It contains a mutation to aspartate at 
P3, estimated to be better in electrostatics and worse in van der Waals than the crystal 
glutamate, and vice-versa for the alternative conformation, as computed from protein 
design. It also contains an isoleucine mutation at P2, which is functionally equivalent 
to the valine mutation in terms of electrostatics, but contains an additional methyl 
group expected to make better packing interactions. Finally, it contains a valine 
to leucine mutation at P2', which is computed to be equivalent electrostatically but 
to make better van der Waals interactions upon binding. Overall, it is difficult to 
at tribute this modest binding improvement (less than expected) to any particular 
residue or combinat ion of residues. Although the isoleucine and leucine mutations 
were consistently computed to be binding improvements, the aspart ate's predictions 
were marginal and depended on the conformation of the wild-type residue at that 
position. Because aspartate is tolerated at the P3' position (as it is in the RT-RH 
peptide), it would be surprising for aspartate alone to be the explanation for only the 
small improvement in affinity. 
Finally, Peptide 3, containing the diagnostic E-P3-Q mutation, has similar affinity 
to the wild-type peptide. The glutamate mutation was only predicted to be favorable 
by charge optimization if the structure could not relax to an alternative conformation 
where the wild-type glut amate makes better electrostatic interactions with Arg8B 
(Figure 4- 1A). This experiment a1 result suggests that the wild-type glut amate at 
P3 may interact more closely with Arg8 in solution than is observed in the crystal 
structure, making it more favorable than it would appear from looking at the crystal 
structure alone. This emphasizes the importance of building charge-optimization 
suggested side chains into the structure, because if a prediction were made from 
electrostatic optimization of the crystal structure alone, this mutation would have 
been expected to be a substantial binding improvement. 
For all peptides studied, the thermodynamics of binding to the inactivated pro- 
tease is dominated by a large favorable change in entropy, which is counterbalanced 
by an smaller but unfavorable change in enthalpy. In addition, all designed muta- 
tions served to increase the favorable contribution of entropy and worsen the enthalpic 
contributions to binding. This may not be surprising given that all of the suggested 
mutations serve to decrease the amount of polar surface area buried upon binding, 
and in some cases increase the total surface area buried. Because these trends tend to 
correlate with the hydrophobic effect and solvent release upon binding (871, it may not 
be surprising that solvent entropy plays a major role in the observed thermodynamics. 
4.2.5 Crystal structures of designed complexes 
After successfully designing peptides that bind tighter to inactivated HIV- 1 protease, 
two important questions arise. The first is whether or not the structures predicted by 
the protein design methodology are an accurate representation of what is occurring 
experimentally. The second, more fundamental to the issue of resistance in HIV 
protease, is if there exist differences in the way that higher affinity peptides bind to 
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the protease as compared to the natural substrates. To address these questions, the 
cryst a1 structures of the three designed complexes were experiment ally determined, 
with crystallographic st atistics outlined in Table 4.3. 
In order to determine whether there were fundamental differences between the way 
that the tightest-binding designed mutant (Peptide 2) and wild-type RT-RH peptides 
bound to the protease, a Ccu double difference plot was constructed to identify re- 
gions of the protein backbone that deviated between the two complexes (Figure 4-4). 
Overall, few regions exhibited significant deviations, and the largest differences were 
associated with surface protease residues such as Gly17, Gly51, and Cys67 where flips 
of the peptide bond geometry occurred. A closer examination of the residues lining 
the active site reveals that the backbone of Ile50 adopts slightly different relative po- 
sitions in the two structures, most likely due to an alternative selection of side-chain 
rotamers. There is some slight positional changes between the A and B monomers 
and relative movement of the peptide N-terminus, however no evidence of large-scale, 
concerted conformational motion was found. 
Although the backbone geometries of the protease and peptide remained fairly 
constant between the natural and tightest-binding complexes, there was a significant 
change in the geometry of the Glu-P3 side chain of the peptide. As described earlier 
for the wild-type RT-RH structure, the Glu-P3 side chain makes direct interactions 
with the side chain of residue Phe53A, even though computation suggested an alter- 
native conformation that could make closer interactions with Arg8B (Figure 4-l A, 
yellow). However, in response to the Thr to Val mutation at P2 in the tightest- 
binding designed mutant (Peptide 2)) the conformation of Glu-P3 adjusts to make a 
new hydrogen-bonding interaction with the side chain of Arg8B1 in a similar fashion 
to the structure predicted computationally. These results suggest that the multiple 
conformations proposed by computation for the Glu-P3 residue were justified, and 
that the energetic barrier between these structures may be low. It is also possible that 
Figure 44:  Double difference plot between Crr atoms in the crystal structures of 
the wild-type RT-RH peptide complex and the tightest-binding designed complex 
(Peptide 2). The largest deviations correspond to the surface residues 17, 51, and 67 
in monomer B. 
the new hydrogen-bonding interaction plays a role in the improved aflinity observed 
for Peptide 2, and may help to explain why the suggested Gln mutation at P3 might 
not be a binding improvement, as Gln-P3 is also capable of hydrogen bonding with 
ArgSB. 
Comparison of predicted to experimental structures 
The crystal structures for the designed complexes were also used to gauge the accuracy 
of the structural predictions from the protein design methodology. The structure 
of each designed complex was compared to the predicted structure by aligning the 
alpha carbons of the protease and examining the deviation between the predicted and 
experiment a1 pept ide side-chain geometries. 
For reference, the crystal structure of the wild-type RT-RH peptide complex, fkom 
which all calculations were based, compares favorably with the wild-type structure 
as generated in protein design. For a11 but two of the side chains, the protein design 
Table 4.3: Crystallographic st at istics of the three RT-RH variant complexes. Stat is- 
tics for the corresponding previously determined RT-RH complex [44] are also pre- 
sented for comparison. 
Structure 
Data Collection 
Resolution (A) 
Temperature 
Space Group 
a (4 
b (4 
c (A) 
Parameter 
Peptide Sequence 
z 
Total Reflections 
Unique Reflections 
Rmerge (%) 
Completeness (%) 
1/01 
WT RT--RH Peptide 1 Peptide 2 Peptide 3 
GAETF*YVDGA G A E F * Y L D G A  G A E F * Y V D G A  GAQTF*YVDGA - 
Crystallographic Refinement 
R value (%) 
Rfree (%) 
Sigma Cutoff 
RMSD in: 
Bond Lengths (A) 
Bond Angles (") 
PDB Code 
2.0 
Cryo 
P212121 
51.2 
57.6 
61.5 
4 
53438 
11909 
3.4 
92.7 
21.2 
2.0 
Cryo 
P212121 
50.9 
57.5 
61.9 
4 
54458 
12332 
7.1 
95.8 
12.5 
2.25 
Cryo 
P212121 
51.0 
58.5 
61.7 
4 
30202 
8523 
6.5 
91 .O 
10.3 
18.4 19.5 16.0 18.7 
22.6 25.7 21.6 24.4 
None None None None 
methodology selected the crystal conformation as optimal. For the two remaining 
peptide side chains, P3 Glu and P3' Asp, conformations were selected from the ro- 
tamer library that were close to the crystal geometry (Deviations - P3 Glu: x1 lo0, 
~2 12", ~3 43" P3' Asp: X I  23", ~2 56") (Figure 4-5A). In addition, the computed 
structure for the protease remained very close to that of the crystal. Overall, the 
total root-mean-square deviation (RMSD) for designed side chains between the crys- 
tallographic and designed complexes for thk wild-type RT-RH sequence was 0.6 A. 
The computationally predicted structure for Peptide 2 agrees very well with the ex- 
perimental structure, with a negligible difference in side-chain geometry. As expected, 
the valine mutation is directly superimposed on the wild-type threonine (Figure 4- 
5B), confirming the hypothesis that this is a shape-conserving mutation. Although 
Peptide 3 did not show an improvement in binding, it was not necessarily due to an 
error in modeling the bound state as the predicted and experimental conformations 
of the P3 glutamine mutation are very similar. The side-chain dihedral angles are vir- 
tually identical, and the only differences in their placement are due to small changes 
in the backbone geometry (Figure 4-5C). 
A comparison of the predicted and experimental structures for Peptide 1 shows 
less agreement. Although much of the side-chain density is missing from the crystal 
structure of the Peptide 1 complex, two out of the three designed side chains are 
visible. The modeled isoleucine mutation at the P2 position differs from the crystal 
by approximately 30 degrees in the first x angle angle for an overall side-chain RMSD 
of 0.8 A (Figure 4-5D). Although a rotarner closer to the crystal structure did exist 
in the search space, its energy was predicted to be only 0.2 kcal/mol higher than 
that of the selected conformat ion, indicative of a relatively flat energy landscape. 
Mutation at the P2' position to leucine was also visible in the structure, and its 
predicted geometry was somewhat different from the experimental observation. The 
first x angle deviates by 41 degrees as the crystal side chain adjusts to make closer 
Figure 4- 5: Comparison of predicted to experiment ally determined structures. For 
reference, comparisons were made between the designed (atom colors) and crystal 
structure (yellow) for the wild-type RT-RH peptide sequence (A). Crystal rotamers 
were selected by design at all but two residues. Designed mutation to valine at P2 in 
Peptide 2 (atom colors) has good structural agreement with both the crystal structure 
of the mutant (yellow) and the wild-type threonine (green) in (B). The glutamate to 
glutamine structural prediction at P3 (atom colors) for Peptide 3 also agrees well 
with its experimental structure (yellow) (C). Mutations at P2 to isoleucine (D) and 
P2' to leucine (E) in Peptide 1 agree less favorably. 
packing interactions with the backbone of Asp30B, rather than the Ile50A side chain 
as predicted by protein design (Figure 4-5E). In the rotamer library used for design, 
there did exist a leucine conformation slightly closer to the observed cryst a1 structure 
(20 degrees closer in xl), but it was not selected because packing interactions with 
the Ile50A side chain were better in the chosen geometry. 
Conclusions 
Two computational techniques to improve binding &nity were successfully applied 
to design peptide sequences that bind tighter to inactivated (D25N) HIV-1 protease 
in an effort to obtain thermodynamic and structural data to aid in the understanding 
of substrate specificity and drug resistance. Charge optimization techniques identified 
two residues in the tightest binding natural substrate peptide (RT-RH), Glu-P3 and 
Thr-P2, that provided opportunities to improve electrostatic complementarity, sug- 
gesting several mutations to enhance binding or serve as diagnostics for elucidating 
energetic contributions of the wild-type residues. Computational protein design tech- 
niques, which allow for side-chain flexibility and shape changing mutations, confirmed 
the predictions from charge optimization, demonstrated the limitations of charge op- 
timizat ion's fixed geometry model, and suggested additional substitutions to further 
improve packing inter act ions at the interface. 
Three designed peptides were tested for inactive protease binding through isother- 
mal titration calorimetry. A single threonine to valine substitution at the P2 position, 
heavily suggested by calculation, led to more than a ten-fold improvement in bind- 
ing, which is a consider able improvement given the small perturbat ion. In addit ion, 
a triple mutant sequence derived from protein design led to a 2-3 fold improvement. 
Substitution of glutamine for glutamate at the P3 position suggests that the wild- 
type residue may be more favorable than calculated from the crystal structure alone. 
It is important to note that the three designed peptides presented here were the only 
peptides tested experimentally, and that only the data presented in this work was 
used to select the designed peptides. 
Thermodynamic measurements of pept ide binding revealed that binding to the 
inactive protease was heavily entropically driven, most likely due to release of solvent 
from the active site upon binding. Mutations suggested by computation tended to 
replace polar groups with less polar groups and increase the total amount of buried 
hydrophobic surface area, resulting in a further increase in the entropic contribution. 
These results may be important in understanding resistance, as peptides that bind 
primarily through the hydrophobic effect without making strongly orientation depen- 
dent interactions may be better suited to adapt to resistance mutations where less 
flexible small-molecule inhibitors cannot. 
Cryst a1 structures of the designed peptide complexes, in addition to validating 
structural predictions from computation, revealed only minor differences between 
complexes of the natural RT-RH substrate and the tightest-binding designed peptide 
(Peptide 2). These findings suggest that using the geometries of natural substrates 
is sufficient to define envelopes that represent the consensus volume of substrates, 
which may be useful in subsequent drug design efforts [44,136-1391. 
An additional application for tighter binding peptides is in the understanding of 
a more recently identified mechanism of drug resistance against protease inhibitors, 
substrate co-evolution [167]. In cases of highly drug resistant protease, compensatory 
mutations can arise in the cleavage sites to improve catalytic efficiency. One of the 
most common of these substrate mutations occurs in the nucleocapsid-pl site (NC- 
pl), where a wild-type alanine in the P2 position is converted to valine in response to 
a V82A drug resistance mutation in the protease. This mutation is analogous to the 
valine P2 mutation predicted and tested to be favorable in the RT-RH background, 
supporting a hypothesis that substrate co-evolution may serve to generally increase 
peptide-protease affinity. 
Overall, computational design methods have been shown to be a useful tool in 
designing tighter binding peptides, providing sequences that are useful in helping to 
underst and how peptides bind HIV- 1 protease, their thermodynamic contributions to 
binding, and rationalizing the use of natural substrate structures as models for future 
drug development. 
4.4 Materials and Methods 
4.4.1 Protein structure preparation 
The crystal structure of inactivated (D25N) HIV-1 protease complexed with RT-RH 
substrate peptide [44] (Protein Data Bank, ID 1KJG) was used as the starting point 
for all calculations. For residues with multiple occupancy, the first conformation was 
selected except for residues Glu 21A and Glu 35A where the second conformation 
was selected to improve the hydrogen-bond network. In addition, the ring of His69B 
was flipped 180' to improve hydrogen bonding. Because the substrate peptide used 
in the crystal structure had blocked terminii, acetyl and methylamide groups were 
added to the N and C terminii of the peptide respectively. All water molecules were 
removed from the structure except for the five waters conserved across all protease- 
substrate complexes [44]. Hydrogens were added to the structure using the HBUILD 
module [116] in the CHARMM computer program [I171 with the PAR AM^^ all-atom 
parameter set [175]. All ionizable residues were left in their standard states at pH 7, 
with histidines neutral and 6-protonated. 
4.4.2 Continuum electrostatic and charge optimization cal- 
culat ions 
All continuum electrostatic calculations were performed using a locally-modified ver- 
sion of the DELPHI computer program [25-27,1211 to solve the linearized Poisson- 
Boltzmann equation. A dielectric constant of 4 was used for the protein and 80 for 
water, as well as an ionic strength of 145 mM in the solvent region. The boundary 
between protein and solvent was represented by a molecular surface computed with 
a probe radius of 1.4 A, and an ion-exclusion layer of 2.0 A surrounded all molecules. 
Partial atomic charges and radii for continuum electrostatic calculations were taken 
from the PARSE parameter set [22], and structures derived from protein design calcula- 
tions were additionally screened using charges and radii from the PAR AM^^ parameter 
set [176,177]. Electrostatic binding and solvat ion contributions for protease-peptide 
complexes designed from charge optimization were calculated using a 257x257~257 
cubic grid and a two-stage boundary condition focusing scheme. The complex was 
placed on the grid such that it occupied first 23% and then 92% of the grid size, 
where the solved potentials from the lower percent fill were used as boundary con- 
ditions for the higher percent fill calculation. This resulted in a final grid spacing 
of 0.23 A. In addition, each result was averaged over 10 translations of the complex 
relative to the grid in order to reduce artifacts from the grid-based representation of 
atomic charges and the molecular surface. Complexes from protein design calcula- 
tions were evaluated similarly, except a 129x1 29x1 29 grid and only one translation 
were used due to the large number of structures that needed evaluation. The matrix 
elements for electrostatic optimization were also computed in a similar fashion, but 
using a 129x129~129 grid, 10 translations and a three-st age over-focusing scheme of 
23%, 92% and 184% percent where the 184% calculation was centered on the single 
atom charged when computing a row of the ligand desolvation matrix. 
Charge optimization was performed as previously described [23,24,30,31,101,102, 
169,171,1731, using locally written software. Each side chain of the peptide had its 
partial atomic charges independently optimized to maximize the rigid electrostatic 
binding free energy of the peptide to the inactivated protease. Each peptide side 
chain was constrained to net charges of -le, Oe and t l e ,  as well as requiring that no 
atom exceed a charge magnitude of 0.85e. In addition, each side chain was constrained 
to have all zero partial atomic charges, thus creating a hydrophobic isostere. For each 
constraint set, the energy difference between the optimal and parameterized charge 
distribution was determined by using the resulting charges with the optimization 
objective function [24,102,173]. All constrained optimizations were carried out using 
the software package LOQO [I 78,1791. 
4.4.3 Modeling of peptide mutations from charge optimiza- 
t ion 
Peptide mutations suggested from charge optimization were built into the RT-RH 
peptide complex structure using the CHARMM computer program [I171 and the 
PAR AM^^ all-atom parameter set [175], using a distance-dependent dielectric con- 
stant of 4r. Two procedures were used, to model each mutant structure. The first 
aimed to find a low-energy structure for each mutation, and all mutant side-chain 
dihedral angles were enumerated every 30 degrees. Each enumerated side-chain con- 
formation was then minimized until convergence, with the rest of the protease and 
peptide held fixed. The lowest energy minimized structure was selected to represent 
the mutation. Alternatively, because charge optimization suggests shape-conserving 
mutations, the mutant side chain was built on top of the wild-type crystal structure 
using the dihedral angles common to both side chains. 
4.4.4 Protein design calculations 
Through the use of locally developed protein design software, the central eight po- 
sitions of the peptide (P4-P4') were allowed to mutate to and select a conforma- 
tion for any of the naturally occurring amino acids except proline. Histidines were 
modeled with all three possible protonation states. In addition, the side chains of 
active-site protease residues 8, 23, 25, 29, 30, 32, 45, 47, 50, 53, 82 and 84 in both 
monomers were allowed to change their conformation but not their identity. In all 
cases, the protein backbone was held fixed. Side-chain conformations were modeled 
discretely from the backbone independent rotamer library of Dunbrack and Karplus 
(May 2000) [180], but with additional rotamers f 10 degrees about the first two x 
angles. In addition, the exact structure of the crystal side chain was permitted as a 
choice in the design. The objective function minimized in the protein design proce- 
dure was the energy of the bound complex. A model of the peptide unfolded state 
was not used in these calculations because short peptides tend not to form stable 
structures [181]. The energy of the bound complex was estimated using an energy 
function pairwise additive in side-chain conformations, consisting of an electrostatics 
term with a distance-dependent dielectric constant of 4r, a van der Waals interaction 
term, and internal dihedral energy as computed by CHARMM [I171 using a modified 
version of the PAR AM^^ parameter set [176,177] where aromatic and sulfhydryl hy- 
drogens are included. For each single, double, and triple mutant peptide sequence, 
the global minimum energy conformation (GMEC) was identified for the complex us- 
ing dead-end elimination (DEE) [I 1,14,70] and A* [13]. These structures were then 
screened for predicted improvements in binding as described below. 
4.4.5 Calculation of binding energetics 
The binding free energy of peptide-inactivat ed protease complexes was estimated 
using a rigid binding model, where the difference between solvation energy in the 
bound and unbound state was added to the vacuum ( E  = 4) interaction energy in 
the bound state. Vacuum binding energies were computed with CHARMM [117], using 
the PAR AM^^ parameter set [175], for mutants derived from charge optimization. 
For mutants suggested from protein design, a modified version of the united-atom 
PARAM 19 parameter set [176,177] where aromatic and sulfhydryl hydrogens were 
added was used for vacuum energies. In addition, mutants from protein design were 
also screened with the AMBER united-atom parameter set [182]. Solvation energies 
were computed using a Poisson-Boltzmann/Surface Area (PBSA) model [22]. The 
linearized Poisson-Boltzmann equation was solved with a locally-modified version 
of DELPHI as described above, and CHARMM was used to compute the analytical 
surface area. PARSE [22] radii and charges were used for all structures, and designed 
complexes from protein design were additionally screened using PAR AM^^ radii and 
charges. To compute the hydrophobic contribution to solvation, the surface area was 
multiplied by 5 cal/mol/A2 [22]. In order to avoid predicted binding improvements 
from depending on possible scaling problems between the electrostatic/solvation and 
van der Waals components of the estimated binding energy, mutations considered as 
improvements were required to be better than wild-type in both of these components 
of the energy function. 
4.4.6 Substrate peptides 
Decameric peptide variants of the HIV-1 reverse transcriptase-RNase H substrate 
(RT-RH) with sequences GADIF*YLDGA (Peptide 1) , GAEVF* W D G A  (Peptide 
2), and GAQTF*WDGA (Peptide 3) were chosen as previously described [44]. The 
peptides were purchased from 21st Century Biochemicals, Marboro, MA. 
4.4.7 Isothermal titration calorimetry 
Thermodynamic parameters of peptide binding were determined using an isothermal 
titration calorimeter, VP-ITC (MicroCal Inc., Northampton, MA). The buffer used 
for all protease and peptide solutions consisted of 10 mM sodium acetate pH 5.0, 2% 
DMSO, and 2 mM Tris(Zcarboxyethy1) phosphine (TCEP). A 1 mM solution of each 
peptide was directly titrated into a solution of 30-70 pM D25N HIV-1 protease in 10 
pl aliquots. The experiments were performed at 15' C. Each experiment was repeated 
at least in triplicate. Data were processed using the Origin 7 software package from 
MicroCal. 
4.4.8 Mutagenesis, protein purification, and crystallization 
The previously described method [167,183] was followed throughout all wet chem- 
istry experiments. A synthetic gene of HIV-1 protease, optimized for Escherichia colz 
codon usage was used as the starting template for mutagenesis to introduce D25N 
substitution. This isosteric mutation inactivates the protease, and it was made using 
the Quickchange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). The pu- 
rified protease, in 50% acetic acid was then refolded by rapid 10-fold dilution into a 
mixture of 0.05 M sodium acetate (pH 5.5), 10% glycerol, 5% ethylene glycol, and 5 
mM dithiothreitol (refolding buffer) kept over ice. The diluted protein was concen- 
trated and dialyzed to remove residual acetic acid. Protease used for crystallization 
was further purified using a Pharmacia Superdex 75 FPLC column equilibrated with 
refolding buffer. Crystals were grown by the hanging drop, vapor diffusion method. 
Stock solutions (25 mM) of substrate peptides used for co-crystallization were pre- 
pared in dimethyl sulfoxide. The protein concentration was approximately 1 mg/ml. 
Small crystals started appearing after 3-7 days with the longest length between 0.1 
and 0.2 mm. 
4.4.9 Crystallographic data collect ion 
The crystals were flash frozen over a nitrogen stream and intensity data were col- 
lected on an in-house Rigaku X-ray generator with a R-axis IV image plate. Frames 
were indexed using DENZO and scaled using SCALEPACK [184,185]. Complete data 
collection statistics are listed in Table 4.3. 
4.4.10 Structure solution and crystallographic refinement 
The crystal structures were solved and refined using the programs within the CCP4i 
interface [186]. Structure solution was carried out by molecular replacement pro- 
gram using AMORE [187]. The crystal structure of wild-type protease variant corn- 
plexed to the inhibitor TMC-114 (PDB accession code 1T3R) (1361 was used as the 
starting model. The molecular replacement phases were further improved by us- 
ing ARP/wARP [I881 by building solvent molecules into the unaccounted regions 
of electron density. Subsequently, interactive model building was carried out using 
0 [189]. Initial 2Fo-Fc and Fo-Fc maps indicated the positions of RT-RH sub- 
strate variants. Conjugate gradient refinement using REFMAC~ [I901 was performed 
by incorporating Schomaker and Trueblood tensor formulation of TLS (translation, 
libration, screw-rotation) parameters [191-1931. The working R (bark) and its cross 
validation (Rfie) were assessed using PROCHECK [194] at the end of each refinement 
round. The refinement statistics are also shown in Table 4.3. 
4.4.11 Analysis of and comparison to experimental struc- 
tures 
The double difference plot comparing the structures of the tightest-binding mutant 
and wild-type peptide complexes was computed by determining the interatomic dis- 
tances between all pairs of Ca  atoms in each structure. The absolute value of the 
difference between these two distance matrices was subsequently calculated. 
Crystal structures for the designed complexes were compared to predicted struc- 
tures by performing a best RMSD fit between all Ca  atoms of just the protease using 
the program PROFIT [157]. The resulting RMS difference between peptide side-chain 
conformat ions was subsequently calculated. 
Chapter 5 
FFTSVD: A Fast Multiscale 
Boundary Element Method Solver 
Suitable for BioMEMS and 
Biomolecule Simulation 1 
Abstract 
We present a fast boundary element method (BEM) algorithm that is well-suited 
for solving electrostatics problems that arise in traditional and Bio-MEMS design. 
The algorithm, FFTSVD, is Green's function independent for low-frequency kernels 
and efficient for inhomogeneous problems. FFTSVD is a multiscale algorithm that 
decomposes the problem domain using an octree and uses sampling to calculate low- 
rank approximations to dominant source distributions and responses. Long-range 
interactions at each length scale are computed using the FFT. Computational results 
illustrate that the FFTSVD algorithm performs better than precorrected-FFT style 
algorithms or the multipole style algorithms in FastCap. 
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5.1 Introduction 
Microelectromechanical systems (MEMS) have recently become a popular platform 
for biological experiments because they offer new avenues for investigating the struc- 
ture and function of biological systems. Their chief advantages over traditional in 
vitro methods are reduced sample requirements, potentially improved detection sen- 
sitivity, and structures of approximately the same dimensions as the systems under 
investigation [195]. Devices have been presented for sorting cells [196], separating 
and sequencing DNA [197], and biomolecule detection [198]. Furthermore, because 
arrays of sensors can be batch fabricated on a single device, parallel experiments and 
high- t hroughput analysis are readily performed. However, since microfabricat ion is 
relatively slow and expensive, numerical simulation of MEMS devices is an essen- 
tial component of the design process [199,200]. Design tools for integrated circuits 
cannot address multiphysics problems, and this has motivated the development of 
several computer-aided MEMS design software packages, most of which are based on 
the finite element method (FEM) and the boundary element method (BEM) [201]. 
BioMEMS, when applied to such problems as biomolecule detection, are often 
functionalized with receptor molecules that bind targets of interest [202]. Molecular 
labels can also be used to aid in the detection process [203]. However, the interactions 
between these molecules, the MEMS device, and the solvent environment are often 
neglected during computational prototyping. In other fields, such as computational 
chemistry and chemical engineering, continuum models of solvation are often used to 
study the electrostatic component of these interactions [29]. These mean-field models 
permit the efficient calculation of many useful properties, including solvation energies 
and electrostatic fields [25,204], and have been shown to correlate well with more 
expensive calculations that include explicit solvent [205]. However, continuum models 
are unable to resolve specific molecular interactions between solvent molecules and 
the solute. A variety of numerical techniques can be used to simulate the continuum 
models, including the finite difference met hod (FDM) , the finite element method 
(FEM), and the boundary element method (BEM) [26,206,207]. 
The boundary element method has a number of advantages relative to FDM and 
FEM, such as requiring only surface discretizations and exactly treating boundary 
conditions at infinity. However, discretizing boundary integral equations produces 
dense linear systems whose memory costs scale as O(n2) and solution costs scale with 
O(n3), where n is the number of discretization unknowns. This rapid rise in cost 
with increasing problem complexity has motivated the development of accelerated 
BEM solvers. Preconditioned Krylov subspace techniques, combined with fast al- 
gorithms for computing matrix-vector (MV) products, can require as little as O(n) 
memory and time to solve BEM problems [208]. Many such algorithms have been 
presented, including the fast multipole method (FMM) [209] l-I-matrices [210-2121, 
the precorrected-FFT met hod [49], wavelet techniques [2 13, 2 141, FFT on multi- 
poles [2 15,2 161, kernel-independent mult ipole met hods [2 17, 2 181, t he hierarchical 
SVD method [50,219], plane-wave expansion based approaches [220], and the PILOT 
algorithm [221]. Some algorithms, such as the original FMM, exploit the decay of 
the integral equation kernel; the precorrected-FFT method makes use of kernel shift- 
invariance. This paper introduces an algorithm that combines the benefits of both of 
these approaches, leading to a method that has excellent memory and time efficiency 
even on highly inhomogeneous problems. 
Fast BEM algorithms whose structures depend on kernel decay suffer from a com- 
mon, well-known problem: computing medium- and long-range interactions is still 
expensive, even when their numerical low rank is exploited. For instance, in the 
fast multipole method, computing the M2L (multipole to local) products dominates 
the matrix-vector product time, since each cube can have as many as 124 or 189 
interacting cubes, depending on the interaction list definition, and the work per 
M2L multiplication scales as O(p4), where p is the expansion order and is related 
to accuracy [47,209]. Much work has focused on reducing this cost; for the FMM, 
plane-wave expansions [220,222] diagonalize the M2L translation, but are typically 
only efficient for large p. The precorrected-FFT (pFFT) algorithm [49] relies on not 
the kernel's decay but rather its translation invariance to achieve high efficiency. The 
pFFT method is Green's function independent, even for highly oscillatory kernels. 
Consequently, the method has been applied in a number of different fields, including 
wide- band impedance extract ion [223], microfluidics [224-2261 and biomolecule elec- 
trostatics [227]. One weakness of the precorrected-FFT method is that its efficiency 
decreases as the problem domain becomes increasingly inhomogeneous [49]. 
In this paper, we introduce a fast BEM algorithm called FFTSVD. The method is 
well-suited to MEMS device simulation because it is Green's function independent and 
maintains high efficiency when solving inhomogeneous problems. The FFTSVD algo- 
rithm is similar to the PILOT algorithm introduced by Gope and Jandhyala [221], in 
that our algorithm is multiscale and based on an octree decomposition of the problem 
domain. Similar to PILOT and IES3, our algorithm uses sampling and QR decom- 
position to calculate reduced represent at ions for long-range interactions. The FFT is 
used to efficiently compute the interact ions, as in the kernel-independent multipole 
met hod [2 181. Numerical results from capacitance extraction problems demonstrate 
that FFTSVD is more memory efficient than FastCap or pFFT and that the algo- 
rithm does not have the homogeneity problem. In addition, we illustrate electrostatic 
force analysis by simulating a MEMS comb drive [226]. Finally, we demonstrate the 
method's kernel-independence by calculating the electrostatic free energy of transfer- 
ring a small fluorescent molecule from the gas phase to aqueous solution, using an 
integral formulation of a popular continuum electrostatics model [207,227]. 
The following section briefly describes a representative MEMS electrostatics prob- 
lem, a boundary element method used to solve the problem, and a more complicated 
surface formulation for calculating the electrostatic component of the solvation en- 
ergy of a biomolecule. Section 3 presents the FFTSVD algorithm. Computational 
results and performance comparisons appear in Section 4. Section 5 describes several 
algorithm variants and summarizes the paper. 
5.2 Background examples 
In this section we describe two electrostatics problems that arise in BioMEMS design 
and describe how they can be addressed using BEM. 
5.2.1 MEMS electrostatic force calculation 
Consider the electrostatically actuated MEMS comb drive illustrated in Figure 5- 
1. Two interdigitated polysilicon combs form the drive; one comb is fixed to the 
substrate and the other is attached to a flexible tether. Applying a voltage difference 
to the two combs results in an electrostatic force between the two structures, and 
the tethered comb moves in response [226]. The electrostatic response of the system 
to an applied voltage difference can be calculated by solving the first kind integral 
equation 
o  (r') G ( r  ; r') dr' = v (r  ) , 
where S is the union of the comb surfaces, V ( r )  is the applied potential on the 
comb surfaces, G(r;  r') = l/ 1 lr - r'l 1 is the free-space Green's function, and o ( r )  is 
the charge density on the comb surfaces. Note that this is a standard capacitance 
extraction problem. 
We can compute the axial electrostatic force between the combs by the relation 
where F ( s )  is the force in the axial direction, s  is the separation between the combs, 
131 
Figure 5-1: An electrostatically actuated MEMS comb drive. 
E is the electrostatic energy of the system, V is the vector of conductor potentials, 
and C(s) is the capacitance matrix, written as a function of the comb separation. 
To solve (5.1) numerically,we discretize the surfaces into n, panels and represent 
( ~ ( r ) ,  the charge density on the surface as a weighted combination of compactly s u p  
ported basis functions defined on the panels: 
Here, fi(r) is the ith basis function and xi the corresponding weight. Forcing the inte- 
gral over the discretized surface to match the known potential at a set of collocation 
points, we form the dense linear system 
The Green's function matrix G is defined by 
where ri is the ith collocation point and bi = V ( r i ) .  Alternatively, one can use a 
Galerkin method, in which case 
Gij = J J f i(r) f j(rl)G(r; r') dr dr' 
and 
The linear system of equations (5.4) is solved using preconditioned GMRES [228]. 
5.2.2 BEM simulation of biomolecule electrostatics 
Electrostatic solvation energy, the cost of transferring a molecule from a nonpolar low 
dielectric medium to an aqueous solution with mobile ions, plays an important role in 
underst anding molecular interact ions and properties. To calculate solvat ion energy, 
continuum electrostatic models are commonly employed. Figure 5-2 illustrates one 
such model. The Richards molecular surface [229] is taken to define the boundary 
a that separates the biomolecule interior and the solvent exterior. The interior is 
modeled as a homogeneous region of low permittivity €1, where the potential p(r)  
is governed by the Poisson equation, and partial atomic charges on the biomolecule 
atoms are modeled as discrete point charges at the atom centers: 
where n, is the number of discrete point charges and qi and ri are the ith charge's 
magnitude and location, respectively. In the solvent region, the linearized Poisson- 
Bolt zmann equation 
~ ~ ~ ( r )  = ~ ~ p ( r )  
Figure 5-2: Continuum model for calculating biomolecule solvation. 
governs the potential, where n, the inverse Debye screening length, depends on the 
concentration of ions in the solution and a higher permittivity €11. We write Green's 
theorem in the interior and exterior regions and then enforce continuity conditions at 
the boundary to produce a pair of coupled integral equations, 
where ra is a point on the surface, f denotes the Cauchy principal value integral, 
GI is the Laplace Green's function, G2 is the real Helmholtz Green's function, 3 
denotes the appropriate double layer Green's function, q( r )  is the potential on the 
surface, and 2 (r) is the normal derivative of the potential on the surface. Readers are 
referred to [207,227] for detailed derivations of the formulation. To solve (5.10,5.11) 
numerically we define a set of basis functions on the discretized surface and represent 
the surface potential and its normal derivative as weighted combinat ions of these basis 
functions: 
We force the discretized integrals to exactly match the known surface conditions at 
the panel centroids; this produces the dense linear system 
where, denoting the ith panel centroid as Ti,  the block matrix entries are 
and the block matrices G2 and 2 are similarly defined. Note that boundary ele- 
ment method solution of this problem requires a Green's function independent fast 
algorithm. 
5.3 The FFTSVD algorithm 
The FFTSVD is a multiscale algorithm like most fast algorithms for low frequency 
applications: to compute the total action of the integral operator on a vector, we 
separate its actions at different length scales and compute them separately, combining 
them only at the end. In describing the FFTSVD algorithm, it is helpful to think of 
the basis functions as sources, J fi(rl)G(r; r1)dr' as the potential produced by source 
i, and the collocation points ri as destinations. Multiplying x by G in Equation (5.4) 
Figure 5-3: The multiscale approach to fast matrix multiplication. 
is then computing potentials at all the destinations due to all sources. Figure 5-3 
illustrates the multiscale approach to fast matrix multiplication: the square S denotes 
a source, and the squares denoted I represent destinations. 
5.3.1 Notation 
Let d and s denote two sets of panels: then Gd,+ is the submatrix of G that maps 
sources in s to responses in d. The number of panels in set i is denoted by ni. 
5.3.2 Octree decomposition 
We first define the problem domain to be the union of all the sets of panels that 
comprise the discretized surfaces. We then place a bounding cube around the domain 
and recursively decompose the cube using octrees. Given a cube s at level 2, the 
nearest neighbors Ns are those cubes at level i that share a face, edge, or vertex with 
s. The interaction list for s is denoted as I, and defined to be the set of cubes at 
level i that are not nearest neighbors to s and not descended from any cube in an 
interaction list of an ancestor of s [230]. Figure 5-4 illustrates the exclusion process 
for a 2-D domain. At every level, each panel is assigned to the cube that contains its 
centroid. Where ambiguity will not result, s denotes either the cube itself or the set of 
panels assigned to it. This assignment rule ensures that each panel-panel interaction 
is treated exactly once. 
Figure 5-4: Interacting squares at two levels of decomposition. 
The coarsest decomposition is termed level 0 and has 43 cubes; coarser decom- 
positions have null interaction lists. We continue decomposing the domain until we 
reach a level 1 at which no cube is assigned more than n,,,,, destinations. At each 
level i, every cube s has a set of interacting cubes Is that are well-separated from s 
with respect to the current cube size. Note that the definition of an interaction list 
is symmetric: d E Is -+ s E Id. 
5.3.3 Sampling dominant sources and responses 
One can compute the potential response 91, in Is due to a source qs in s by the dense 
matrix-vector product 
However, the separation between s and I, motivates the approximation 
where V,,, has orthogonal columns [50]. The matrix KySrc is small and represents 
the k source distributions in s that produce dominant effects in I,. It is a reduced 
row basis for GIs,,. The projection of q, onto Vs,src loosely parallels the fast multipole 
method's calculation of multipoles from sources, in the sense that both the multipole 
expansion and the product V,5rCq, capture the important pieces of q, when calculating 
far-field interactions. We call VsPSrc the source compression matrix. 
A similar low-rank approximation can be made to find the response in a cube d 
given a source distribution in Id: 
Here, Ud,dest is small and represents the k dominant potential responses in d, the 
destination cube, due to source distributions in Id. We call Ud,dest the destination 
compression matrix; Ud,dest is a reduced column basis for Gd,Id. 
Since it is impractical to compute GIs,, and Gs,Is for each cube s, we use a sampling 
procedure inspired by the Kapur and Long hierarchical SVD method [50]. Figures 5- 
sampled rows of approximate dominant right 
singular vectors of G 
Figure 5-5: Computing dominant row basis for GI,, using sampling. 
5 and 5-6 illustrate the process of finding a reduced row basis V,,,. To determine 
the row basis, we begin by selecting one destination per interacting cube, computing 
the corresponding rows of GI,,,, and performing rank-revealing QR factorization with 
reorthogonalization on the transpose of the submatrix. If the submatrix rank is 
less than half the number of sampled destinations, the QR-determined row basis 
is considered to be adequate. Otherwise, an additional destination is sampled for 
each interacting cube; the extra destination is chosen to be well-separated from the 
originally chosen destination. The transpose of the new submatrix is factorized and 
again required to have rank less than half the total number of samples. The process 
of resampling is continued until the required rank threshold is met. 
To compute the reduced column basis Ud,dBt for the matrix Gar,, we select a set 
of well separated panels in Id, compute the corresponding columns of Gd,&, and QR 
factorize the submatrix. 
Collocation points 
Sampled collocation points 
A Basis function support 
Figure 5-6: Sampling a small set of long-range interactions. 
5.3.4 Computing long-range interactions 
Consider two well separated cubes s and d. Because the cubes are well separated, we 
could find a low-rank approximation to Gd,, by truncating its SVD: 
where the hat denotes truncation to k columns, k < n,. Since the source compression 
matrix V,,, finds an approximation to the dominant row space of GIs,,, we expect 
that it also approximates the dominant row space of Gd,,, which is a submatrix of 
G I ~  ,s -  Similarly, we expect that Ud,&& approximates the dominant column space of 
Gd,,. A small matrix Kd,, maps source distributions in the reduced basis VsySrc to 
Figure 5-7: Schematic of the FFTSVD method for computing long-range interactions. 
responses in the reduced basis Ud,dest: 
and it is easy to see that 
Kd,s = ~ & ~ t ~ d , s ~ , s r c .  
Note that Kd,s is not diagonal because Ud,deat and V,,src only approximate the singular 
vectors of Gd,+. If K,src E Rnsxks and Ud,dat E RndXkd, then Kd,s E RkdXks. 
The action of the K matrices can be computed in a number of different ways: they 
can be computed explicitly, via multipoles, or via an FFT. Explicit storage is memory 
intensive, and multipole representations are Green's function dependent. We have 
therefore chosen to implement the memory-efficient, Green's function independent 
FFT translation method presented by Ying et al. [218]. 
5.3.5 Diagonalizing long-range interactions with the FFT 
Our method projects sources to a grid, uses an FFT convolution to accomplish trans- 
lation between source and destination, and interpolates results back from the grid. 
Figure 5-7 illustrates the approach. We introduce two matrices: Pgj  projects sources 
in cube j to the cube grid, and Ij,g interpolates from the grid in cube j to the evalua- 
tion points in j. We use an equivalent density scheme similar to those used by Phillips 
and White [49] and Biros et al. [217] to determine the projection and interpolation 
matrices. 
Projection matrix calculation 
Given a cube s and the basis function weights qs for panels in s, we wish to find a set 
of grid charges q,,, that reproduce the potential field far from s. We accomplish this 
by defining a sphere I' bounding s and picking a set of quadrature points [231] on the 
sphere. Denoting quadrature point i on I? by rr,i, the mapping between qs and the 
responses at the quadrature points can be written as GrPs, where 
Gr,s,ij = J G(rr,i ;rl)drl* 
panel j 
The mapping between grid charges and responses at the quadrature points can be 
written as 
where rg,j is the position of the jth grid point. If more quadrature points than grid 
points are used for the matching, solving a least squares problem gives the desired 
projection P,,,: 
PgYs = ~ ~ ~ $ r , s .  (5.27) 
In practice, one uses the singular value decomposition to solve for P,,,. 
Interpolat ion matrix calculation 
Given grid potentials qd in a cube d, we find the potentials cpd at the panel centroids 
in d by interpolation. For problems in which centroid collocation is used to generate 
a linear system of equations, the interpolation matrix is calculated as 
where Grid denotes the Green's function matrix from the quadrature points on I? to the 
panel centroids in d. If Galerkin methods are used rather than centroid collocation, 
the interpolation matrix is the transpose of the projection matrix. 
Diagonal translation 
Once the grid charges in s are known, a spatial convolution with the Green's function 
produces the potentials at the grid points in the destination cube d. This spatial 
convolution is diagonalized by the Fourier transform; we write the transform matrix 
as 3, its inverse by F1, and the transform of the Green's function matrix by Gd,+. 
After calculating the grid potentials in d, interpolation produces the potentials at the 
desired evaluation points. The matrix GdTs is therefore written as 
The products Id,g3-1 and FP,,, could be stored, but in our experience this precom- 
put at ion only marginally improves the matrix-vect or product time while increasing 
memory use since 3 and F-' are padded and complex. 
In addition to diagonalizing the translation operation between cubes, the FFT sig- 
nificantly decreases memory requirements. Using explicit K matrices requires storing 
a small dense matrix for each pair of cubes; using FFT translation eliminates the ex- 
pensive per-pair matrix cost. Instead, each cube has its own Pg and I, matrices, which 
are used for all long-range interactions. In addition, because the Green's function is 
translationally invariant, we only need to store a small number of G matrices for 
each octree level; each one represents a particular relative translation between source 
and destination cubes. Because these matrices are diagonal, storage requirements are 
minimal. 
Since translation is the dominant cost in the FFTSVD matrix-vector product, 
efficient implement at ion of the translation procedure is essential to maximizing per- 
formance. The translation operat ion is simply an element-wise multiplication of two 
complex vectors, therefore, for g, grid points per cube side, each translation vector is 
(29, - [(29p - 1)/2 + 11 complex numbers long when using the FFTW library [232]. 
This number takes into account padding and symmetry. For example, with g, = 3, 
75 complex numbers are required, resulting in 250 individual multiplies during the 
translation operation. This number has been reduced by taking advantage of vec- 
torizat ion. Many modern CPUs include instructions that can assist in multiplying 
complex numbers within a register, effectively halving the number of required mul- 
tiplies. For comparison, standard fast multipole method translations require more 
multiplications since they are not diagonal, and cannot be vectorized as easily since 
they involve matrix-vector products. In addition, we have yet to exploit additional 
ways to accelerate the FFTSVD translation operation. These include using symme- 
tries between related translation vectors (G), such as those that translate in opposite 
directions, and exploiting the fact that for axial translations, many G elements are 
purely real. 
5.3.6 Local interactions 
At the finest level of the decomposition, interactions between nearest neighbor cubes 
are computed directly by calculating the corresponding dense submatrices of G. These 
submatrices are denoted by DiYj where j is the source cube and i the destination. We 
bound the complexity of the local interaction computation by continuing the octree 
decomposition until each cube has fewer than n,, panels. 
5.3.7 Algorithm detail 
The mapping from source cube s to destination cube d can thus be written as 
The computations are grouped to eliminate redundant multiplications; the matrix 
products u z ~ ~ , ~  and Pg,,V, are stored for each cube rather than recomputed at every 
iteration. Below, we introduce the restriction operator Mj(" that restricts a global 
vector to a local vector associated with cube j at level i; let the inverse operator map 
a local vector to the global by inserting appropriate zeros. Let LQenote the set of 
cubes at level i. Given a charge vector q, the matrix-vector product is computed by 
the following procedure: 
1. DOWNWARD PASS FOR LONG-RANGE INTERACTIONS: For levels i = 
0) 1). . . , I ! :  
(a) PROJECT INTO DOMINANT SOURCE SPACE: For each cube j E La) 
compute 
Cj = ~ ( p g  j 4,s") ~ , 5 ~ ~ ~ j ( ~ ) q -  (5.31) 
(b) COMPUTE LONG-RANGE INTERACTIONS: For each cube j E Li, 
compute 
(c) DETERMINE TOTAL DOMINANT RESPONSE: For each cube j E Li) 
2. SUM DIRECT INTERACTIONS: For each cube d at level 1,  add the contribu- 
tions from neighboring cubes Nd: 
5.4 Computational results 
To demonstrate the accuracy, speed, and memory efficiency of the FFTSVD algo- 
rithm, we have used FFTSVD to solve for self and mutual capacitances in various 
geometries. A MEMS comb drive example [226] illustrates electrostatic force calcu- 
lation using FFTSVD. In addition, to show Green's function independence and use 
of double layer kernels, we have used FFTSVD to solve for the electrostatics of sol- 
vation for the highly charged dye molecule fluorescein. Fluorescein is often used as a 
fluorescent label in BioMEMS applications [233,234], and its electrostatic properties 
in aqueous solution modulate its interaction with other molecules and surfaces. 
The FFTSVD algorithm has several adjustable parameters: EQR is the reduced 
basis tolerance; gp is the number of FFT grid points on each side of a finest-level 
cube; nP,, is the maximum number of panels in a finest-level cube; nqud is the 
number of quadrature points used on the equivalent density sphere, tolGMREs is the 
tolerance on the relative residual that the resulting linear equations are solved to. At 
the two finest levels, gp FFT grid points per cube edge are used, and the number of 
grid points per edge increases by one for each successively coarser level; experience 
has shown that using different numbers of grid points per edge provides significant 
accuracy improvements for marginal memory and time costs. The parameters used 
for the following results are for EQR, 3 for gp, 32 for nP,,,, 25 for nqud, and 
for tolGMREs unless otherwise specified. 
For capacitance calculations, we compare performance to FastCap, based on the 
fast multipole method [47], and fftcap++, based on the pFFT++ implementation 
of the precorrected-FFT method [235]. All programs were compiled with full opti- 
mizations using the Intel C++ compiler version 8.1 and benchmarked on an Intel 
Pentium 4 3.0-GHz desktop computer with 2 GB of RAM. All parameter settings in 
Fast Cap and fftcap++ were left at their defaults, except for the tolerance on solving 
the resulting linear equations, which was set to unless otherwise specified. 
5.4.1 Self-capacitance of a sphere 
In order to test the accuracy of the FFTSVD method, we have applied it to solving 
for the self-capacitance of a unit l-m radius sphere, a quantity known analytically. 
Figure 5-8 shows the improvement in accuracy with increasing sphere discretization 
for FFTSVD with values of 3 and 5 for gp,  2nd and 4th order multipoles in FastCap, 
and default settings for fftcap++. A tolerance of for the relative residual when 
solving the BEM equations was used in all programs. The analytical value for the 
self-capacitance of a l-m radius sphere is 0.111265 nF as computed by Gauss' law. 
The results show that FFTSVD with a value of 3 for gp tends to be more accurate 
than 2nd order multipoles in FastCap. In addition, FFTSVD with low values of g, 
tends to overshoot the analytical solution while FastCap tends to undershoot with 
truncation of multipole order. These findings are consistent across many geometries 
when examining convergence behavior. 
5.4.2 Woven bus example (homogeneous problem) 
As stated previously, one of the advantages of the FFTSVD method is its use of 
diagonal translation operators. This advantage becomes apparent in cases of homo- 
geneous geometry, since a large number of translation operations are required. To 
examine performance in a problem with homogeneous geometry, we have applied 
FFTSVD to solving for the mutual capacitances between woven bus conductors as 
in Figure 5-9. Table 5.1 summarizes the results for several woven bus capacitance 
I + FastCap 2nd order( I 
- e - FastCap 4th Order 
* map++ l i 
Number of Panels 
Figure 5-8: Accuracy versus number of panels for FFTSVD, FastCap and fftcap++ 
solving the unit sphere self-capacitance problem. 
Table 5.1: Comparison of FastCap (FC), fftcap++ (FFT++) and FFTSVD (FS) per- 
formance in terms of matriu-vector product time (MV) and memory usage (MEM) 
on homogeneous woven bus capacitance problems with 2, 5 and 10 crossings (we 
ven02n03, woven05n03, woven1 0n03) and 10 crossings with lower discretization (we 
problems. FFTSVD can achieve slightly better speed and memory performance than 
venlOn01). 
precorrected-FFT, which is expected to excel at problems with uniform distribution, 
and significantly better performance as compared to FastCap. 
Inhomogeneous capacitance problem 
Problem 
woven02n03 
woven05n03 
wovenlOnO1 
waven10n03 
One of the disadvantages of the precorrected-FFT method is that it lays down a 
FFT++ MEM (MB) 
23 
41 1 
69 
818 
uniform grid over the entire problem domain, and the simulation time grows roughly 
in proportion to the number of grid points. For simulations in which most of the 
domain is empty, therefore, the precorrected-FFT algorithm is inefficient. We have 
FS MV (a) 
0.01 
0.09 
0.04 
0.41 
Panels 
3168 
187110 
8160 
73440 
FS MEM (MB) 
11 
110 
41 
466 
FC MV (s) 
0.03 
0.17 
0.08 
0.73 
FC MEM (MB) I FFT++ M V  (8) 
30 
206 
89 
901 
0.02 
0.22 
0.04 
0.51 
Figure 5-9: Homogeneous woven bus capacitance problem (wovenlOn01). 
demonstrated this inefficiency, and FFTSVD's relative advantage, by configuring a 
set of conductors as shown in Figure 5-10. Almost all of the panels in this system 
are at the edges of a cube bounding the domain. Figure 5-11 plots the matrix- 
vector product times for the FFTSVD, FastCap and fftcap++ codes, and Figure 5-12 
plots the memory requirements. As expected, the precorrected-FFT based fftcap++ 
code has poor performance, especially for fine discretizations of the inhomogeneous 
problem. FFTSVD performs consistently better than fftcap++ and generally better 
than FastCap. The sharp jumps in FFTSVD and fftcap++ matrix-vector product 
time with increasing panel count are due to a change in selection of the optimal octree 
decomposition depth or FFT grid size, respectively. 
5.4.4 MEMS comb drive 
We have simulated the MEMS comb drive illustrated in Figure 5-1 [226]. We ap- 
plied a voltage difference of 1 V to the two structures and used a fourth-order fi- 
nite difference scheme to approximate the derivative in Equation (5.2). Because the 
149 
Figure 5- 10: Inhomogeneous capacitance problem. 
 umbero of Panels 
Figure 5-11: Matrix-vector product times for FFTSVD, Fastcap and fftcap++ codes 
solving the inhomogeneous capacitance problem. 
+ FastCap 2nd Orde 
Number of Panels 
Figure 5-12: Memory requirements for FFTSVD, FastCap and fftcap++ codes solving 
the inhomogeneous capacitance problem. 
finite-difference scheme for force calculation requires high accuracy in the capacitance 
calculations, more stringent parameters are required for these simulations. We have 
used = EQR = lo-', gp = 5, ~ Q U A D  = 64, and for each discretization 
we have fixed n,,,, such that the octree decomposition depth is equal for each of 
the four geometries. 
The contribution of each panel to the axial force is plotted in Figure 5-13 and the 
total axial electrostatic force is plotted in Figure 5-14 as a function of the number of 
panels used to discretize the comb drive. We have used general triangles and note that 
the discretization scheme is poorly tuned for the calculation of electrostatic forces; 
nonuniform meshes achieve superior accuracy at reduced panel counts [236]. The force 
can also be calculated by integrating the squared charge density over the conductor 
surface, but this approach requires specialized treatment because the charge density 
becomes infinite at the edges and corners of the conductors [237,238]. 
u 
Figure 5-13: Magnitudes of panel contributions to the axial electrostatic force. Units 
are pN. 
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Figure 5-14: Calculated total axial electrostatic force on one comb. 
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Figure 5- 15: Computed electrostatic solvat ion energy of fluorescein with increasing 
problem discretization. 
5.4.5 Solvat ion of fluorescein 
We have used the integral formulation in Equations (5.10) and (5.11) to calculate 
the solvation energy of fluorescein. To prepare a model for solvation calculations, 
its structure and partial atomic charges were determined from quantum mechanical 
calculations. Radii were assigned to each atom and used to generate a triangulation 
of the molecular surface. The interior of the fluorescein molecule was assigned a 
dielectric constant of 4, and the exterior was assigned a dielectric constant of 80 (for 
water) with an ionic strength of 0.145 M (n = 0.124 kl). FFTSVD was used to 
solve for both the electrostatic solvatioq energy (Figure 5-15), as well as the total 
C 
electrostatic potential on the surface of the fluorescein molecule (Figure 5-16). We 
note that the long-range single and double layer integrals can be computed using only 
one set of of translation operations. Different projection operators are used to find 
the corresponding grid charges due to monopole and dipole distributions, and the 
grid charges can then be summed for translation. 
Figure 5-16: Electrostatic solvation potentials on the molecular surface of fluorescein. 
Units are kcal mol-' e-' . 
5.5 Discussion 
5.5.1 Algorithm variants 
For problems with a small number of integral operators, memory constraints may 
not be a significant consideration. In these cases, the matrices Kd,+ can be stored 
explicitly. These Kd,+ matrices are computed using Equation (5.24), but instead of 
computing Gd,, explicitly, we project , translate and interpolate an identity matrix 
using the methodology outlined in Section 5.3.5. Although setup time and memory 
use increase when explicit K-matrices are used, the matrix-vector product time is 
significantly reduced. We have also implemented a parameter that allows a tradeoff 
between speed and memory use through K-matrices. Pairs of interacting octree cubes 
that contain fewer panels than the parameter are handled with explicit K-matrices, 
while all other cubes use the FFT-based translation. In this manner, the balance 
between speed and memory can be fine-tuned for the given application. 
It is also straightforward to create an FFTSVD variant that runs in linear time; 
the same method used to generate the projection and interpolation matrices can be 
used to create "upward pass" and "downward pass" operators such as those found in 
mult ipole algorithms. This variant algorithm is essentially equivalent to the kernel- 
independent method by Ying et al. [218], except that we allow all the grid charges to 
be nonzero. The Ying method, in contrast, uses only grid charges on the surface of 
the cube. 
The linear-time FFTSVD method requires a greater number of grid points per 
cube, due to the loss of degrees of freedom during each upward pass from child 
to parent cube. In addition, the SVD based compression of dominant sources and 
responses is no longer computed, since these bases are now taken directly from child 
cubes. This method is extremely memory efficient since dominant source and response 
bases are no longer stored, but it trades off performance to achieve it due to the larger 
required grid sizes. 
Finally, the multilevel structure of FFTSVD allows easy parallelization. Each pro- 
cessor can be assigned responsibility for a set of cubes on coarse levels, and the com- 
putation can proceed independently until the final potentid responses are summed. 
We have implemented parallel FFTSVD using both OpenMP and MPI libraries with 
good results. 
Summary 
We have developed a fast algorithm for computing the dense matrix-vector prod- 
ucts required to solve boundary element problems using Krylov subspace iterative 
methods. The FFTSVD method is a multiscale algorithm; an octree decomposes the 
matrix action into different length scales. For each length scale, we use sampling to 
calculate reduced bases for the interactions between well-separated groups of pan- 
els. The FFT is used to diagonalize the translation operation that computes the 
long-range interactions. The method described here relies on both kernel decay and 
translation invariance. 
Numerical results illustrate that FFTSVD is much more memory-efficient than 
FastCap or precorrected-FFT, and that it is generally faster than either technique 
on a variety of problems. In addition, FFTSVD is Green's function independent, 
unlike FastCap, and the method performs well even when the problem domain is 
sparsely populated, unlike precorrected-FFT. Our implementation is well-suited to 
solve problems with multiple dielectric regions. Finally, we note that the structure 
of the algorithm permits treatment of kernels that are not translation-invariant ; for 
such problems,the K-matrix algorithm variant should be used rather than the FFT. 
Together, the algorithm's performance and flexibility make FFTSVD an excellent 
candidate for fast BEM solvers for microfluidic and microelectromechanical problems 
that appear in BioMEMS design. 
Chapter 6 
Accurate Solution of Multi-region 
Continuum Electrostatic Problems 
Using the Linearized 
Poisson-Boltzmann Equation and 
Curved Boundary Elements 
Abstract 
We present a boundary-element method (BEM) implementation for solving prob- 
lems in biomolecular electrostatics using the linearized Poisson-Boltzmann equation. 
The motivating factor behind this implementation was the desire to create an ef- 
ficient and accurate solver capable of precisely describing the molecular topologies 
prevalent in continuum models. Underlying this implement at ion are three key fea- 
tures that address many of t he well-known practical challenges associated with the 
boundary-element method. First, we present a general boundary-integral approach 
capable of modeling an arbitrary number of embedded homogeneous dielectric regions 
with differing dielectric constants, possible salt treatment, and point charges. Sec- 
ond, molecular and accessible surfaces used to describe dielectric and ion-exclusion 
boundaries are discretized with curved boundary elements that faithfully reproduce 
even complicated geometries. Robust numerical integration methods are employed 
to accurately evaluate singular and near-singular integrals over the curved boundary 
elements. Third, we avoid explicitly forming the dense BEM matrix, and instead 
solve the linear system with preconditioned GMRES, using the FFTSVD algorithm 
to accelerate matrix-vector multiplication. A comparison of the presented BEM im- 
plement at ion and standard finite-diff erence techniques demonstrates that for certain 
classes of electrostatic calculations, the improved convergence properties of the BEM 
approach can have a significant impact on computed energetics. These results sug- 
gest that solvers with improved accuracy may be important to ensure that predictions 
based on continuum models are limited by the models themselves rather than by er- 
rors in the models' numerical evaluation. 
'All work presented in this chapter w e  performed in collaboration with J. P. Bardhan and 
J. K. White at the Massachusetts Institute of Technology, Department of Electrical Engineering and 
Computer Science. 
6.1 Introduction 
Continuum theories of solvation have become common tools for molecular mod- 
eling, and have led to an improved understanding of electrostatic interactions in 
biomolecular systems [27,29]. One of the most popular models of continuum solva- 
tion treats a molecule and its solvent environment as homogeneous regions of low 
and high dielectric const ants respectively, with embedded point charges represent- 
ing the molecular charge distribution and Debye-Hiickel theory modeling the effect 
of salt. The linearized Poisson-Boltzmann equation governs this continuum model, 
and this equation has received much attention in recent years [239-2411. The lin- 
earized Poisson-Boltzmann equation (LPBE), an elliptic partial differential equation 
(PDE) [242], is well understood theoretically and can be solved numerically using a va- 
riety of techniques including finite-difference methods (FDM) [25,26,28,122,243-2461 
finite-element methods (FEM) [206,247-2491, and boundary-element methods (BEM) 
[250-2611. 
Boundary-element methods offer several inherent advantages over volume-based 
methods for solving the LPBE with regions of homogeneous dielectric [262]. For 
example, the BEM only requires discretization of problem boundaries rather than the 
entire infinite domain, and inherently captures the correct zero-potential boundary 
condition at infinity. In comparison to finite-difference methods, the BEM has the 
ability to model point charges exactly, rather than requiring grid projection. 
Unfortunately, boundary-element methods require sophisticated numerical tech- 
niques in order to be competitive with the flexibility and performance of volume-based 
met hods. Several challenges complicate the implement at ion of BEM techniques for 
biomolecule electrostatics. The first challenge arises from the surface-based analysis of 
the problem. Some Poisson-Boltzmann modeling problems require treatment of mul- 
tiple embedded or disconnected regions with differing dielectric constants and screen- 
ing parameters [263,264]. These features allow the simulation of solvent-filled cavities 
within macromolecules, salt-filled regions in large cavities, and an ion-exclusion layer 
surrounding the molecule with solvent permittivity but no salt. Multiple regions are 
easily modeled in volume methods like FDM and FEM because the dielectric const ant 
and the presence of salt can be assigned to each grid point or volume element indepen- 
dently. Implementing these features using BEM requires the discretization of every 
interface between dielectric regions and between those governed by differing PDEs. 
In contrast, volume-based methods need no additional degrees of freedom. Previous 
BEM approaches have addressed these limitations by developing specific formulations 
to treat multiple embedded dielectric regions without salt [263], multiple disconnected 
dielectric bodies with salt [264], and hybrid boundary-elementlfinite-difference meth- 
ods to treat ion-exclusion layers [265]. 
A second important challenge for biomolecule BEM is the strong dependence of 
solution accuracy on the quality of the surface representation. In this work and in 
most others, the dielectric and ion-exclusion surfaces are described according to one 
of two definitions. Accessible surfaces [266] are defined as a union of spheres, where 
the atomic radii are expanded by a probe's radius. Molecular surfaces [229,267,268] 
represent the surface of closest approach of a probe sphere rolled over a union of 
spheres representing a molecule. These curved surfaces, which consist of portions of 
spheres and t orii, are analytically defined but often difficult to discretize because the 
surfaces have cusps and singularities. Most boundary-element methods for solving 
the LPBE represent these surfaces approximately using large numbers of planar tri- 
angular elements, or panels, that can never truly capture the curved geometries. The 
importance of using curved elements has already been discussed [269,270], but previ- 
ous implementations have introduced other approximations. For example, other work 
has modified the molecular surface definition to avoid singularities and thin regions, 
used elements with low-order curvature that cannot accurately represent spheres or 
torii, or discretized surfaces using standard spherical triangles that cannot exactly 
represent the intersections between atoms. 
A third challenge for BEM is that discretization of surface integral equations gives 
rise to dense linear systems of equations. As a result, memory costs scale quadratically 
in the number of unknowns. In contrast, the FDM and FEM generate sparse matrices 
that reflect the local nature of the differential operators. Solving the BEM linear sys- 
tem by matrix factorization requires O(n3) time, where n is the number of unknowns. 
Computational costs rapidly become prohibitive for systems with more than lo4 un- 
knowns, which is currently insufficient to accurately model large macromolecules such 
as proteins. The quadratic memory and cubic time costs can be reduced to linear 
or near-linear complexity by combining two approximation schemes. First, the linear 
systems are solved approximately, rather than exactly, using Krylov subspace itera- 
tive methods such as the conjugate gradient method (CG) or the generalized mini- 
mum residual algorithm (GMRES) [228]. Every iteration of a dense Krylov subspace 
method requires the multiplication of a vector by the BEM matrix, costing a pro- 
hibitive O(n2) memory and time. A second approximation reduces the matrix-vector 
product cost by interpreting the formation of the product as an n-body potential 
calculation [47]. This interpret at ion enables the use of techniques such as mult ipole 
methods [47,209,255,257,259,260], or multiscale methods [258], to reduce the solu- 
tion costs to O(n) or 0 (n log n) . Multipole met hods require specialized expansions 
for every governing equation, and expansions for the LPBE have been developed in 
recent years [271]. One disadvantage of the fast multipole method (FMM) in partic- 
ular is that the computational costs grow rapidly when improving accuracy [272] due 
to dense translation operations between mult ipole and local expansions, motivating 
the development of more efficient techniques [272-2741. 
Another challenge for the BEM is that the computation of elements in the dense 
systems of linear equations requires the integration of possibly singular functions over 
the panels used to discretize the boundary surfaces. These integrations can be inter- 
preted as the calculation of the potential at an evaluation point due to a charge distri- 
bution defined on a boundary element. In contrast, the matrix elements for FDM and 
FEM problems are relatively easily computed. Although analytical expressions exist 
for the integral of the Laplace (Poisson) kernel over flat triangular panels [275,276], 
integration of the the LPBE kernel, or integration over general curved domains, re- 
quire numerical approximation. When the evaluation point is sufficiently far from 
the panel, quadrature rules can be used to perform numerical integration, even over 
curved panels [252,254]. However, when the evaluation point is near or on the panel, 
even high-order quadrature rules do not suffice to capture the singularity. The evalu- 
ation of near-singular and singular integrals has been noted to be a limiting factor in 
the accuracy of BEM implementations for molecular electrostatics [256], and a variety 
of techniques have been developed to either avoid computing these integrals [256] or 
to approximate them with specialized quadrature rules [277]. 
In this paper we present a boundary-element method implementation for solv- 
ing the linearized Poisson-Boltzmann equation (LPBE) that addresses all of these 
challenges, with the ultimate goal of achieving high accuracy given reasonable com- 
putational resources. Three key features underlie the implementation. First, we have 
developed a general boundary-integral approach that can easily treat an arbitrary 
number of embedded regions of homogeneous dielectric with different dielectric con- 
stants and possibly salt. Second, the accessible and molecular surfaces are discretized 
using curved boundary elements that accurately capture the problem geometry, em- 
ploying robust methods to compute self- and near-field integrals. Third, the dense 
linear systems are solved using preconditioned Krylov subspace methods and the 
FFTSVD algorithm [274]. 
Our Green's-theorem-based integral-equation formalism allows for ion-exclusion 
layers, solvent-filled cavities in the solute, and multiple homogeneous dielectric re- 
gions. Finite-difference and finite-element simulations have long been capable of mod- 
eling problems with these features, but this paper presents the first detailed derivation 
for BEM treatment. The accessible and molecular surfaces are represented essentially 
exactly using curved boundary-element discretizations that accurately reproduce sin- 
gularities, cusps, and thin regions. Accurate numerical integration techniques for 
the singular Laplace (Poisson) and LPBE Green's functions [270] allow the BEM to 
achieve exceptional accuracy. The FFTSVD algorithm [274] efficiently sparsifies the 
dense BEM matrix, and memory and time requirements scale effectively linearly in 
the number of boundary elements. This fast BEM technique can be applied without 
modification to compress all of the integral operators in biomolecule electrostatics. 
h r t  hermore, the dense translation operat ions that dominate the FMM computational 
cost are replaced in the FFTSVD method with more efficient diagonal translations, 
allowing for a better tradeoff between computational expense and accuracy. 
After describing the boundary-element implementation, we present a set of com- 
putational experiments in order to assess the relative accuracy and computational 
cost of finite-difference and boundary-element method simulations for several cate- 
gories of calculations. We calculate the electrostatic contributions to free energies 
of solvation for an analytically solvable sphere geometry, a short peptide derived 
from an HIV-1 substrate site [43], and the barnase-barstar protein complex [278]. 
We also compute rigid and non-rigid electrostatic binding free energies for the wild- 
type barnase-bar st ar complex as well as three single mutant s. Solvat ion calculations 
demonstrate that the BEM presented here provides better convergence as a func- 
tion of compute time. Rigid-binding results also suggest that the BEM converges 
more rapidly than FDM. However, when comparing differential rigid binding energies 
between wild-type and mutant protein complexes, where the structure remains the 
same except at the site of mutation, even low-resolution finite-difference simulations 
seem to accurately capture this difference. The curved BEM regains an accuracy ad- 
vantage for differential non-rigid binding calculations, suggesting that the accuracy of 
Figure 6- 1 : A one-surface problem in molecular electrostatics. The molecular interior 
(Region I) is surrounded by a salt solution with high dielectric constant and inverse 
Debye length K (Region I I ) .  
finite-difference rigid binding may result from fortuitous cancellation of error. Finally, 
we demonstrate that the BEM implementation offers a clear advantage in accuracy 
and comparable simulation time for calculations that require repeated solution of the 
same problem geometry with different sets of atomic charges. Electrostatic compo- 
nent analysis [173,279,280] and charge optimization [23,24] are types of calculations 
that fall into this category. 
6.2 Theory 
6.2.1 Green's theorem integral formulation 
We begin our presentation of the multi-region integral formulation by deriving the one- 
surface Green's-theorem-based integral formulation described by Yoon and Lenhoff 
[207]. This method is also known as the non-derivative Green's theorem formulation 
[261,269]. Figure 6-1 illustrates the problem and notation. 
A single boundary a divides space into two regions. The molecular interior, labeled 
region I, has a uniform dielectric constant €1 and contains n, discrete point charges. 
The ith point charge, located at ri, is of value qi. In region I, the electrostatic potential 
+I(r) is governed by a Poisson equation 
where 6(r - ri) is the Dirac delta function translated by ri. 
The solvent region 11 exterior to a represents solvent with mobile ions; we model 
the region as having a uniform dielectric constant €11 and an inverse Debye length 
n. In this region, the electrostatic potential q511(r) is assumed to obey the linearized 
Poisson-Bolt zmann equation: 
The free-space Green's functions for the Poisson and linearized Poisson- 
Boltzmann equations are 
1 GI(r;r l )  = Region I 4 ~ 1  lr - rll 1 
- 
u 
G ~ ~ ( r ; r ' )  - 4T11r-r~~ Region I1 
respectively. Across the boundary surface a, the electrostatic potential and the normal 
displacement are continuous [281]. Using the relation D = EE, where the electric field 
E satisfies E = -V+, we can write the continuity conditions for a point ra on the 
surface a as 
In Equation 6.6, the normal direction is defined to point into the solvent region. 
After specifying the problem domains and boundary conditions, one applies 
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Green's theorem in both regions. Green's Theorem, 
where @(r) and 0(r) are two scalar fields, allows the determination of the potential at 
a point in a volume V given the free-space Green's function for the governing equation 
in V as well as the potential and its normal derivative at the bounding surface 0. 
We first apply Green's theorem to find the potential at a point rl in region I, 
which has the bounding surface R = a. Using the Green's function (Equation 6.3) 
and substituting Q(rl) = GI (rI; r'), O(rl) = $I (r') , and Equation 6.1, we have 
In Equation 6.8 and throughout this section, the normal derivative of GI is taken 
with respect to the integration variable r': that is, 3 (rI; r') denotes the potential at 
r~ induced by a normally-oriented dipole at r'. Simplifying the left-hand side using 
the definition of the Green's function, 
V ~ G ~ ( T I ;  r') = --S(~I - TI), (6.9) 
eliminates the volume integral in Equation 6.8, and by rearranging terms one obtains 
an expression for the potential at r~ as a function of the solute charge distribution 
and the boundary conditions: 
To apply Green's theorem in region 11, one must first bound the region by in- 
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troducing a hypothetical surface F at infinity, and using the substitutions q(r') = 
GII (rII; r'), @(r') = q511(r'), Equation 6.4, and the LPBE Green's function defini- 
tion. Assuming the potential obeys regularity conditions at infinity (2531, the surface 
integrals over vanish, and we can write the potential at a point r-11 in region 11 as 
and here, as in Equation 6.10, the normal direction is defined to point into region II. 
We derive a pair of coupled integral equations by letting the points r~ and r11 
approach a point ra on the surface. Using Equation 6.10, 
41(ra) = lim 4I(rI) 
TI  4 T a  (6.12) 
The second term in Equation 6.13 can be interpreted as the potential induced by 
a dipole layer of charge on the surface. Such a potential is discontinuous as the 
evaluation point crosses the surface and must be handled with care. We write 
where f represents a Cauchy principal value integral, and we assume that the limit 
as 9-1 + ra has been taken from the direction opposite the normal. A similar limiting 
process applied to Equation 6.11, in which we let r-11 -+ ra, yields 
Finally, we eliminate the unknowns +II(ra) and ?&(ra) using the continuity con- 
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ditions (Equations 6.5 and 6.6). Two coupled integral equations result: 
Introducing an abbreviated notation allows the equations to be written as 
where $a and 2 denote the surface potential and normal displacement on a, I 
denotes the identity operator, EI,JI abbreviates z, and SFv and DY,, denote the 
single- and double-layer operators that compute potential at the surface u due to a 
monopole or dipole charge density on surface v, given the Green's function GI(r; r'). 
The operator SY, is defined such that: 
(r') dA' ; 
similarly, 
In Equation 6.18, we have also defined GYYi = GI (ra; Ti). 
6.2.2 Numerical solution using the boundary-element 
method 
To simultaneously solve Equations 6.16 and 6.1 7 using the boundar y-element met hod 
(BEM), we first approximate the surface variables $I(ra) and %(ra) as weighted 
combinations of a set of n basis functions XI (r), ~2 (r), . . . , Xn (r) on the surface: 
The unknown weights uk and vk are then found by forcing the integral equation to 
be satisfied as closely as possible in some choice of metric. 
In this work, we discretize the surfaces into a discrete set of np non-overlapping 
curved boundary elements and use piecewise-constant basis functions that have a 
value of one on a single panel and are zero everywhere else: 
1 if ra is on panel k 
~ k ( r a )  = 
1 O otherwise. 
Defining the integral equation residual to be the difference between the known 
condition on the surface and the integral operator applied to the approximate solution, 
one can form a square linear system by forcing the residual to equal zero at the 
boundary-element centroids, a technique known as centroid collocation [282]. Using 
the piecewise-constant basis functions and denoting the centroid of panel i as r,, the 
discretized (matrix) form of the operator SFa from Equation 6.19 has entries 
and the double-layer discretized operator D$ similarly has entries 
D. . = ~ G I  f -  (rci; rf)dA;. I J  panel j an(?-') 
The tot a1 matrix equation representing the discret ized form of Equation 6.18 therefore 
has dimension 273,. Once this equation is solved, the potential anywhere in space may 
be calculated using the discretized forms of Equations 6.10 and 6.11. 
6.2.3 Extension to multiple dielectrics, solvent cavities, and 
ion-exclusion layers 
Continuum electrostatics models of biomolecular systems can be defined by multiple 
embedded regions of differing homogeneous dielectric constant and salt treatment. 
Integral-equation formulations that can solve these problems often possess a compli- 
cated block structure because there exist numerous operators that couple variables 
on one surface to conditions on other surfaces. To illustrate this block structure, we 
next present Green's theorem formulations for two-surface and three-surface example 
problems. We then describe how a tree-based representation of the enclosed regions 
facilitates the determination of the appropriate Green's-theorem-based integral oper- 
ator for arbitrary multi-region problems. 
Two-surface formulation 
Figure 6-2 is a schematic of a two-surface problem in molecular electrostatics; salt 
ions are not permitted to directly reach the molecular surface a, but instead are 
bounded by an accessible surface b a specified distance outside the molecule. The en- 
closed volume between the surfaces is termed the ion-exclusion layer. Region I, again 
representing the molecular interior, has dielectric constant €1 and n, point charges. 
The ion-exclusion layer, region 11, has dielectric constant €11, and in this region, the 
Laplace equation governs the electrostatic potential. Region I I I represents solvent 
with mobile ions and has dielectric constant €111 (usually the same as err) but con- 
tains a Debye-Hiickel salt treatment; the potential in this region is governed by the 
linearized Poisson-Boltzmann equation. This problem has continuity conditions at 
both a and b: 
The associated integral equations have four surface variables, which are the potential 
and normal derivative on both surfaces: 4 ,  , , 2. The free-space Green's 
functions in each region are again denoted by G with the region label as subscript: 
GII (r; r'), for instance, denotes the free-space Laplace Green's function. As in the 
one-surface derivation, we apply Green's theorem in each region using the appropri- 
ate substitutions, let the field points approach the bounding surfaces, and eliminate 
redundant variables using the continuity conditions. The resulting operator takes the 
form 
which can be solved with the boundary-element method described above. 
Note that the integral operator contains several zero blocks. These blocks arise 
from the application of Green's theorem in regions for which one or more surfaces 
do not form part of that region's bounding surface. For instance, surface b forms no 
portion of the bounding surface for region I, and consequently variables on surface b 
contribute nothing to the integral equation derived by applying Green's theorem in 
region I. Note also that two of the integral equations derive from the application of 
Figure 6-2: A two-surface problem in molecular electrostatics. The molecular interior 
(Region I) is surrounded by an ion-exclusion layer with solvent dielectric and no salt 
(Region 11), which in turn is surrounded by solvent with a salt treatment (Region 
I I I ) .  
Green's theorem in region II. 
Three surface formulation 
To identify more general trends in the construction of multi-boundary integral opera- 
tors, we extend the two surface formulation by adding a solvent-filled cavity inside the 
protein interior (Figure 6-3). In this problem and for the remainder of this section, 
we will follow the convention that region I is the outermost solvent region. The addi- 
tional region I V  has dielectric constant E I ~  (generally equal to EI and eII), and is not 
large enough to contain an ion-exclusion surface. Again, we apply Green's theorem 
in every region, take limits on the surface integrals as the field points approach the 
boundaries, and enforce continuity conditions. The resulting operator takes the form 
In this expression, the charges in region 111 contribute to two of the integral 
equations, both of which derive from the application of Green's theorem in the region. 
The point-charge contributions are found by taking limits as the field point in the 
region approaches the exterior and interior bounding surfaces. Note again that some 
of the off-diagonal 2 x 2 blocks contain nonzero 1 x 2 blocks. These operators represent 
the contribution of a region's interior (or exterior) bounding surface to the integral 
equation derived by letting the field point in the region approach an exterior (or 
interior) bounding surface. 
nee-  based general formulation 
To derive an integral operator for an arbitrary configuration of embedded boundaries 
with regions of differing homogeneous dielectric, point charges, and salt treatment, 
we represent the topology using a tree. Traversing the nodes of the tree, irrespective 
of the order in which they are visited, allows multiplication by the entire integral op- 
Figure 6-3: A three-surface problem in molecular electrostatics. This geometry is 
analogous to the two-surface problem (Figure 6-2) except that a solvent-filled cavity 
has been added within the molecular interior (Region IV).  Note that in contrast to 
previous examples, the regions and surfaces have been labeled in reverse order. 
erator taking into account all necessary interactions. Each node of the tree represents 
one region, and is associated with a dielectric constant and possibly salt treatment 
or point charges. The tree is constructed such that the node for a given region X 
is assigned to be the child of the node corresponding to the region surrounding X. 
Region I, which is bounded only by a hypothetical surface at infinity, is defined to 
be the root node. Furthermore, we associate with each node the exterior bounding 
surface of the corresponding region. Figure 6-4B is a tree diagram constructed to 
describe the system shown in Figure 6-4A. 
The example geometry used here may be representative of an encounter complex 
in protein-protein binding, where two nearly associated binding partners (Regions 
IIIa and IIIb) are surrounded by a single ion-exclusion layer (Region 11) . There are 
also several solvent-filled cavities present in both binding partners (Regions IVa-c), 
and one cavity is large enough to contain a small ion-exclusion layer (Region V). 
Applying the multi-surface integral operator 
A multi-region electrostatics problem with n surfaces generates a system of 2n coupled 
integral equations. For each surface, one writes Green's theorem for the regions 
exterior and interior to the surface and takes the appropriate limits as the evaluation 
Figure 6-4: Tree representation of a general surface problem. The example molecular 
geometry shown in (A) might correspond to an encounter complex between two asso- 
ciating proteins (Regions I I Ia and I I Ib) , surrounded by a single ion-exclusion layer 
(Region 11) , which in turn is surrounded by solvent with salt (Region I). The binding 
partners contain several solvent filled cavities (Regions IVa-,-), and one cavity is large 
enough to contain a small ion-exclusion layer (Region V). The tree representation for 
this example multi-surface geometry is shown in (B). 
points approach the surface. Accordingly, one may refer to the resulting integral 
equations as the exterior and interior equations corresponding to the surface. 
An integral equation derived from an application of Green's theorem contains 
contributions from the surfaces bounding the region. As an example, consider the 
interior equation for surface nIIIb. Applying Green's theorem in region IIIb defines 
the potential at a point in this region as a function of the surface potential and its 
normal derivative on flIIIb, QIvb, and RIv,. Taking the limit of the Green's theorem 
expression as the field point approaches nIIIb, we obtain the interior equation. Clearly, 
a surface's interior equation contains contributions from the surface as well as its 
children. Similarly, a surface's exterior equation contains contributions from the 
surface, its parent, and its siblings. This can be seen by letting the field point approach 
any of the cavity surfaces. 
Multi-surface problems demand that careful attention be paid to the definition of 
the surface normal. In this work we follow the mathematical convention that a normal 
always points outward from the finite volume enclosed by the surface. To apply the 
entire multi-surface operator for an arbitrary problem, we first define a tree such as 
shown in Figure 6-4B. The tree is traversed depth first, and at each node we apply 
several integral operators, which in the discretized problem correspond to dense block 
matrix-vector multiplications. Because each block multiplication may be interpreted 
as the computation of the potential at a surface due to a distribution of monopole or 
dipole charge on another surface, we refer to the two surfaces as the source surface 
and the destination surface. The set of block multiplications is determined by the 
topology of the surfaces, and is defined such that every non-zero block in the integral 
operator is applied exactly once. 
We define four types of block integral operators: the self-surface interior opera- 
tor, the self-surface exterior operat or, the non-self interior operators, and the non-self 
exterior operators. As previously discussed, each operator represents an interaction 
between two surfaces. The labels interior and exterior specify whether the inte- 
gral operator arises from an application of Green's theorem to the region interior or 
exterior to the source surface. The self and non-self operators are distinguished be- 
cause the discontinuity in the self operator double-layer calculation requires specific 
treatment. 
For every node, the following block matrix-vector multiplications are performed. 
Let the current node correspond to the region X. Denote its parent region by W, 
sibling regions by Si, and child regions by Y,. Lowercase letters correspond to the 
outer bounding surfaces for these regions. Every dense block is applied to the vector 
1. Apply the self-surface interior operator 
and add the result to the node's interior equation. 
2. Apply the self-surface exterior operator 
and add the result to the node's exterior equation. 
3. Apply the appropriate non-self exterior operator 
and add the result to the interior equation of the parent node. 
4. For each sibling node Si, apply the appropriate non-self exterior operator 
and add the result to the exterior equation of the sibling node. 
5. For each child node Y,, apply the appropriate non-self interior operator 
and add the result to the exterior equation of the child node. 
6.2.4 Matrix compression with the FFTSVD algorithm 
As discussed in the Introduction, boundary-element methods give rise to dense matrix 
equations whose solution by LU factorization or Gaussian elimination requires O(n3) 
time and O(n2) memory for a system with n unknowns. Combining Krylov-subspace 
iterative methods with fast-solver algorithms reduces these costs to nearly 0 (n )  . The 
Krylov method requires only a way to apply the matrix A to a vector; in contrast, 
LU factorization and Gauss elimination require explicit access to every entry of A. 
In this work, we use the FFTSVD algorithm [274] to rapidly apply the dense integral 
operators. 
FFTSVD, like multipole methods, exploits the smooth decay of the Green's func- 
tions as the distance between source and evaluation point increases. Both types of 
methods use a spatial decomposition of the set of boundary elements to separate 
near-field interactions, which are computed exactly, from far-field or long-range in- 
teractions, which can be accurately approximated. The long-range interactions are 
approximated by projecting the dominant panel source distributions, computed using 
an approximate singular value decomposition (SVD), onto a grid. Grid-grid inter- 
actions are computed via the fast Fourier transform (FFT), and the dominant re- 
sponses are interpolated back to the destination integral equation collocation points. 
An overview of the FFTSVD method is presented in Figure 6-5, and a fully detailed 
description of the algorithm can be found in reference [274]. 
For the general multi-boundary Green's theorem formulation, each node in the 
tree contains an FFTSVD-compressed operator that simultaneously stores both the 
single- and double-layer interactions between all panels that bound the region. 
6.2.5 Preconditioning 
It has been previously noted in the literature that the non-derivative Green's theorem 
formulation can lead to ill-conditioned systems of linear equations, especially with 
decreasing boundary-element size [259]. To address this issue, we have implemented 
preconditioning in order to efficiently solve these systems with iterative methods. By 
definition, a preconditioner is any matrix P such that the equation PAX = P b  has 
better convergence properties than the original system Ax = b when the systems are 
solved iteratively. In general, Krylov iterative methods are most efficient at solving 
Near-Field Interactions 
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Figure 6-5: An overview of the FFTSVD matrix compression algorithm. FFTSVD 
uses a multi-level octree spatial decomposition to separate panel-evaluation point 
interactions into near- and far-field components at multiple length scales. When 
two cubes at the finest length scale are nearby, interactions are computed through 
direct integration. However, when two interacting cubes are well separated, dominant 
sources are projected onto a cubic grid and translated to a grid surrounding the 
recipient cube. The FFT is used to accelerate this translation operation. Finally, the 
grid potentials can be interpolated back onto the dominant responses of the panel 
centroids. This Figure has been adapted from [274]. 
linear systems with clustered eigenvalues [283]. Because the identity matrix I (or 
multiples) has an optimal clustering, P is generally selected such that P = A-' but 
is inexpensive to form and apply. 
For the discretized integral operator matrices that arise from the Green's theorem 
formulation, the dominant entries tend to be the self-influence terms, for which the 
evaluation point is on the element over which the integral is performed. Consequently, 
a reasonable choice for P is the inverse of a sparse matrix that contains only these 
self-term entries. As an examination of Equations 6.18, 6.30, and 6.31 should make 
clear, the sparse matrix that includes just the self-influence terms is not diagonal, but 
no row has more than two non-zero off-diagonals. 
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6.2.6 Curved panel discretization 
In order to generate the basis functions used in the boundary-element method, we 
discretize the molecular and accessible surfaces that define the problem into curved 
elements that can exactly represent the underlying geometry [270]. Accessible surfaces 
[266], also called expanded van der Waals surfaces, are generally used to model the ion- 
exclusion layer and can be completely described by convex spherical patches bounded 
by circular arcs. These circular arcs are not necessarily geodesic arcs, and thus we use 
the concept of a generalized spherical triangle (GST) (Figure 6-6A) [270,284]. A GST 
is a three-sided curved element that lies on the surface of a sphere, where each edge 
is a portion of a circular arc. If the arc center for all three edges happens to be the 
center of the sphere, a traditional spherical triangle is recovered. A spherical patch 
can be discretized into a set of GSTs by starting with a flat element triangulation, 
and then assigning the appropriate circular arc to each element edge. Edges that 
lie along the interface between atoms are assigned non-geodesic arcs that follow the 
curve of intersection, while all other edges are assigned geodesic arcs. 
Molecular surfaces [229,267,268], used here to model dielectric interfaces, are 
the surfaces of closest approach for the surface of a probe sphere that is rolled over 
a molecule. They can be described by three types of surface patches [267]. Convex 
spherical patches are defined where the probe sphere is in contact with only one atom, 
and can be described by portions of a sphere bounded by circular arcs and discretized 
with GSTs. Concave spherical re-entrant patches are formed when the probe touches 
three or more atoms simultaneously, and are also described by GSTs. When the probe 
simultaneously touches two atoms, a portion of a torus is generated. Toroidal regions 
are discretized into four-sided curved torus panels (Figure 6-6B) that are isomorphic 
to a rectangle. A fully meshed curved panel discretization for the barnase-barstar 
complex molecular surface is shown in Figure 6-7. 
Techniques for integrating singular Green's functions over these curved GST and 
Figure 6-6: The two types of curved panels used to discretize accessible and molecular 
surfaces. A generalized spherical triangle (GST) (A), is a three-sided region on the 
surface of a sphere bounded by three circular arcs. These arcs are not necessarily 
geodesic arcs. Torus patches on molecular surfaces are discretized using toroidal 
panels (B), which are isomorphic to a rectangle. 
torus panels have been developed, and are discussed in detail in [270]. Briefly, when 
the evaluation point in the integrand is far away from the panel, low-order quadrature 
rules are used to perform numerical integration. These quadrature rules are generated 
by creating a smooth mapping between a reference flat triangle or rectangle (for GSTs 
and torus panels respectively) that relates a known quadrature rule on these simple 
domains [285] to those applicable on the curved panels. When the evaluation point is 
near or on the curved panel, even high-order quadrature rules do not suffice to capture 
the singularity. As a result, we adopt specialized methods for each panel type and 
Green's function. For the single-layer Laplace (Poisson) kernel, we integrate over 
GSTs using a technique that reproduces the effect of panel curvature using a higher- 
order distribution on a reference flat triangle [286]. Single-layer Laplace integrals over 
torus panels are evaluated using a panel-splitting approach, which avoids integration 
near the singularity using recursive subdivision. When integrating the double-layer 
Laplace kernel in the near-field over both GST and torus panels, we exploit the fact 
Figure 6-7: A rendering of a curved panel discretization for the molecular surface of 
the barnase-barstar protein complex. Red regions indicate convex spherical patches, 
green regions are re-entrant spherical patches, and blue regions are toroidal patches. 
Black lines indicate the boundaries between panels. The graphic depicts an approxi- 
mation to the discretized geometry used for calculation. Every GST and torus panel 
has been approximated by a very large number of flat triangles for the purpose of 
visualization only, and the true surface normal in conjunction with Phong shading 
have been used to render the image. 
that the double-layer potential is equal to the solid angle subtended by the curved 
panel when observed from the evaluation point [281,287]. In order to integrate the 
linearized Poisson-Boltzmann kernel or its normal derivative in the near field, we 
adopt a previously presented desingularization technique [259]. This method divides 
the integral into a singular Laplace component that can be integrated as described 
above, and a smooth component that can be integrated using quadrature. 
6.3 Computational details 
6.3.1 Peptide and protein structure preparation 
The structure of a peptide derived from an HIV-1 protease cleavage site was obtained 
from the Protein Data Bank (PDB) with accession code 1F7A 1431. This structure 
contains nine visible residues of a decameric peptide bound to an inactivated mutant 
of HIV-1 protease; only the peptide was considered in further calculations. An N- 
terminal acetyl blocking group and a C-terminal methylamide blocking group were 
added to the peptide. The wild-type structure for the barnase-barstar protein com- 
plex was also obtained from the PDB using accession code 1BRS [278]. To prepare 
this structure for calculation, we followed a previous protocol 1311 where all but a set 
of 12 interfacial water molecules were removed. For both the peptide and barnase- 
barstar structures, hydrogen atoms were added using the HBUILD module [116] in 
the CHARMM computer program [117] using the PAR AM^^ parameter set [I751 and 
a distance-dependent dielectric constant of 4. In addition, side-chain atoms that 
were missing from the crystal structures were rebuilt using CHARMM and the default 
PAR AM^^ geometry. All ionizable residues were left in their standard states at pH 7. 
6.3.2 Modeling of barnase-barstar mutations 
Three point mutations (E73Q in barnase, D39A in barstar, and T42A in barstar) 
were built into the barnase-barstar complex for subsequent analysis. The alanine 
mutations were created by cutting back the wild-type residue to the P-carbon. The 
E73Q mutation was built by sampling glutamine side-chain dihedral angles in 30- 
degree increments using CHARMM [I171 and the PAR AM^^ parameter set [175]. For 
each sampled conformation, the side chain was energy minimized until convergence 
keeping all other atoms in the structure fixed. The lowest energy minimized geometry 
was taken to represent the E73Q mutation. 
6.3.3 BEM and FFTSVD parameters 
Parameters used in the FFTSVD algorithm included a drop tolerance of for SVD 
compression, spatial decomposition until each cube contained no more than 32 panels, 
and a grid size of 4 x 4 x 4 in each finest-level cube to represent dominant sources 
and responses during FFT translation. The boundary-element matrix equations were 
solved using the Krylov subspace method GMRES [228] to a relative residual of lo-'. 
All curved BEM calculations were performed on a 2-way dual-core 2.0 GHz Opteron 
machine running a parallel version of the FFTSVD library. All presented timings are 
the sum of CPU usage across all four processors. 
6.3.4 Finite-difference solver and parameters 
In order to compare our curved-panel boundary-element solver to finite-difference 
methods (FDM), we have implemented a FDM solver using previously described 
techniques [28] and an analytical surface representation. This implementation uses 
successive over-relaxation (SOR) with an optimized acceleration factor to solve the 
finite-difference equations to a relative residual of lo-'. In order to handle truncation 
of the boundary condition at infinity, a focusing scheme [26] was employed in all FDM 
calculations where the molecule of interest occupied first 23% and then 92% of the 
finite-diff erence grid. For the low- percent fill run, a Debye-Huckel screened potential 
in solvent dielectric was used to assign potentials to the boundary of the cubic grid. 
For the high-percent fill run, boundary potentials were taken by interpolation from 
the low-percent fill solution. Although it is common to average results from multiple 
translations of the molecule relative to the grid in order to reduce error due to the 
grid representation [26], only one placement was used here to make a fair comparison 
to the curved BEM, which is insensitive to translations or rotations of the geometry. 
Cubic grids used to discretize molecular geometries in the FDM spanned 129 to 481 
grid points per side in increments of 32, which are all solvable within 4 GB of computer 
memory. These sizes correspond to grid resolutions of approximately 2.3 to 8.6 grid 
points per Angstrom for the barnase-barstar complex. All FDM calculations were 
performed in serial on a 2-way dual-core 2.0 GHz Opteron machine. 
6.3.5 Electrostatic solvation and binding calculations 
All continuum electrostatics calculations were performed using a molecular dielectric 
constant of 4, a solvent dielectric constant of 80, a molecular surface with probe 
radius 1.4 A for dielectric interfaces, an accessible surface with probe radius 2.0 A 
for ion-exclusion layers, and an ionic strength of 145 mM. In order to compute the 
solvation free energy of a molecule, we take the difference between the energy of the 
solvated state and a reference state where the solvent dielectric constant is equal to 
the molecular dielectric constant and no salt is present. The BEM calculates this 
energy difference directly, and an explicit reference state is not needed. In the FDM 
implement at ion, the energy of the reference st ate is explicitly computed to cancel grid 
energy. 
For rigid-binding calculations, the electrostatic component of the free energy of 
binding was computed as the sum of Coulombic interactions in the bound state and 
the differential solvation energy between the bound complex and infinitely separated 
individual binding partners. For the FDM, proper grid placement was used to acceler- 
ate the calculation by canceling the grid energy in the complex with grid energies for 
the individual binding partners. Because the BEM only computes the reaction poten- 
tial rather than the total electrostatic potential, the Coulombic interactions between 
the binding parters must be explicitly added. 
Non-rigid electrostatic binding energies were computed by first energy minimizing 
the geometry of the complex and each of the isolated binding partners separately. 
The minimization was performed using CHARMM and the PAR AM^^ parameter set, 
relaxing all atoms with 1,000 steps of adapted basis Newton-Raphson (ABNR) mini- 
mization using a distance-dependent dielectric constant of 4. The binding energy was 
then computed using a thermodynamic cycle where the two isolated binding partners 
were first desolvated to a vacuum with the molecular dielectric constant. In vacuum, 
the partners were deformed to their bound-state structures and then rigidly bound, 
computing all electrostatic changes with Coulomb's law in molecular dielectric. Fi- 
nally, the complex was re-solvated. The sum of the energetic changes in these three 
steps was taken as the non-rigid electrostatic binding free energy. Due to the change 
in geometry between the bound and unbound states in non-rigid binding, the FDM 
grid energy cancellation technique could not be used, and explicit reference states 
were employed for all FDM solvation calculations. 
6.3.6 Generating curved panel discretizat ions 
Molecular and accessible surfaces were discretized into curved panels starting with 
high-quality flat triangular meshes for spherical regions from the program NET- 
GEN [288]. These panels were then converted, along with torus patches, to curved 
panels using previously described methods [270]. Curved-panel discretizations for 
185 
molecular geometries were generated such that memory requirements did not exceed 
4 GB. For the sphere test case, discretizations were obtained between roughly 80 and 
58,000 curved panels including ion-exclusion and dielectric interface surfaces. For 
the peptide example, panel counts spanned approximately 5,200 to 128,000, and for 
the various barnase-barstar complexes, the span was roughly 92,000 to 310,000 total 
curved panels. 
6.4 Results and Discussion 
For all calculations, we compared our boundary element results to those generated 
using finite-difference methods. Although geometric measures can be defined for such 
comparisons (255,2581, we chose to use compute time as our metric, to determine 
which method can achieve superior convergence properties given a certain amount of 
time. We could not guarantee that the geometry of the problem being solved was 
exactly the same in both methods because different algorithms were used to generate 
molecular boundaries. Therefore, for systems without closed-form solutions, the level 
of convergence for a particular method was assessed solely on how little the solution 
changed as the compute time increased. 
6.4.1 Electrostatic solvat ion free energies 
One of the simplest linearized Poisson-Bolt zmann calculations is the computation 
of the electrostatic component of the free energy associated with the transfer of a 
molecule from low- to high-dielectric medium, where the high-dielectric region con- 
t ains an ion-exclusion layer with salt outside. This quantity, known as the electrostatic 
solvation free energy, is useful in many calculations and forms the basis for computing 
more complex quantities such as electrostatic binding energies. We first validated the 
multi-surface formulation by computing the solvation free energy for a simple spheri- 
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Figure 6-8: Convergence plot for the solvation free energy for a sphere with an ec- 
centric charge and ion-exclusion layer. The relative error from the analytical solution 
is plotted as a function of compute time. Results are compared between the curved 
BEM and FDM implementations. The curved BEM accuracy is limited to 5-45 digits 
given the settings used in the FFTSVD matrix compression. 
cal test case, which has a closed-form solution. Then, we gauged the accuracy of the 
solver by examining more complicated geometries including a peptide derived from 
an HIV-1 substrate site and the barnasebarstar protein-protein complex. 
Sphere with ion-exclusion layer 
In order to test the correctness of the multiple surface formulation, the electrostatic 
solvation free energy for a sphere of radius 1.0 A with a charge of +le placed 0.5 
away from the center was computed. An ion-exclusion layer was added 2.0 A outside 
the sphere surface, creating a two boundary problem. BEM and FDM solutions were 
compared to the analytical solvation energy for this geometry [24] to generate the 
convergence plot shown in Figure 6-8. 
From the sphere convergence results, it is clear that the curved BEM method is 
able to achieve superior accuracy given the same amount of compute time as the finite 
difference method. For this problem, the FDM is limited to 2-3 digits of accuracy, 
even when using resolutions greater than 50 grid points per Angstrom. The limited 
ability of finite-difference methods to achieve high accuracy has been noted previously 
in the literature [289], although we obtain better than 1% accuracy on this sphere 
example. The accuracy of the curved BEM is limited to 5-6 digits given the settings 
selected in the FFTSVD matrix compression procedure. Additional accuracy can be 
achieved by increasing the size of the grids used to represent long-range interactions, 
at the expense of additional computational cost. 
HIV-1 protease substrate peptide 
To evaluate the method on a more complex example, the electrostatic solvation free 
energy for a peptide derived from an HIV-1 substrate site was computed using BEM 
and FDM including salt and an ion-exclusion layer. The computed solvation energy 
was plotted as a function of compute time (Figure 6-9A). It is clear from examining 
Figure 6-9A that the solutions provided by the curved BEM implementation seem 
more converged than those obtained from the FDM. Although it is unclear whether 
the two methods &ll converge to the same answer for this complex geometry, the 
solution at the finest discretization levels for the curved BEM are changing by as 
little as kcal/mol, while those from FDM are still changing on the order of 
tenths of kcal/mol. 
Barnase-barstar complex 
In order to be competitive with finite-difference methods, the curved boundary- 
element method presented here must be able to achieve high accuracy per unit com- 
pute time on large macromolecules, where the number of curved panels required to 
discretize the geometry can be large. To test the solver on a moderately sized pro- 
tein system, we computed the solvation free energy of the barnase-barstar protein 
complex [278,290,291], a model binding system for which electrostatic interactions 
have been shown to be important [31,291-2941. In addition to an ion-exclusion layer, 
the problem geometry included four solvent-filled cavities inside the main dielectric 
Figure 6-9: Computed solvation free energies, using curved BEM and FDM, for an 
HIV-1 substrate peptide (A) and the barnase-barstar complex (B). The absolute 
electrostatic solvation free energy is plotted as a function of compute time, and the 
selected discretizations used up to 4 GB of computer memory. 
boundary. A comparison between the BEM and FDM for computing the absolute 
solvation energy of this complex is shown in Figure 6-9B. Even the finest BEM and 
FDM discretizations that can be solved on a computer with 4 GB of memory give 
answers that differ by 8-9 kcal/mol. Furthermore, it is difficult to establish whether 
the two methods will converge to the same answer. However, the curved BEM profile 
does appear to be relatively flat, even though the solution changed by approximately 
0.2 kcal/mol between the two highest-resolut ion calculations. 
As can be seen in Figure 6-9B, even the lowest BEM discretization obtained for the 
barnase-barst ar complex requires more compute time than the highest discretization 
used for the FDM. The timings for the FDM remain relatively constant across the 
presented problems because they depend primarily on the grid size. In contrast, the 
BEM requires more curved panels to discretize a larger molecular surface, resulting 
in significantly increased simulation cost. 
The accuracy of the BEM scales with the panel density; accordingly, the larger 
barnase-barstar complex cannot be discretized at the same level as was feasible for 
the peptide example. The BEM-calculation solvation energies in Figures 6-9A and 
6-9B exhibit similar curvature, and the "knees" of the two curves are separated by 
approximately a factor of ten in compute time. This difference is as expected con- 
sidering the ratio of the surface areas for the peptide and barnase-barstar complex 
(952 A2 and 8019 A2 respectively). The level of FDM convergence might also be 
expected to suffer for larger problems due to decreasing grid resolution given the 
same number of grid points. Surprisingly, the FDM appeared to lose less relative 
accuracy with increasing problem size as compared to the BEM. For the peptide and 
barnasebarstar solvation energies, the highest resolution FDM calculations were still 
changing by approximately 0.05 and 0.5 kcal/mol respectively. In the curved BEM 
results, they were changing by 0.001 and 0.2 kcal/mol, indicating a larger fold loss in 
convergence. 
6.4.2 Importance of preconditioning 
To demonstrate how effectively the block-diagonal preconditioner accelerates conver- 
gence of the iterative solution of the BEM equations, we repeated the solvation energy 
calculation for one discretization of the peptide example using several precondition- 
ers. Specifically, we performed the calculation without preconditioning, with a purely 
diagonal preconditioner , and with the presented block-diagonal preconditioner . As 
shown in Figure 6-10, the number of GMRES iterations required to achieve a relative 
residual of without preconditioning was 422. The purely diagonal preconditioner 
required 198 iterations, and the full block-diagonal preconditioner reduced this even 
further to 40 iterations. The block-diagonal preconditioner generally allows even 
complex geometries such as proteins to be solved to a relative residual of in 
approximately 100 GMRES iterations or less. 
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Figure 6-10: Comparison of preconditioning strategies when solving for the electro- 
static solvation free energy of an HIV-1 protease substrate peptide discretized with 
18,657 and 7,089 panels on the dielectric and ion-exclusion surfaces respectively. The 
block-diagonal preconditioner significantly reduces the number of GMRES iterations 
required to solve the linear system of BEM equations to a relative residual of 
6.4.3 Rigid electrostatic binding free energies 
Another useful quantity often calculated using the LPBE model is the rigid electro- 
static binding free energy between a pair of interacting molecules. One component 
of this quantity is the difference in solvation energy between the bound state and 
two unbound states where the binding partners are rigidly separated to infinity. This 
differential electrostatic solvat ion is added to the direct Coulombic interact ions made 
between the partners in the bound state. To measure the role that LPBE solver accu- 
racy plays in this class of calculations, as well as compare the curved BEM to FDM, 
we computed the rigid electrostatic binding free energies for the wild- type barnase- 
barstar complex and three experimentally characterized single mutants (E73Q in 
barnase, T42A and D39A in barstar) [291,295,296] that have been previously shown 
to have a significant effect on electrostatic binding calculations [292,297-2991. These 
mutations were built into the wild-type barnase-barst ar complex with minimal per- 
turbation, where all atoms remained in the same position except at the site of muta- 
tion. 
The results of these rigid electrostatic binding calculations are shown in Figure 6- 
11. For the wild-type barnase-barstar structure as well as the mutant complexes, the 
BEM calculations showed smaller changes in the computed energies with increasing 
problem discretization. 
6.4.4 Differential rigid electrostatic binding free energies be- 
tween mutants and wild type 
Often, when comparing a set of protein mutations to identify those with improved elec- 
trostatic properties, one is more interested in the relative electrostatic rigid binding 
free energies as compared to wild type than the absolute binding energies themselves. 
To gauge the effect of solver accuracy on relative binding free energies, we calculated 
the difference in rigid electrostatic binding free energy between each mutant and the 
wild type at every level of problem discretization (Figure 6-12). 
For all mutants studied, both methods appear to be converged to tenths of 
kcal/mol or better, and give very similar relative binding energies. Low discretiza- 
tions of the FDM provide solutions very close to the final answer in a very short 
amount of time. This may be due to error cancellation because the mutant struc- 
tures differ little from the wild type. For problems in which electrostatic energies are 
being compared between structures for which most atoms are located at identical po- 
sitions, finit e-difference met hods may be a better choice than t he boundary-element 
met hod presented here. Minimal-perturbation relative- binding calculations are often 
used when making predictions to improve protein binding or stability, especially in 
the field of protein design 167-691. 
6.4.5 Non-rigid electrostatic binding free energies 
The rigid binding model, although a useful approximation, is deficient in that it does 
not allow structural relaxation in the bound and unbound states. Consequently, a 
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Figure 6-12: Comparison between curved BEM and FDM for computing relative 
rigid electrostatic binding energies between mutant and wild-type barnase-barstar 
complexes. Results are shown for the mutations E73Q in barstar (A), D39A in barnase 
(B), and T42A in barnase (C). The relative binding energy is plotted as a function 
of the compute time for the mutant complex rigid binding energy. 
variety of methods have been presented in the literature for treating non-rigid effects 
in protein-protein binding using continuum electrostatics [300,301]. One feature 
most techniques share is that there is no longer a direct correspondence between the 
majority of atomic coordinates in the bound and unbound states. As a result, we 
hypothesized that the FDM would no longer be able to take advantage of cancellation 
of error when computing non-rigid binding effects, and that the accuracy of the over- 
all calculation would depend strongly on the ability to independently converge the 
solvation energy for each state. To test this idea, we implemented a crude non-rigid 
binding scheme involving independent minimization of the complex and unbound 
binding partners and a thermodynamic cycle to compute electrostatic energies. The 
non-rigid electrostatic binding energies for mutants were subtracted from those for the 
wild-type barnasebarstar complex to generate non-rigid relative binding energies. 
As shown in Figure 6-13, the curved BEM method regains an accuracy advantage 
in non-rigid binding calculations. The curves in this plot resemble those from absolute 
binding energy calculations (Figure 6-1 1). The finite-difference solution does not 
appear to be well converged at low resolution, and seems to gradually approach the 
boundar y-element solution. 
Because grid cancellation could not be exploited in non-rigid binding to avoid 
reference state calculations in the FDM, we computed the solvation of each state 
independently allowing the protein complex or binding partners to fill the entire 
finite-difference grid. Therefore, when subtracting the solvation energies of binding 
partners from the bound complex, we were subtracting calculations solved at very 
different grid resolutions. To determine if this was responsible for the inability of 
FDM to converge relative non-rigid electrostatic binding energies, we repeated the 
calculation using fixed grid placement to ensure that the solvation energy of each state 
was computed at roughly the same number of grid points per Angstrom. However, 
this modification did not improve the ability of FDM to converge relative non-rigid 
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Figure 813: Comparison between curved BEM and FDM for computing relative non- 
rigid electrostatic binding energies between mutant and wild-type barnase-barstar 
complexes. Results are shown for the mutations E73Q on barstar (A), D39A on 
barnase (B), and T42A on barnase (C) The relative binding energy is plotted as a 
function of the compute time for the mutant complex non-rigid binding energy. 
binding energies (data not shown). 
Multiple electrostatic solves for the same problem ge- 
ometry 
As shown in the previous Results sections, the curved BEM, although offering better 
convergence properties, is quite time consuming on large geometries such as proteins. 
The dominant computational cost in our implement at ion is compressing the integral 
operators using the FFTSVD algorithm, which primarily involves computing costly 
integrals over nearby curved panels. In contrast, the FDM requires very little time to 
initialize the system of linear equations and spends almost all compute time solving 
them. However, there exist several types of useful electrostatic calculations that 
involve multiple simulations of the same problem geometry; for these problems, the 
expensive BEM "setup" time can be amortized over all calculations. 
One such example is charge optimization [23,24,31], which determines the optimal 
partial atomic charges for a ligand that minimize the electrostatic component of its 
binding free energy with a receptor molecule. In charge optimization, two geometries 
for the ligand are considered: the bound state, where it is complexed with the receptor 
molecule, and the unbound state, where it is isolated in solution. Each ligand charge is 
set to +le  independently, leaving all others at zero, and one determines the difference 
in solvation potential at the ligand charge locations between the bound and unbound 
states by solving the LPBE twice. This produces the ligand desolvation matrix, an 
important component of the charge optimization equation [23,24]. Overall, 2n solves 
of the LPBE are required, where n is the number of atoms in the ligand. When using 
the BEM, each state's integral operator only needs to be compressed once, and the 
compressed operator can be used to solve the n right-hand sides that only depend on 
the atomic charges. 
To compare the performance of the curved BEM and FDM on a charge optimiza- 
tion problem, we computed the ligand desolvation matrix for barst ar in the wild-type 
barnase-barstar complex. In total, 1403 simulations were performed in each of the 
bound and unbound states. In Table 6.1 we report the time required to compute the 
ligand desolvation matrix for three discretization levels of the finite-difference and 
curved boundary-element methods. The panel densities and grid spacings mentioned 
in Table 6.1 may be compared to the labeled points on the absolute binding free 
energy plot shown in Figure 6-llA. 
For the finer discretization BEM calculations, the compute time is comparable to 
Table 6.1: Compute time required to calculate the entries of the ligand desolvation 
matrix for barnase in the wild-type barnase-barstar complex. For both the curved 
BEM and FDM, the calculation was repeated at three discretization levels. For the 
I Panels Per Angstrom2 I Time (s) 
curved BEM, the panel density reported is for all surfaces in the bound state geometry. 
Method 
FDM 
that required for the finer FDM discretizations. Relating these discretization levels to 
the convergence plot suggests that for these multiple-solve problems, the BEM may 
offer superior accuracy for similar computational cost. 
Curved BEM 
6.5 Conclusions 
Grid Points Per Angstrom 
2.3 
4.6 
In conclusion, we have presented an implementation of the boundary-element method 
Time (s) 
41,868 
637,930 
- 
9.4 
12.6 
for linearized Poisson-Boltzmann continuum electrostatics that is capable of achieving 
755,343 
1,347,300 
high accuracy and solving the same topologies of dielectric boundaries, point charges, 
and salt regions that volume-based methods are capable of solving. Several techniques 
were employed to overcome several of the well-known practical limitations of the 
BEM. These included a general Green's-theorem integral formulation for multiple 
embedded regions, curved panel discretization with robust integration methods, and 
preconditioned Krylov subspace methods combined with matrix compression using 
the FFTSVD algorithm. 
Comparing the performance of the curved BEM against a reference finite-difference 
solver identified types of calculations for which improved accuracy may be important. 
For example, when computing absolute electrostatic solvat ion free energies or the 
electrostatic component of rigid binding energies, the curved BEM method offers su- 
perior convergence properties. Even at the highest discretizations possible within 4 
GB of computer memory, finite-difference methods did not appear to be converged, as 
the solutions continued to change significantly with increased expenditure of comput- 
ing resources. However, when comparing differential rigid binding energies between 
mutant and wild-type protein complexes, even coarse finite-difference simulations 
sufficed to capture relative effects. This is not surprising considering that the local 
structural perturbations allow for cancellation of error. Relative rigid binding cal- 
culations with local geometry perturbations are prevalent in ranking the results of 
molecular design efforts [173], and finite-difference methods are an attractive tool 
for this class of computation. However, when non-rigid effects were introduced into 
the binding model, and the bound and unbound states were allowed to relax inde- 
pendently, finite-difference methods lost their convergence advantage. Therefore, as 
more sophisticated non-rigid models of binding are employed in ranking results of 
molecular design calculations, higher accuracy LPBE solvers such as the presented 
curved BEM may become necessary to make reliable predictions. 
In the current implement at ion, the computational resources required to obtain 
solutions converged to tenths of kcal/mol on protein geometries are somewhat higher 
than what would be commonly available on a desktop workstation at this time. In 
order to compute a well converged protein solvation or binding energy in a few hours, 
a workstation with four processors and 4 GB of memory are currently required. Be- 
cause the problem geometry is already represented essentially exactly, it is likely that 
the primary source of error in the method arises from the use of piecewise-constant 
representations of the surface variables. Higher-order basis functions may allow a 
significant reduction in the number of unknowns, and thus the required memory. 
However, two complications that may limit higher-order methods are that the nu- 
merical integrations are more time consuming, and that the compressibility of the 
discretized operator may decrease. It is not yet clear where the optimal tradeoff lies 
between basis function complexity and these complications, and improvements in this 
area should be capable of reducing the time and memory usage of the curved BEM 
implement at ion to more accessible levels. 
Chapter 7 
General Conclusions 
In conclusion, several computational techniques were developed and/or applied to 
solve problems in molecular design and the evaluation of energetic properties in molec- 
ular systems. A small-molecule design strategy, based on inverse methods and com- 
binat orial search, was successfully developed and validat ed on several test systems. 
This work utilized an inverse phrasing of the small-molecule design problem to reduce 
the search space of potential ligands down to solving the functional group position- 
ing problem on a set of discrete molecular scaffolds placed throughout the binding 
site. Grid-based energy functions and a pairwise solvation approximation played an 
important role in rapidly and accurately approximate binding energies. To account 
for the inaccuracies involved in the combinatorial search scoring function, more so- 
phisticated binding energy models that were non-pairwise and slow to compute were 
applied in a hierarchical fashion to identify top-ranking compounds in a full binding 
energy model. 
Validation of the method in engineered binding sites within the core of T4 
lysozyme identified strengths and limitations of the presented inverse design strategy. 
Given the scoring and parameter sets currently used, the inverse strategy appears to 
do a better job optimizing the shape components of the binding free energy rather 
than the electrostatic components. As was observed in the T4 lysozyme system, polar 
groups were often buried for their favorable packing interactions and did not make 
hydrogen bonding interactions with the site. From the work presented here and other 
computational experiments, it is possible that the van der Waals component of the 
current energy function may not be suitably parameterized for the burial of polar 
groups in hydrophobic pockets, or the electrostatic desolvation penalties of the polar 
groups may be underestimated. In order to avoid this problem in the design of HIV-1 
protease inhibitors, a hydrogen bond filter was added to the design protocol to com- 
pletely eliminate functional groups that bury unsatisfied polar groups. However, this 
solution to the problem is based on phenomenology and not physics, and is not likely 
to be a robust solution to the problem. Improving the binding energy function in a 
physics-based approach would be a fruitful avenue of future research, as the inverse 
design method is capable of using any scoring function that is pairwise additive. 
The inverse design strategy was able to partially overcome this energy function 
issue because the complete nature of the combinatorial search approach allowed the 
shape and electrostatic contributions to the binding energy to be decoupled for a large 
portion of ligand space. Compounds that scored the most favorably in electrostatics 
were more similar to compounds known to bind in both the T4 lysozyme and E. colz 
chorismate mutase systems. The idea of selecting compounds from the search space 
that ranked the best in electrostatics and moderately well in packing was a recurring 
theme throughout all of the inverse design work. Validation in the HIV-1 protease 
system demonstrated another advantage of the inverse approach, which is that it 
allowed a fair comparison to be made between the fitness of two combinatorial libraries 
for targeting the protease active site because of a consistent sampling procedure and 
complete search. 
Although the theoretical validation presented in Chapter 2 was encouraging, it was 
insufficient to prove that the inverse design method could propose novel compounds 
that would bind tightly experimentally. Therefore, the inverse design method was 
applied in a biologically relevant problem for which collaborators were willing to 
chemically synthesize and experiment ally test comput at ionally designed molecules. 
The goal of the collaboration was to test the substrate envelope hypothesis strategy 
as an inhibitor design principle to avoid drug resistance using HIV-1 protease as a 
model system. Using the known structures of HIV-1 protease-substrate complexes, it 
was postulated that inhibitors that remained inside the consensus substrate volume 
would be less likely to induce drug resistance because mutations that prevent inhibitor 
binding would also affect substrate processing. The inverse small-molecule design 
technique was applied using the substrate envelope instead of an optimal ligand shape, 
a molecular scaffold similar to those present in several protease inhibitors, and a naive 
functional group library to diversify the scaffold at three positions. 
Twenty designed compounds were proposed for synthesis, and fifteen of these were 
actually synthesized and experiment ally tested for binding in the wild-type HIV- 1 
protease. All fifteen had observable binding to the protease, with the top four com- 
pounds exhibiting inhibition constants (Ki) between 30-50 nM. Clinically approved 
inhibitors range in binding from 0.002-0.1 nM. It is difficult to determine whether this 
represents a significant accomplishment for computational techniques. The designed 
inhibitors relied on a well-known molecular scaffold, and several groups predicted to 
be very favorable for binding, such as the isoxazole ring, ended up being poor for 
binding experimentally. However, considering other factors, such as the functional 
group library used in this first round of design possibly missing important classes 
of functional groups, and the fact that the crystal structures of designed compounds 
agree well with prediction, it is the belief of the author that the inverse design method 
is capable of enriching compound libraries for tight binding in practice. 
When the four top binding designed compounds were tested for inhibition against 
three drug resistant mutant proteases, the compounds exhibited relatively flat resis- 
tance profiles, losing no more than 6-13 fold activity compared to wild type. These 
numbers are similar to the clinical inhibitor amprenavir (11 fold), and much less than 
the clinical inhibitor lopinavir (1,220 fold). Although the designed compounds do 
well in these three particular mutants, it could be argued that the reason why they 
have broad specificity is that they share a similar scaffold to amprenavir. For future 
work, it would be very important to test the designed compounds in an amprenavir- 
specific resistance mutant, containing the I50V mutation, which has been reported 
to selectively reduce amprenavir binding by more than 100 fold [302]. If the designed 
compounds still perform well in this mutant, it would suggest that the functional 
groups chosen by the substrate envelope calculation, and not the scaffold chosen from 
the literature, were responsible for broad specificity. 
Although it has not been formally demonstrated, there is a notion in the HIV 
research community that protease inhibitors with lower affinity to the wild type, such 
as those designed here, may inherently have broader specificity. In order to avoid 
this issue, it will be necessary to design tighter binding inhibitors that stay within 
the substrate envelope. Tighter binding compounds would also be extremely useful 
for cell-based assays and in vitro passaging experiments to see if it is possible to 
evolve resistance against envelope inhibitors. One possible way to achieve this goal 
through computational design would be to apply the inverse method using a substrate 
envelope placed inside a receptor structure derived from a complex with an inhibitor 
that uses the same scaffold as the one used for design. This was shown in Chapter 3 
to improve the ability of computational methods to correctly rank compound affinity. 
In addition, it would be useful to enrich the functional group library with compounds 
known to work well in the HIV-1 protease subsites. These avenues are currently being 
explored, and preliminary results are encouraging. 
In Chapter 4, charge optimization techniques and inverse protein design methods 
were applied to improve the affinity of a substrate peptide for an inactivated (D25N) 
mutant of HIV-1 protease. The motivation behind this project was to obtain cleaner 
thermodynamic data that could be used to gain insight into the way that the sub- 
strates interact with the protease, which could in turn be used for inhibitor design. 
Of three peptides synthesized and experiment ally tested for binding with calorimetry, 
the two that were expected to bind tighter did by 10-12 fold and 2-3 fold respec- 
t ively. The single t hreonine-t o-valine mutation that led to the dramatic improvement 
in binding free energy avoided burying an unsatisfied polar group. Although peptide 
binding was measured to be entropically driven, it is unclear whether these results can 
be extended to the active protease, where the aspartyl dyad is present. In addition, 
we hoped that the crystal structure of the 10-12-fold tighter binding peptide would 
reveal fundamental differences in the way that tighter binding peptides interact with 
the protease that could be exploited for inhibitor design. Unfortunately, the crys- 
tal structure of the tight binding peptide did not appear to be statistically different 
from that of the wild type RT-RH substrate. Further work on this project might 
include measuring catalytic rates for the designed peptides to determine if they are 
substrates, or the synthesis and testing of additional peptides suggested by protein 
design to identify even tighter binders. 
The curved-panel boundary-element method solver presented in Chapters 5 and 6 
describes an effort to improve accuracy when solving multi-region molecular contin- 
uum electrostatics problems with the linearized Poisson-Boltzmann equation (LPBE). 
Many practical challenges needed to be overcome to develop such a method, includ- 
ing the development of a matrix compression algorithm called FFTSVD, presented 
in Chapter 5. FFTSVD can sparsify the dense interaction matrices that arise in 
boundary-element formulations when solving partial differential equations such as 
the LPBE. The method combined the most sophisticated features from existing tech- 
niques into an algorithm that performed better, used less memory, and was capable 
of improving accuracy with less computational expense as compared to existing com- 
pression met hods. 
Using FFTSVD and other techniques, it was possible to develop an accurate 
curved boundary-element solver for the LPBE that was capable of solving multi-layer 
biomolecular continuum electrostatics problems to high accuracy. The method com- 
pared favorably to existing finite-difference approaches in terms of accuracy, demon- 
strating that for many classes of electrostatic problems, errors in solution accuracy 
may dominate the predictions made from the model. However, one limitation of the 
current implementation was that its computational cost was somewhat high. Future 
work on this project should be dedicated to improving the accuracy per unit time 
of the solver. Several possible ways to achieve this goal include using higher-order 
basis functions on the curved elements, using alternative integral formulations that 
are better conditioned, improving the speed of computing near-singular or singular 
integrals over curved panels, or developing more uniform meshing schemes that avoid 
high panel densities in local regions. 
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